Oral cancer via the bargain bin : the role of smokeless tobacco in the etiology of oral cancer by Zohaib, Khan
  
ORAL CANCER VIA THE BARGAIN BIN: THE ROLE 
OF SMOKELESS TOBACCO IN THE ETIOLOGY OF 
ORAL CANCER 
 
 
A dissertation submitted to the University of Bremen in partial 
fulfillment of the requirements for the degree of 
Doctor of Public Health (Dr. P.H.) 
 
by 
 
 Zohaib Khan  
Bremen, November 2016. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Defended on March 14, 2017. 
Reviewers  
1. Prof. Dr. Hajo Zeeb 
2. Prof. Dr. Wolfgang Ahrens
  
 Dedication 
I 
DEDICATION 
 
On the morning of December ??, ????, I was sitting on a chair across an oral cancer patient 
in a hospital in Peshawar, noting down her verbal responses on a data collection tool for the 
case-control study described in this dissertation. On that same morning, ??? children and 
staff members of the Army Public School, Peshawar, went to school, but unlike me, they 
never returned to their homes in the afternoon. Those ??? human beings had been brutally 
killed in the name of “religion” by people who follow the religion of “TERRORISM”. Pakistan 
had probably witnessed its darkest day. A day that made parents think twice about sending 
their children to schools anymore, and a day, which seemingly suggested that bullets were 
mightier than the pen. 
As the reality of the barbaric events of December ??, ????, began to sink in, the Pakistani 
nation realized that it cannot afford to see another “December ??”, and that it cannot let the 
terrorists win. This realization culminated in a single-minded commitment, among both the 
people and the Government of Pakistan, to eradicate terrorism from the country. Almost 
two years and three successful anti-terrorism military operations later, Pakistan is a much 
safer haven for its people, parents are not afraid to send their children to schools and 
perhaps, the balance is tilting in the favor of the pen again. This dissertation is dedicated to 
the architects of a better Pakistan, who in their martyrdom induced a positive change that 
perhaps no research could or ever will. 
Dear Khaula Bibi, Ahmed Ali, Abdullah Ghani, Abrar Hussain, Adnan Hussain, Bilal Arshad, 
Shahzad Ijaz, Shahzeb, Ziaullah Islam, Azaan toryalay, Fahid Hussain, Gul Sher, Hamid Ali, 
Azhar Naseer, Rizwan Sareer, Asfand, Hammad Malik, Wahabuddin,Wasif Ali, Yasirullah, 
Adil Shahzad, Ailian Khan, Ammar Iqbal, Arham Khan, Atifur Rehman, Awais Ahmed, Awais 
Nasir, Baqir Ali, Fahad Hussain, Fazal Raheem, Muhammad Furqan, Humayun Iqbal, Hamid 
Saif, Hamza Kamran, Haris Nawaz, Hasnain Sharif, Khushnood Zeb, Abdullah Zafar, 
Ghasaan Khan, Haris Khan, Muhammad Salman, Tayyab Fawad, Nangyal Tariq, Shaheer 
Khan, Omer Khan, Saifullah, Shahood Alam, Sher Nawaz, Mujahid Hussain, Ali Abbas, Sohail 
Aslam, Husnain Shah, Tanweer Hussain, Uzair Ahmad, Uzair Ali, Umair Arshad, Ahmed 
  
 Dedication 
II 
Ilahi, Ahmed Mujtaba, Asad Aziz, Asfand Khan, Bahraam Ahmad, Basit Ali, Farhan Jalal, 
Muhammad Waqar, Haider Amin, Hamza Ali, Hayat Ullah, Ali Rehman, Ammar Khan, 
Mohsin Murtaza, Muhammad Shafqat, Muhammad Tahir, Uzair khan, Mouzzam Zulfiqar, 
Malik Taimoor, Usama Tahir, Mohammad Yaseen, Noorullah, Usama Zafar, Rafique Raza, 
Saadur Rehman, Shahbaz Ali, Shamowail Tariq, Shayan Nasir, Afaq Ahmed, Maheer Rizwan, 
Mobeen Aslam, Mohammad Ali, Usama bin Tariq, Zeeshan Ali, Zeeshan Shafique, Hassan 
Zeb, Huzaifa Aftab, Mubeen Afridi, Muzamil Umer, Umar Hayat, Nadeem Hussain, Shah 
Fahad, Sher Shah, Sohail Sadar, Abdullah Shah, Syed Zulqarnain, Usman Sadiq, Zargham 
Mazhar, Zeeshan Ahmed, Sahiban Durrani, Aimal Khan, Ibrar Zahid, Imran Ali, Ishaq Amin, 
Muhammad Imran, Zeeshan Afridi, Shafiqur Rehman, Yasir Iqbal, Mahir Ali, Muhammad 
Daud, Saqib Ghani, Zain Iqbal, Azam Afridi, Waseem Iqbal, Muhammad Sami, Ehsanullah, 
Muhammad Hussain, Hafsa Khush, Shanaz Naeem,Sadia Gul, Mudassar Khan, Hajra Sharif, 
Benish Umer, Muhammad Bilal, Sahar Afshan, Farhat Bibi, Samia Zareen, Akbar Zaman, 
Zahir Shah, Muhammad Shafiq, Nawab Ali, Sajjad Ali, Sofia Hijab, Pervaiz Akhtar, 
Muhammad Saeed, Tahira Qazi, Muhammad Altaf, and Naveed Iqbal, you will never be 
forgotten.
  
 Abstract 
III 
ABSTRACT 
 
Background: Oral cancer combined with the other cancers of the head and neck region 
constitute the sixth most common cancer in the world. Oral cancer is a major public health 
challenge in South Asia. Pakistan, India, Bangladesh and Sri Lanka have some of the highest 
incidence and prevalence rates of oral cancer in the world. Approximately ??,??? new cases 
of oral cancer are diagnosed each year in Pakistan and around ?,??? Pakistanis lose their 
lives to this malignancy every year. There is a disconnect between the research findings from 
the developed countries and the developing countries, with regards to the risk of oral cancer 
associated with smokeless tobacco use. Given the differences in the composition of the 
smokeless tobacco products used in different parts of the world, it is imperative that the 
health risks related with each of these products are assessed on an individual basis. 
Methods: A case-control study was carried out in the Khyber Pakhtunkhwa province of 
Pakistan from September ???? until May ????, to quantify the risk of oral cancer associated 
with the use of Naswar (smokeless tobacco). Additionally, three systematic reviews 
(including meta-analyses) of observational studies and two narrative reviews were carried 
out to address the secondary objectives of this dissertation. Results: We found an increased 
risk of oral cancer associated with the use of smokeless tobacco products in South Asia. The 
use of smokeless tobacco was also associated with an elevated risk of oral potentially 
malignant disorders. In Khyber Pakhtunkhwa, Pakistan, Ever-users of Naswar had a ??-fold 
increase in the risk of oral cancer compared to Never-users [Odds ratio (OR)]=??.? [(??% 
Confidence Interval (CI), (?.?-??.?)]. An elevated risk of oral cancer associated with Naswar 
use was found among both women and men. The risk of oral cancer increased with the 
increasing frequency, total duration, and the intensity of Naswar use. ??% of the oral cancer 
burden of Khyber Pakhtunkhwa was attributable to Naswar. Discussion: The findings of 
the systematic reviews and the case-control study on Naswar are comparable to the existing 
literature. The results clearly demonstrate a high risk of oral cancer and related disorders, 
associated with the use of smokeless tobacco products like Naswar, Betel quid, and Gutkha. 
There is a lack of oral cancer research in Pakistan and the tobacco control policies of the 
country largely focus on tobacco smoking while neglecting smokeless tobacco. In order to 
tackle the growing burden of oral cancer in South Asia in general and Pakistan in particular, 
policies need to be in place to curb the use of smokeless tobacco products. These products 
need to be regulated and brought under the tobacco tax-net. Changes to the composition of 
these products, to make them less harmful to health, should also be looked into as an 
intervention.  
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ABSTRAKT 
Hintergrund: Weltweit bildet Mundkrebs zusammen mit anderen Krebsarten der Kopf-
Hals-Region die sechsthäufigste Krebsart. Mundkrebs ist eine große Herausforderung im 
Bereich der öffentlichen Gesundheit in Südasien. Pakistan, Indien, Bangladesch und Sri 
Lanka haben einige der höchsten Inzidenz- und Prävalenzraten von Mundkrebs. Rund 
??.??? neue Fälle werden jedes Jahr in Pakistan berichtet und rund ?.??? Pakistanis 
verlieren jährlich ihr Leben aufgrund dieser Krebserkrankung. Rauchen gilt als wichtiger 
Risikofaktor, allerdings gibt es Unterschiede in den Forschungsergebnissen aus den 
entwickelten Ländern und den Entwicklungsländern in Bezug auf die Gefahr des 
Mundkrebses durch die Verwendung von rauchlosem Tabak. Angesichts der 
unterschiedlichen inhaltlichen Zusammensetzung von rauchlosen Tabakprodukten in 
verschiedenen Teilen der Welt ist es zwingend erforderlich, dass die gesundheitlichen 
Risiken im Zusammenhang mit jeder Form dieser Produkte auf individueller Basis 
quantifiziert werden. Methoden: Es wurde eine Fall-Kontroll-Studie in der Provinz Khyber 
Pakhtunkhwa Pakistan zwischen September ???? und Mai ???? durchgeführt, Um das 
Risiko von oralen Krebs im Zusammenhang mit Naswar (rauchlosem tabak) verwenden. 
Ferner wurden drei systematische Reviews (inklusive Meta-Analysen) von 
Beobachtungsstudien sowie zwei narrative Bewertungen erarbeitet, die die sekundären Ziele 
dieser Dissertation umfassen. Ergebnisse: Im Zuge der Fall-Kontroll-Studie wurde ein stark 
erhöhtes Risiko für Mundkrebs in Zusammenhang mit der Verwendung von rauchlosen 
Tabakwaren in der Khyber Pakhtunkhwa Region, Pakistan, beobachtet. Zudem war die 
Verwendung von rauchlosem Tabak mit einem erhöhten Risiko von möglicherweise 
malignen oralen Erkrankungen assoziiert. Naswar Nutzer hatten ein ??-fach erhöhtes des 
Mundkrebsrisikos im Vergleich zu Personen, die Naswar nie genutzt haben [Odds ratio 
(OR)]=??.?, [??% Konfidenzinetrvall, (?.?-??.?)]. Ein erhöhtes Risiko für Mundkrebs 
wurden bei Frauen und Männern beobachtet. Das Mundkrebsrisiko stieg mit zunehmender 
Häufigkeit, Dauer und Intensität der Nutzung von Naswar. Circa ??% aller 
Mundkrebserkrankungen in der Khyber Pakhtunkhwa Region ist der Nutzung durch 
Naswar zuzuschreiben. Diskussion: Die Ergebnisse der Bewertungen und der Fall-
Kontroll-Studie zu Naswar sind im Einklang mit der vorhandenen Literatur. Die 
vorliegenden Ergebnisse zeigen ein hohes Risiko für Mundkrebs und verwandte 
Erkrankungen, die im Zusammenhang mit der Anwendung von rauchlosen Tabakprodukten 
wie Naswar, Betel quid, Gutkha stehen. Es besteht ein Mangel an entsprechender 
Krebsforschung in Pakistan sowie bei Anti-Tabak-Maßnahmen des Landes, die  die Riskoen 
rauchlosen Tabaks vernachlässigen. Um die zunehmende Krankheitslast durch Mundkrebs 
in Südasien im Allgemeinen und insbesondere in Pakistan anzugehen, bedarf es 
Maßnahmen vor Ort, um die Verwendung von rauchlosen Tabakwaren einzudämmen. Diese 
Produkte müssen reguliert und unter die Tabaksteuer gestellt werden. Änderungen in der 
Zusammensetzung dieser Produkte müssen angestoßen werden, damit sie weniger 
schädlich für die Gesundheit sind. Diese Maßnahmen sollten ferner hinsichtlich ihres 
Erfolges übergeprüft werden. 
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FOREWORD 
 
Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, 
so that we may fear less. 
                                                                                                                                          -Marie Curie 
Pakistan has been a perennial member of the Ivy League of oral cancer incidence and 
prevalence. Oral cancer ranks as the second most common malignancy in Pakistan among 
both sexes, and the most prevalent cancer among men. My interest in oral cancer piqued 
during the formative years of my dentistry career (????-??). While working as a “House 
Officer” at the “Khyber College of Dentistry” in Peshawar, Pakistan, I would come across at 
least one oral cancer patient on a daily basis. It was through the skimming of the 
documented social/personal histories of these patients that made me realize, that most of 
them had one thing in common i.e. the habit of Naswar (a form of smokeless tobacco). A 
Naswar packet roughly costs ?/?Oth of a cigarette pack in Pakistan. The easy availability and 
cheap prices make Naswar an attractive product to tobacco users. Naswar use is considered 
as a cultural practice and a social norm in the Khyber Pakhtunkhwa, Pakistan.  
It was not, until much later (????), that I finally got a chance to be able to assess the 
association between Naswar use and the risk of oral cancer in Khyber Pakhtunkhwa, 
Pakistan, in a formal manner. I, with the help of my advisor Prof. Dr. Hajo Zeeb, and the 
valuable input from Prof. Dr. Wolfgang Ahrens, designed a case-control study to assess the 
association between Naswar use and oral cancer. The study was based on the template of the 
“Alcohol Related Cancer and Genetic susceptibility in Europe (ARCAGE)” study [?]. We 
devised the data collection tools and study protocols from October ???? until March ????. 
Ethical approval for the study was granted by the Research and Ethics Board of the Khyber 
medical University, Peshawar and data collection in Pakistan began in September ????. 
Although hampered by some local events in Peshawar, we were successful in recruiting the 
required number of participants by the end of May ????. The data cleaning and analysis was 
carried out until December ????. We have, since then submitted a manuscript to 
International peer-reviewed journals based on the data collected during the study. During 
this time i.e. from the conception of the case-control study until the submission of the 
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manuscript related to the study, I also carried out a scoping review of oral cancer research in 
Pakistan and two systematic reviews on the risk of oral cancer, and oral potentially 
malignant disorders, associated with smokeless tobacco use. Additionally, a pooled analysis 
of case-control studies from Pakistan, a review of the smokeless tobacco control policy in 
Pakistan, and a guest editorial on the use of Naswar and the associated risk of oral cancer 
constitute my doctoral research work. The details of the research studies carried out in the 
context of this body of work, including the objectives, methods, results and a discussion of 
the results, are provided in the various chapters of this dissertation.  
I am confident that my findings will add new knowledge to the existing knowledge base on 
the deleterious effects of smokeless tobacco use. These findings have the potential to 
influence tobacco control policies and inform cancer control strategies in Pakistan. 
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1 INTRODUCTION  
 
“It's a disease so horrible, it defies metaphor - people use cancer as a metaphor for the worst 
things in life, but there are no metaphors dreadful enough to describe cancer”  
                     -Charlie Jane Anders 
Oral cancer is an ancient disease. The earliest description of the condition can be found in 
the “Sushruta Samhita”, a Sanskrit surgery text from the ??? BC [?], that refers to it as 
“Mukharbuda”, a malignancy of the buccal mucosa [?]. Oral cancer is characterized by an 
aggressive course, culminating in severe local tissue destruction and distant metastasis [?]. 
The sequelae of oral cancer, in addition to disability and mortality, include a diminished 
quality of life because of the anatomical, aesthetic, and functional role of the oral cavity [?].  
Oral cancer combined with the other head and neck cancers constitutes the sixth most 
common cancer in the world [?]. According to the latest estimates of the International 
Agency for Research on Cancer (IARC), worldwide, more than ???,??? new cases of oral 
cancer are diagnosed each year with a five-year prevalence of more than ???,??? cases. Oral 
cancer accounts for nearly ???,??? deaths each year. Oral cancer has surpassed lung cancer 
as the most prevalent cancer among men in Pakistan and is the second most common 
malignancy in women. Approximately ??,??? new cases of oral cancer are diagnosed each 
year in Pakistan and about ?,??? Pakistanis die annually of oral cancer [?]. 
Although oral cancer has a multifactorial etiology, tobacco use and alcohol are universally 
considered as the major risk factors for oral cancer [?]. Recent estimates suggest that 
smokeless tobacco (SLT) use led to a loss of ?.? million “disability adjusted life years” and 
??,??? deaths due to cancers of the mouth, pharynx, and esophagus [?]. SLT is a form of 
tobacco that is used without burning the product [??]. An estimated ??? million people use 
SLT in some form in South and South East Asia, implying that more than ??% of the world’s 
SLT burden lies in this region [??]. ??.?% of Pakistan’s population uses SLT products [??], and 
its use is gaining more popularity in the wake of rising cigarette prices in the country. Given 
the high prevalence of oral cancer and the use of SLT, there is a striking lack of etiological 
research on oral cancer in Pakistan, with negligible local evidence to inform tobacco and 
cancer control policies in the country [??]. Of particular note is the scarcity of research on 
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Naswar and the associated risk of oral cancer in Pakistan. Naswar is an SLT product that is 
used predominantly in Pakistan and Afghanistan, and to a lesser extent in India, Bangladesh, 
and Central Asia [??]. In ????, the IARC also acknowledged the lack of epidemiological data 
to establish the carcinogenicity of Naswar in humans, in its monograph on smokeless 
tobacco [??]. 
Although evidence from South Asia (mostly India) points toward a potentially causal 
association between oral cancer and smokeless tobacco use [??-??], some investigations from 
industrialized countries, particularly Sweden, where SLT use is common, do not show an 
increased risk of oral cancer linked to the use of SLT products [??, ??]. This has led to 
recommendations from certain sections of the scientific community that smokeless tobacco 
can be used as means of “tobacco harm reduction” [??, ??]. There are also suggestions that 
some forms of SLT can be used as less hazardous and considerably cheaper alternatives to 
smoking and nicotine replacement therapies in smoking cessation [??]. Additionally, in 
some parts of Pakistan, it is also considered as a medicinal herb used to relieve pain, rather 
than a potentially addictive and perilous tobacco product [??]. 
1.1 RATIONALE 
The disconnect between research findings from the Industrial and developing countries 
about the risk of oral cancer associated with the use of smokeless tobacco, the lack of 
etiological research on Naswar and oral cancer in Pakistan, and the “harm reduction” debate 
regarding smokeless tobacco, served as rationale to conduct the studies carried out in the 
context of this body of work. 
1.2 OBJECTIVES 
This body of work is guided by the following objectives. 
1.2.1 General Objective 
To study the role of smokeless tobacco as a determinant of oral cancer incidence and 
prevention in Pakistan. 
 
 
 
       Introduction 
? 
1.2.2 Specific Objectives 
i. To assess the risk of oral cancer associated with Naswar use in Khyber Pakhtunkhwa, 
Pakistan. 
ii. To appraise the quantitative as well as thematic aspects of the oral cancer research 
output from Pakistan. 
iii. To determine the risk of oral cancer associated with SLT use in South Asia by 
systematically reviewing evidence. 
iv. To assess the risk of Oral Potentially Malignant Disorders associated with SLT use in 
South Asia. 
v. To estimate the pooled risk for oral cancer associated with Naswar use, from 
epidemiological studies carried out in Pakistan. 
vi. To identify gaps, regarding smokeless tobacco control, in the tobacco control policy 
of Pakistan. 
vii. To formulate policy recommendations based on the evidence generated by this body 
of work. 
1.3 DISSERTATION STRUCTURE 
The work done in the context of this dissertation is hereafter described in eight chapters and 
nine articles (Three published, three accepted for publication, two under peer review and 
one in preparation), which are provided in the appendices (I – VIII).  
Chapter ? provides an overview of oral cancer including its clinical and histopathological 
features, the global epidemiology of oral cancer, and a description of its risk factors. 
Chapter ? deals with smokeless tobacco and covers its nomenclature and global distribution. 
It sheds light on the association of different disease, particularly cancers, with the use of 
smokeless tobacco. The chapter also provides an insight into the biochemical basis of 
smokeless tobacco carcinogenesis. 
Chapter ? addresses the public health domains of Non-communicable disease prevention, 
and causality, and how the intersection of these two provided the conceptual framework for 
this body of work.  
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Chapter ? includes a description of the research methods that were used for the case-control 
study that was carried out in Khyber Pakhtunkhwa province, Pakistan (Article V). It also 
briefly sheds light on the research methods used in preparing the other manuscripts 
included in this dissertation.  
Chapter ? elucidates the scientific findings, listed according to the objectives that guided 
this body of work.  
Chapter ? presents a discussion of the research findings, how these findings fit the criteria 
for causality, and the strengths and limitations pertaining to the methods used to address 
the aims of this body of work. 
Chapter ? provides specific conclusions related to the objectives of this body of work, as well 
as providing overall conclusions, and implications for policy. 
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2  THE CURIOUS CASE OF ORAL CANCER 
 
"...the radium has once again begun to eat away at something...and my world is what it was 
previously, a small island of pain floating on an ocean of indifference."  
                      -Sigmund Freud (on suffering from oral cancer) to Marie Bonaparte (??.?.????). 
2.1 ORAL CANCER DEFINITION 
The many peculiarities of oral cancer begin with the very definition of the disease, as there 
is none, which is universally agreed upon [??]. A ???? literature search in PubMed returned 
?? different terms used for oral cancer [??]. The problem stems from the range of anatomical 
sites that are included in oral cavity and oropharynx, as the definition of cancer itself, is very 
clear in the literature [??].This discourse on the nomenclature of oral cancer often leads to 
difficulties in retrieving research material on oral cancer for comparative purposes, thus 
potentially hampering the research process [??]. 
For the purpose of this dissertation, the term “oral cancer” will be used collectively for the 
malignancies of oral cavity and oropharynx. In accordance with the “International 
Classification of Disease ??th revision-(ICD-??)” [??], a malignant neoplasm of the lip, 
tongue, buccal mucosa or any other part of the oral cavity or oropharynx will be considered 
as oral cancer (Table ?.?). 
2.2 CLINICAL FEATURES 
Oral cancer usually begins as a silent disease with no or minimal clinical signs and symptoms 
[??]. It may be preceded by pre-malignant conditions, collectively known as “Oral 
Potentially Malignant Disorders” [??]. Although oral cancer develops in a visible anatomical 
site, the malignancy is often at an advanced stage, at the time of the initial diagnosis [??]. 
Some of the middle to late stage signs and symptoms include the ulceration of the tumor 
that does not heal, difficulty in speaking, trismus, dysphagia, bad breath, and mobile teeth. 
Pain may be felt when the tumor is infected or compresses the nearby nerves [??].  
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2.3 HISTOPATHOLOGICAL FEATURES 
More than ??% of the oral cancers are squamous cell carcinomas arising from the epithelial 
lining of the oral cavity [??]. The rest of the oral cancers are comprised of verrucous 
carcinoma, adenosquamous carcinoma, mucoepidermoid cancer, adenoid carcinoma 
cuniculatum and some other very rare forms [??]. 
2.4 DIAGNOSIS 
A provisional diagnosis of oral cancer is usually through visual inspection and clinical signs 
and symptoms. Histological confirmation (Gold standard) of the tumor is used to establish 
a definitive diagnosis. More recently, Magnetic Resonance Imaging and Computed 
Tomography have been increasingly used to aid in the diagnosis of oral cancer [??]. 
ICD-10 code ICD-9 equivalent Anatomical site 
C00 140.0-140.9 Lip 
C01 141 Base of tongue 
C02 141.1-141.9 Other & unspecified parts of tongue 
C03 143.0-143.9 Gum 
C04 144.0-144.9 Floor of mouth 
C05 145.2-145.5 Palate 
C06 145.0-145.1,145.6-145.9 Other & unspecified parts of mouth 
C09 146.0-146.2 Tonsil 
C10 146.3-146.9 Oropharynx 
C14 149.0-149.9 Other & ill-defined sites of lip, OC* & Pharynx 
Table ?.?. Anatomical subsites for oral cancer based on the international 
classification of disease-??th revision. 
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2.5 GLOBAL EPIDEMIOLOGY OF ORAL CANCER1 
Globally, there is a marked geographical variation in oral cancer incidence and mortality, 
with two-thirds of the oral cancer burden lying in the developing countries [??]. Oral cancer 
is twice more common in males as compared to females. The usual onset of the disease is in 
the sixth and seventh decade of life, although in some parts of the world the onset may be at 
an early age [??]. Figure ?.? describes the incidence of, and mortality due to, oral cancer in 
different geographic regions of the world. Figure ?.? highlights the top ?? countries in the 
world with the highest mortality and incidence of oral cancer.  
2.5.1 Oral Cancer in South Asia 
Oral cancer is a huge public health problem in South Asia [??]. It accounts for one-third of 
all cancers in India [??]. Bangladesh and Sri Lanka rank second and fourth in the world 
respectively, with regards to oral cancer incidence. In Pakistan, it accounts for ??% of all new 
cancer cases. Recent trends show an increase in the incidence rates of oral cancer in Pakistan, 
and it is feared that the country may face an oral cancer epidemic by the year ???? [??]. The 
five-year prevalence of oral cancer in Pakistan, in men and women, is ??,??? and ??,???, 
respectively.  
2.6 RISK FACTORS FOR ORAL CANCER 
Oral cancer has a multifactorial etiology. Analogous to its incidence, there are marked 
differences in risk factors for oral cancer between different geographic locations.  
2.6.1 Tobacco use2  
Tobacco and alcohol constitute the biggest preventable risk factors for oral cancer [??]. 
Smoking tobacco in any form e.g. cigarette, cigars, cigarillo, bidi, hookah, chillum or sheesha 
is considered as a risk for oral cancer [??]. IARC has placed tobacco in the group ? of 
                                                 
1 Unless cited otherwise, all figures reported in the sub-section ?.? have been taken from most recent edition 
of GLOBOCAN [?]. All rates are per ???,??? population. 
 
2 Smokeless tobacco is described in chapter ?.  
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carcinogens for oral and pharyngeal cancers [??]. A ???? meta-analysis of ?? observational 
studies reported a pooled relative risk (mRR) of ?.? [??% Confidence Interval (CI), ?.?-?.?] 
for oral cancer associated with cigarette smoking, compared to non-smokers [??]. Another 
meta-analysis of ?? case-control studies revealed a pooled odds ratio (mOR) of ?.? (??% CI, 
?.?-?.?) for smokers compared to non-smokers [??]. Similarly, Bidi smoking, which is a 
common practice in some Asian countries was reported to increase the risk of oral cancer by 
more than three-fold compared to non-smokers in a meta-analysis of ?? studies, mOR=?.? 
(??% CI, ?.?-?.?) [??]. Chang et al., in a meta-analysis of cohort studies on smoking-related 
mortality, reported mortality ratios ranging from ?.? to ?.? for oral cancer from cigar 
smoking [??]. All the cited reviews reported a dose-response relationship between tobacco 
smoking and oral cancer. 
2.6.2 Alcohol Drinking 
Alcohol is a major risk factor for oral cancer and along with tobacco is responsible for about 
??% of all oral cancer cases in the world [??]. A ???? meta-analysis of ?? studies concluded 
that the risk of oral cancer is almost five times elevated among long-term alcohol users 
compared to non-users, mRR=?.? (??% CI, ?.?-?.?) [??]. Another pooled analysis reported 
a ??-fold higher risk of oral cancer associated with the consumption of ??? grams of alcohol 
per day, mRR=??.? (??% CI, ?.?-??.?) compared to non-drinkers, but this estimate was not 
adjusted for smoking [??]. Li et al., reported pooled relative risks of ?.? (??% CI, ?.?-?.?) for 
light (⩽ ??.? g/day), ?.? (??% CI, ?.?-?.?) for moderate (??.?-??.? g/day), and ?.? (??% CI, 
?.?-?.?) for heavy (⩾ ?? g/day) drinkers respectively, when compared to non-drinkers [??]. 
Although alcohol is an independent risk factor for oral cancer, it is the synergistic effect of 
alcohol consumption and tobacco use, which might be a reason for the very high risk of oral 
and pharyngeal cancers associated with these habits. Among the ??% cases attributed to 
tobacco and alcohol use, in a multi-center European study on upper aero-digestive tract 
cancers, only one percent was attributed to alcohol, ??% to tobacco, while ??% were 
accredited to the joint effect of both alcohol and tobacco use [??]. 
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ASR (W): Age-standardized rate (Standard world population) 
Figure ?.?. Global Incidence and mortality related to oral cancer based on the ???? estimates by the IARC [?].
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ASR (W): Age-standardized rate (Standard world population) 
 
          Figure ?.?. Countries with the highest incidence and mortality of oral cancer based on the ???? estimates by 
the IARC [?]. 
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2.6.3 Diet 
Diet has a modifying effect on the risk of cancer. Diet rich in saturated fats and processed 
meat is associated with an elevated risk of cancer. Conversely, a diet consisting of fruit, 
fibrous food items, and dairy products has been shown to have a protective effect [??]. 
Notani et al reported a two-fold increase in the risk of upper aero-digestive tract cancers in 
subjects who did not consume vegetables daily compared to those who did [??]. A cohort 
study of ??,??? post-menopausal women reported an RR of ?.? (??% CI, ?.?-?.?) for oral 
cancer, in the highest tertile of whole grain users compared to the lowest tertile. The same 
study reported an RR of ?.? (??% CI, ?.?-?.?) for oral cancer, among users of yellow/orange 
vegetables in the highest tertile, compared to the users in the lowest tertile [??]. 
Mediterranean diet, which is high in vegetables and monounsaturated fats, is associated 
with a decrease in the risk of upper aero-digestive tract cancers [??]. A meta-analysis by Xu 
et al. reported an increased risk of oral cancer in South America with the use of meat mRR =  
?.? (??% CI, ?.?-?.?) [??]. Levi et al., reported a four-fold increase in the risk of oral cancer 
among the highest quartile of processed red meat consumers compared to the lowest 
quartile, odds ratio (OR)=?.? (??% CI, ?.?-?.?) [??]. 
2.6.4 Oral Hygiene 
Oral hygiene plays an important role in the development of oral cancer [??]. Results from a 
large multicenter case-control study from Europe reported that a poor condition of the 
mouth almost tripled the risk of head and neck cancer, OR=?.? (??% CI, ?.?-?.?) [??]. A 
large study from Latin America reported a comparatively lower but still significant risk of 
oral cancer associated with poor oral hygiene compared to good oral hygiene, OR=?.? (??% 
CI, ?.?-?.?) [??]. Similarly, the lack of toothbrush use, OR=?.? (??% CI, ?.?-?.?) and daily 
mouthwash use, OR=?.? (??% CI, ?.?-?.?) increased the risk of head and neck cancers in 
Latin America [??]. A study from Brazil reported a three-fold increase in the risk of oral and 
pharyngeal cancer with bleeding gums, which is a sign of periodontal disease and often 
results from poor oral hygiene, OR=?.? (??% CI ?.?-?.?) [??]. Shamami et al., in a systematic 
review of case-control and cohort studies concluded that independent of smoking and 
alcohol use, periodontal disease and tooth loss, are a risk factor for oral cancer [??]. 
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Mouthwashes, which are used as an aid to maintaining good oral hygiene, pose a unique 
dilemma in this regard. Recent evidence suggests an increase in the risk of oropharyngeal 
cancer with the use of mouthwash [??].This may be due to the alcoholic content of some of 
these mouthwashes. Contrastingly, some systematic reviews have reported no significant 
increase in the risk of oral cancer with the regular use of mouthwash, mRR=?.? (??% CI (?.?-
?.?) [??]. This disconnect in evidence regarding the risk of oral cancer associated with 
mouthwashes, warrants further scientific investigation. 
2.6.5 Social and demographic risk factors 
Oral cancer is similar to the other health-related phenomena, in the sense that a socio-
demographic gradient exists, with regards to its incidence. Conway and colleagues have 
reported that a lower occupational and social class was associated with the incidence of oral 
cancer in both high and low-income countries, mOR=?.? (??% CI, ?.?-?.?) [??]. A literature 
review carried out by Liu suggests that lower levels of education (OR range, ?.?? ~ ?.?) and 
lower monthly income (OR range ?.? ~ ?.??), are related to an increased risk of oral cancer 
[??]. A study from India reported a five-fold increase in the risk of oral cancer associated 
with low education, compared to higher education, OR=?.? (??% CI, ?.?-?.?) [??]. Another 
Indian study reported a three-fold increase in the risk of oral cancer among subjects with an 
income lower than ?,??? Rupees compared to the ones in the highest salary stratum, 
OR=?.? (??% CI ?.?-?.?) [??].  
Oral cancer is more common among men than in women. This difference is more 
pronounced in Europe and the Americas and less so in South Asia [??]. There have been 
suggestions that differences in the hormonal environment might be one of the reasons for 
this disparity [??]. Ethnic differences also play a major role with regards to oral cancer. The 
Non-Hispanic white races in the USA have a far higher rate of oral cancer incidence as 
compared to the white Hispanic races [??]. Moreover, black males have a higher incidence 
of oral cancer as compared to white males [??]. The very high incidence of oral cancer in the 
Indian subcontinent as compared to other parts of the world also suggests a role of ethnicity. 
Csikar et al. demonstrated a higher incidence of oral cancer among women of South Asian 
origin as compared to other ethnic groups in England [??]. These differences exist both inter 
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and intra-countries, and even though most can be explained by diet and habits like smoking 
and alcohol etc, there are suggestions that genetic factors may be involved [??]. 
2.6.6 Human Papilloma Virus 
The incidence of smoking is decreasing worldwide but the incidence of oral cancers seems 
to be increasing [??, ??], suggesting the emergence of new risk factors. Human Papilloma 
Virus (HPV) is a one such risk factor for oral cancer. Mehanna et al., have reported a ??% 
increase in the prevalence of HPV among oropharyngeal cases when comparing studies 
conducted prior to the year ???? and studies carried out after ???? till ???? [??]. The 
increase in the prevalence of HPV infection among oropharyngeal cancers has been more 
pronounced in Europe and to a lesser extent but still high, in the United States [??]. HPV 
type ?? and ?? are considered as the main subtypes responsible for oral cancers, moreover, 
HPV ?? has also been found in cases of oropharyngeal cancers [??]. Evidence from 
Industrialized countries suggests a causal link between oral cancer and HPV. However, more 
research is needed in the context of developing countries. Tobacco remains the major risk 
factor in the developing countries and there are suggestions that prevalence of HPV DNA in 
cases who were current or former tobacco users are low compared to non-users. [??].
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3 SEVERAL SHADES OF SMOKELESS (TOBACCO) 
 
“...tobacco is the only legally available consumer product which kills people when it is used 
entirely as intended”. 
                     - The Oxford Medical Companion  
The term “smokeless tobacco” as the name implies, refers to all forms of tobacco use that do 
not involve the burning of the product [??]. Smokeless tobacco (SLT) use includes either, or 
a combination of, chewing, sucking, inhaling, or dipping tobacco. SLT is used as such 
(leaves) or mixed with other ingredients to make it more palatable, and/or to facilitate a 
more efficient delivery of the active ingredients to the bloodstream [??]. Biologically, SLT 
differs from smoking in the mechanism of delivery of the active agent i.e. nicotine. During 
smoking, nicotine reaches the bloodstream via the smoke that is inhaled through the lungs, 
while for smokeless tobacco the absorption of nicotine into the blood is usually through the 
oral or nasal mucosa [??]. Additionally, for some forms of SLT e.g. chewing leaves, the 
absorption of the active ingredients may also take place through the lining of the other parts 
of the gastrointestinal tract e.g. the stomach or intestine [??].  
Smokeless tobacco use is prevalent all over the world. Recent estimates suggest that more 
than ??? million people in ?? countries use SLT [??]. The highest prevalence of SLT is in 
developing countries, particularly in the South and South East Asian countries of India, 
Pakistan, and Bangladesh [??]. According to the WHO estimates, almost ??% of the SLT 
burden of the world lies in South Asia [??]. The types of SLT products, however, vary between 
regions even within a single country. Among industrialized countries, America and Sweden 
have the highest prevalence of SLT use [??]. The prevalence of SLT use across the globe is 
provided in figure ?.? . 
3.1 A BRIEF HISTORY OF SMOKELESS TOBACCO 
The first documented use of tobacco can be traced back to the Native American Indians 
during the ??th century [??]. Columbus and other explorers of that time got acquainted with 
the tobacco use habits of the “New World”, where it was consumed to curb the appetite and 
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thirst, as well as for medicinal and cosmetic purposes [??]. Tobacco was brought to Europe 
during the ??th century [??]. Before long, the cultivation of tobacco started in mainland 
Europe. However, the American colonies remained the chief exporters of tobacco, as it 
gained more popularity in Europe [??]. Tobacco was introduced in Asia during the British 
colonial era, where it soon found its way into the centuries-old tradition of betel quid 
chewing, by becoming an ingredient of the quid [??]. The European colonizers were also 
responsible for the spread of tobacco to Africa, where it was first introduced in Egypt [??].  
Commercial production of the powdered form of tobacco, usually known as snuff, started in 
the sixteenth century in Spain and by the ??h century, snuff factories had opened in various 
parts of the British Isles [??]. Snuff quickly became a status symbol, used by the royals and 
the dandies. By the mid ??th century, snuff factories had also opened in Northern America 
and Sweden, but the North Americans still preferred chewing tobacco to the more formal 
European method of snuff use [??, ??]. 
3.2 SMOKELESS TOBACCO IN SOUTH ASIA 
South Asia is the largest consumer of SLT in the world with approximately ??? million 
people using it in some form [??]. It is estimated that ?.? million south Asians die every year 
due to the use of different forms of tobacco [??]. Tobacco was first introduced in south Asia 
mainly for smoking purposes. The British naval staff started chewing tobacco when smoking 
got banned from ships to avoid the risk of fire. This prompted the use of tobacco in betel 
quid. The use of tobacco in quid spread rapidly, and soon cultivation of tobacco started in 
the Indian subcontinent [??], other forms of SLT e.g. Gutkha, Nass, and Paan masala, 
quickly followed [??]. In South Asia, SLT has been embraced in various forms, with regional 
variations, and has become culturally and socially acceptable [??]. 
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Figure ?.?. Prevalence(%) of smokeless tobacco use in different parts of the world, adapted from the 
World Tobacco Atlas [??].  
.
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3.3 TYPES OF SMOKELESS TOBACCO 
The IARC classifies SLT products according to the method of their use i.e. chewing, sucking, 
other oral uses, and nasal uses. It has identified ?? types of products that are prevalent word 
wide [??]. The classification of the smokeless tobacco products according to their method 
of use is presented hereafter. 
3.3.1 Chewing Tobacco products 
These include Betel quid, Gutka, Iq’mik, Khaini, Khiwam, Loose leaf, Mawa, Plug, Tobacco 
chewing gum, Twist or roll and Zarda. 
3.3.2 Sucking Tobacco products  
Chimó, Dry snuff, Gutkha, Khaini, Loose-leaf, Maras, Mishri, Moist snuff, Naswar, Plug, 
Shammah, Snus, Tobacco tablets, Toombak  
3.3.3 Other oral products 
Creamy stuff, Gudhaku, Gul, Mishri, Red tooth powder, Tuibur 
3.3.4 Nasal use products 
Dry snuff and Liquid snuff 
The distribution of SLT products by the regions of their use are described in Table ?.?. 
3.3.5 Types of smokeless tobacco used in Pakistan 
According to the ???? Global Adult Tobacco survey, around ?? million Pakistanis indulge in 
the habit of SLT use [??] . The most common forms of SLT products used in Pakistan are 
Paan (Betel quid) with tobacco, Gutkha, and Naswar [??]. Using SLT products is a culturally 
and socially acceptable practice in the Pakistani society [??, ??]. There are marked regional 
variations in the type of SLT use practices in Pakistan. In the southern parts of the country, 
the use of paan with tobacco is more common, while in the northern part of Pakistan Naswar 
is the predominant type of SLT form [??, ??]. Following is a brief description of the different 
SLT products used in Pakistan. Since “Naswar” is the focus of this dissertation, it is described 
in more detail. 
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Data source: Smokeless tobacco fact sheet - National Cancer Institute and Center for Disease control, USA 
[??]. 
 
3.3.5.1 Paan 
Paan is usually made by vendors or prepared at home, although commercial preparation is 
also becoming common. To make a Paan, slaked lime and catechu (extract from the acacia  
tree) are pasted onto a betel leaf. Other ingredients such as tobacco, areca nut, and flavoring 
agents are then added, and the leaf is folded into a funnel shape to be chewed. Raw, sun 
dried or roasted tobacco is used in paan, depending on the preference of the customer [???]. 
According to a nationally representative survey from Pakistan, ?.?% of the study participants 
regularly chewed Paan with tobacco [??]. 
 
Region Type of smokeless tobacco 
Americas 
? Chewing (North America): Loose leaf, Plug-Moist, 
Plug-chew, Twist or roll 
? Dry snuff (North America): Iq'mik, Ariva (nicotine 
lozenges) 
? Moist snuff (Venezuela): Chimo 
Europe 
? Snus or snuff (Sweden) 
? Gutkha (United Kingdom) 
? Dry snuff (United Kingdom) 
Asia 
? Central Asia: Gul, Nass or Naswar, Pan Masala or Betel 
quid, Zarda 
? East/Southeast Asia: Gutkha, Pan Masala or Betel quid 
? South Asia, including Indian subcontinent: Creamy 
snuff, Gul, Gutkha, Khaini, Mawa, Mishri or Masheri, 
Misheri, Qiwam or Kima, Red tooth powder, Snus or 
snuff (Naswar) 
Middle East ? Nass or Naswar, Niswar, Shammah, Zarda 
Africa ? Sudan: Toombak 
Table ?.?. Prevalence of different types of smokeless tobacco products by 
region.  
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3.3.5.2 Gutkha 
Gutkha usually comes in the form of dry granules that are packaged in an easy to carry plastic 
packet. In essence, it is the commercially manufactured version of Paan or betel quid with 
tobacco, but unlike Paan, it is not perishable [???]. One province in Pakistan has banned the 
sale and consumption of Gutkha due to its health risks. A ???? study from Pakistan found 
the prevalence of Gutkha to be ?.?% [??]. 
3.3.5.3 Naswar 
Naswar (or Nass) is a mixture of sun-dried, partially cured and powdered local tobacco 
(Nicotiana Rustica), ash, oil, flavoring agents (e.g. cardamom, menthol), coloring agents, 
and slaked lime [???]. It is made locally in a cement lined cavity to which water and lime are 
added. Thereafter, the tobacco is added, followed by the coloring and flavoring agents [??]. 
A heavy wooden mallet pounds the ingredients into a mixture, to which water and oil are 
added for binding [???]. Naswar can also be used in an unbounded mixture form. The 
product is then packed into plastic packets or ornamental boxes, ready to be used. The usage 
involves the shaping of Naswar into a round pellet with fingers, and placing it in the buccal 
vestibule or under the tongue [??]. It is estimated that more than ?% of Pakistan’s population 
use Naswar [??]. The product is particularly more popular in the Khyber Pakhtunkhwa 
province of the country, where the prevalence of its use is more than ??% [??].  
3.4 SMOKELESS, NOT HARMLESS  
A variety of diseases have been linked with SLT use, including cancers, potentially malignant 
conditions, cardiovascular diseases, gastrointestinal disorders, and dental conditions [???-
???]. For the purpose of this dissertation, the focus of this section will be on oral cancer. 
3.4.1 Biochemical considerations 
SLT has been labeled as carcinogenic by the IARC [???]. SLT contains more than ?? 
carcinogenic agents [???]. These include the non-volatile alkaloid-derived tobacco-specific 
N-nitrosamines (TSNA), N-nitrosoamino acids, volatile N-nitrosamines, metals, certain 
volatile aldehydes, urethane, polynuclear aromatic hydrocarbons, lactones, and radioactive 
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material like polonium-??? and uranium-??? and -??? [???]. Nicotine is the main 
psychoactive agent in smokeless tobacco and to facilitate its rapid absorption, the 
manufacturers keep the alkalinity (pH) of SLT products very high [???]. This, in turn, induces 
the formation of more TSNAs [???].  
Nicotine causes dependence [???], and a higher nicotine level means stronger cravings, and 
a more frequent or prolonged use of the product, leading to a higher exposure to the 
carcinogenic agents in SLT [??]. Nicotine plays an important role in cancer initiation through 
the activation of signaling pathways, tumor cell growth, angiogenesis, migration, and 
invasion [???]. Slaked lime, another constituent of various SLT products, has been shown to 
have carcinogenic potential. It induces the production of reactive oxygen species (ROS) in 
the saliva of chewers and facilitates the hydrolysis of arecoline into arecaidine. This enables 
increased fibroblast proliferation and collagen synthesis, which are essential for 
premalignant and malignant transformation of the affected tissues [???-???]. 
Table ?.? indicates that the Naswar used in Pakistan has one of the highest pH among the 
different types of SLT products used around the world. The Nicotiana Rustica species of 
tobacco, from which Naswar is made, has a higher nicotine content than Nicotiana 
Tabacum, which is usually used in cigarettes [??, ???, ???]. A study of ?? brands of Naswar 
from Pakistan revealed a nicotine content of ?.??-??.? mg/g, of which more than ??% was 
in free form, making Naswar one of the highest free-form nicotine containing SLT product 
in the world [???]. Naswar also has a very high TSNA content compared to the other forms 
of SLT used in Pakistan. Table ?.? refers to the comparison of Naswar with some other 
popular SLT products. Naswar also contains cadmium, chromium, nickel, arsenic, and 
beryllium, which are Group I carcinogens, and lead, nitrate, and nitrite, which are Group II 
carcinogens [???]. The IARC classifies Group I carcinogens as agents/mixture/exposure 
circumstances that have been shown to be carcinogenic in humans, and Group II 
carcinogens as those agents/mixture/exposure circumstances that have been proven 
carcinogenic in experimental animals but evidence for their carcinogenicity in humans is 
yet, inadequate. 
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*Milligram per gram; TSNA=tobacco-specific nitrosamines; Source: Stanfill et al. ???? [???]. 
 
3.4.2 No smoke, ample evidence 
Tobacco smoke is recognized as injurious to health but despite the absence of smoke, SLT 
products can be equally harmful to the health of the user.  
3.4.2.1 Smokeless tobacco and cancer  
Smokeless tobacco is associated with multiple cancers. Boffetta et al., reported elevated risks 
of esophageal cancer, mRR=?.? (??% CI, ?.?-?.?) and pancreatic cancer mRR=?.? (??% CI, ?.?-
?.?) [???], associated with SLT use. Another review of European and North American studies, 
reported a slight increase in the risk of stomach, mRR=?.?? (??% CI, ?.?–?.?), pancreatic, 
mRR=?.?, (??% CI, ?.?–?.?), and prostate, mRR=?.? (??% CI, ?.?–?.?), cancers associated 
with the use of SLT [???]. A recent meta-analysis of Indian literature stated a significant 
association between the risk of pharyngeal, mRR=?.? (??% CI, ?.?-?.?), laryngeal, mRR=?.? 
(??% CI, ?.?-?.?), esophageal, mRR=?.? (??% CI, ?.?-?.?) and stomach, mRR=?.? (??% CI, 
?.?-?.?), cancers and the use of SLT products [??]. There are suggestions in the literature that 
smokeless tobacco increases the risk of penile cancer and renal cell carcinoma [???]. 
Product name pH Total nicotine* Free nicotine* TSNA 
Naswar (Pakistan) 8.76–9.14 10.5–14.2 8.84–13.2 478–1,380 
Nasway (Uzbekistan) 8.43 8.89 6.36 1,100 
Gutkha (Pakistan) 8.20–8.54 0.16–2.08 0.12–1.08 83.9–1,560 
Gutkha (India) 8.46–8.88 1.09–2.33 0.86–1.78 370–2,250 
Mainpuri (Pakistan) 7.65 1.28 0.38 219 
Mawa (India) 8.31 0.16 0.11 96 
Snus (Sweden) 7.9 16.7 7.6 6.0-25.2 
Table ?.?. Biochemical comparison of Naswar with other SLT products 
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3.4.2.2  Smokeless tobacco and oral cancer 
The majority of SLT products are used via the oral cavity, hence, the oral cavity is at the 
greatest risk of malignant transformation associated with the use of these products [???]. 
Based on studies carried across Europe and the Americas, Bofetta et al. reported a pooled RR 
of ?.? (??% CI, ?.?-?.?) for oral cancer among SLT users compared to non-users [???]. 
Stratification by geography, however, limited the risk to studies from the U.S, with the 
European studies not reflecting an increased risk of oral cancer with the use of SLT. Other 
reviews state a minimal increase in the risk of oral cancer with the use of SLT products used 
in the western world [??]. In contrast, a study carried out in Sudan reported a considerable 
increase in the risk of oral cancer with the use of a local form of SLT product, “Toombak”, 
OR=??.? (??% CI, ?.?-??.?) [???]. The difference between the reported risks from various 
geographical regions may be attributed to the manufacture of relatively safer SLT products, 
with significantly lower known carcinogen levels e.g. Swedish Snuff [??, ???]. 
3.4.3 Evidence from South Asia 
Four independent systematic reviews of observational studies from South Asia, with varying 
focus and inclusion criteria, have reported a high risk of oral cancer associated with SLT. 
Guha et al., found an mRR of ?.? (??% CI, ?.?-??.?) among the users of Paan, compared to 
non-users [???]. Gupta et al., reported a pooled OR of ?.? (??% CI, ?.?-?.?) and an mRR of 
?.?? (??% CI, ?.?-??.?) among users of betel quid compared to non-users when combining 
case-control and cohort studies respectively [??]. Sinha et al., reported an mOR of ?.? (??% 
CI, ?.?-?.?) for oral cancer among users of SLT compared to non-users, without specifying 
the subtype of SLT [??]. Khan et al., reported an mOR of ?.? (??% CI, ?.?-?.?) among users of 
SLT products other than betel quid, compared to non-users [???]. The reviews were 
unanimous in reporting a comparatively higher risk of oral cancer among female SLT users 
than men, and the existence of an exposure-response relationship between SLT and oral 
cancer. 
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3.5 BIO-EPIDEMIOLOGICAL MODEL OF NASWAR INDUCED CARCINOGENESIS 
Figure ?.? refers to a proposed bio-epidemiological model of carcinogenesis induced by 
Naswar use. This model is adapted from the smoking-induced lung carcinogenesis model 
proposed by Hecht [???]. The process begins with the initiation of Naswar use followed by 
nicotine addiction, leading to the sustained use of the Naswar. Carcinogens present in 
Naswar are absorbed into the blood and processed by the body, resulting in the metabolic 
activation of TSNAs and the subsequent formation of DNA adducts. This is followed by 
genetic mutations, which may ultimately lead to tumor formation. At the same time, co-risk 
factors, some of which work through the same biological mechanism as Naswar, exert their 
influence, resulting in either hastening or retarding the process of carcinogenesis. 
During the metabolic activation stage, cytochrome P??? enzymes activate the TSNAs [???]. 
The activated TSNAs induce primary lesions in the DNA, which usually include nucleotide 
methylations and pyridyloxo-butylations [???]. When DNA adducts persist unrepaired, 
permanent DNA mutations, such as in the RAS oncogene or the TP?? tumor suppressor 
gene, can occur. This may result in uncontrolled cell growth and cancer [???]. Other 
contributory mechanisms to tumor promotion and co-carcinogenesis include chronic local 
inflammation and irritation, oxidative stress, and Reactive Oxygen Species [???].
 Several shades of smokeless (Tobacco) 
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Figure ?.?. Bio-epidemiological model of carcinogenesis associated with Naswar. Adapted from Hecht, ???? [???] 
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4 CONCEPTUAL FRAMEWORK: AT THE INTERSECTION OF CAUSALITY AND CHRONIC 
DISEASE PREVENTION. 
 
“We may never understand illnesses such as cancer. In fact, we may never cure it. But an ounce 
of prevention is worth more than a million pounds of cure”  
            - David Agus 
This doctoral research is anchored in two separate but often over-arching public health 
concepts/domains of chronic disease prevention and causality (Fig ?.?). This chapter will 
focus on the different models of chronic disease prevention, and explore the classical and 
contemporary aspects of causality. This will be followed by a brief description of how these 
concepts have guided the rationale and operationalization of the research carried out in the 
context of this body of work. 
4.1 CHRONIC DISEASE PREVENTION 
Chronic or non-communicable diseases (NCDs) are the largest cause of death globally [???, 
???]. According to the WHO, the expected number of deaths attributable to NCDs will rise 
from ??.? million in ???? to ??.? million by ???? [???]. Cancers constitute a major part of 
NCDs, with recent reports suggesting more than ?? million new cases diagnosed each year 
[???, ???]. Low and middle-income countries (LMIC) suffer from a double burden of disease 
i.e. both communicable and NCDs [???]. In ????, more than three-quarters of the global 
NCD burden was contributed by the LMIC [???]. In Pakistan, NCDs account for more than 
??% of all deaths annually [???]. Cancer alone is responsible for more than ???,??? annual 
deaths in the country [?]. 
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*The four domains of chronic disease prevention-Center for Disease Control, Atlanta, USA [???]. 
 
Figure ?.?. The conceptual flow diagram for this dissertation 
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The rapidly increasing global incidence of NCDs has become a major challenge for most 
countries [???]. In ????, the member states of the United Nations agreed to adopt an 
integrated approach to combat and prevent chronic disease [???]. Research plays an 
important role in chronic disease prevention [???]. To tackle public health problems 
effectively, practice and policy should be based on sound research evidence [???]. Although 
LMICs suffer from the highest burden of NCDs, there is a scarcity of NCD research evidence 
generated from these countries [???]. The importance of NCD research has been 
emphasized upon in a number of key NCD control documents, relative to Pakistan. Table 
?.? refers to some of these key documents and how the issue of research has been addressed 
in each one of these. 
From the review of the key documents and the cancer prevention models reported in the 
literature [???-???], it is evident that research on the risk factors for cancer and other NCDs 
is imperative to the prevention and control of these diseases. This theoretical construct 
served as a rationale for carrying out epidemiological research on oral cancer in Pakistan, 
commencing with a scoping review of oral cancer research output, and culminating in the 
analysis of the cumulative evidence of the risk of oral cancer associated with Naswar. The 
scoping review [??], identified research gaps, and potential areas for future research, while 
the systematic reviews [??, ???], established SLT as a major player in the etiology of oral 
cancer in South Asia. The reviews also identified some potential future SLT research areas 
e.g. Naswar use, which has not been researched extensively.  
4.2 CAUSALITY, CAUSAL INFERENCE, AND EPIDEMIOLOGY 
 “de nihilo nihil” (nothing can be born of nothing) 
                                                                                                                                              – Lucretius 
In epidemiology, a cause can operationally be defined as a factor that alters the occurrence 
of a disease [???]. Causality has always been a major point of debate in both science and 
philosophy [???, ???]. Epidemiological studies typically focus on the examination of 
associations between an outcome and an exposure/intervention. This association, though, 
may not be termed as a causal one because of the potential presence of alternative 
explanations e.g. i. It could be a random variation or play of chance, ii. The outcome may be  
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*WHO office of the Eastern Mediterranean Region, **WHO country office Pakistan, ***Hellenic Cancer 
Society, International Congress on Oral Cancer, Hellenic Association for the Treatment of Maxillofacial 
Cancer. 
Organization Name of the 
document 
Domain Context Relevant 
section 
Recommendation/s providing a 
conceptual basis for this dissertation. 
WHO Global action 
plan for 
prevention and 
control of non-
communicable 
disease (2013-
2020) 
NCDs 
control & 
prevention 
Global Objectives 
# 5 and # 6. 
i. To promote and support national 
capacity for high-quality research and 
development for the prevention and 
control of non-communicable diseases. 
ii. To monitor the trends and 
determinants of non-communicable 
diseases and evaluate progress in their 
prevention and control. 
WHO 
(EMRO)* 
 
 
 
 
 
 
Plan of action for 
the prevention 
and control of 
non-
communicable 
diseases in the 
Eastern 
Mediterranean 
Region. 
NCDs 
control & 
prevention 
Regional 
including 
Pakistan. 
 
Objectives 
# 4 and # 6. 
i. Promote research for the prevention 
and control of non-communicable 
diseases. 
ii. Monitor non-communicable diseases 
and their determinants and evaluate 
progress at the national, regional and 
global levels. 
WHO 
(Pakistan)** 
National action 
plan for NCD 
control 
NCD control 
& prevention 
Pakistan Section 
2.2.3 
Research should focus on identifying 
causal associations for risk factors that 
have implications for setting targets for 
preventive interventions. 
WHO and 
partners*** 
“Crete 
Declaration on 
oral cancer 
prevention 2005-
a commitment to 
action” 
Oral cancer 
control & 
prevention 
Global Section a 
and b. 
i. Provision of systematic 
epidemiological information on the 
prevalence of oral cancer and cancer 
risks in countries, particularly in the 
developing world. 
ii. Promotion of research into 
understanding biological, behavioral and 
psychosocial factors in oral cancer, 
emphasizing the interrelationship 
between oral health and general health. 
 Table ?.?. Importance of research in the prevention and control of NCDs and oral cancer 
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a cause of the exposure (reverse causality), iii) It could be a result of the systematic error, iv. 
The chronic diseases usually have a multi-factorial, as opposed to a single factor etiology, so 
there might be confounding. Until all these alternative explanations have been ruled out, an 
association cannot be deemed as causation [???, ???].To assess the causal nature of the 
association between two or more variables, epidemiologists have used various models 
grounded in philosophy, epidemiology, and even computer science [???]. Models of 
causality like the Miasma theory, the Germ theory, and Robert Koch’s postulates have played 
a significant role in reducing the burden of communicable disease [???]. However, with the 
coming to fore of the NCDs in the post second world war era, these models were considered 
inadequate to answer the multi-factorial etiology of chronic disease [???]. In ????, Sir Austin 
Bradford Hill came up with nine different criteria [???], which have ever since been used 
extensively in epidemiology to assess associations for causality [???]. Rothman in ???? 
proposed another model, popularly known as “Causal Pies”, which deem multiple sufficient 
causes, each made up of several component causes, to be responsible for disease causation. 
He suggested that each sufficient cause acts like a pie made of the component causes and 
when these component causes join to complete the pie; the outcome is a disease [???]. More 
recently, models embedded in counterfactual thinking have been proposed to assess 
causality in epidemiology. The scientific ground for the counterfactual causality is based on 
the difference between outcomes in the presence of one set of conditions, and the presence 
of an alternative set of conditions i.e. What would be the outcome if the conditions were 
altered from the actual conditions that were observed ?. These models have an inclination 
towards the process of scientific inquiry by experimentation [???, ???]. Causal diagrams or 
“Directed Acyclical Graphs” are rooted in artificial intelligence and are becoming 
increasingly popular among epidemiologists [???]. These diagrams describe causal pathways 
based on uni-directional relationships between different measured and unmeasured study 
variables [???, ???]. Robins [???-???], and Greenland [???], introduced causal diagrams in 
epidemiology, providing a simple method to visually assess epidemiological associations 
between outcomes and predictor variables [???]. These diagrams aid researchers in data 
collection by identifying potential confounders that have to be conditioned during the 
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analysis. Moreover, they also identify variables, whose adjustment could potentially 
introduce bias, where none previously existed [???].  
Although randomized experiments accompanied by causal diagrams, provide a robust 
method to assess causal associations, it is not always possible to conduct experimental 
studies in humans, for practical and ethical reasons [???]. Hence, well-designed 
observational studies still play a major role in the assessment of causality. There have been 
recent calls for a more pluralistic approach to determine causality, rather than following just 
one model, as the main aim of all the epidemiological models is to prevent disease [???]. 
4.3 CAUSALITY IN CANCER EPIDEMIOLOGY 
Cancer risk assessment can sometimes be a controversial issue due to the inherent 
limitations of observational studies, which are by far the most used designs in cancer 
epidemiology [???, ???]. Nonetheless, evidence from these studies remains as one of the 
primary influencers of cancer control policy and practice [???, ???]. The International 
Agency for Research on Cancer (IARC) assesses the carcinogenicity of various agents in 
humans [???]. The evidence for this assessment comes from epidemiological studies in 
human beings, laboratory studies on animals, and mechanistic considerations [???]. Owing 
to the difficulties of carrying out randomized studies in humans [???], epidemiological 
evidence for establishing a causal association between a putative risk factor and cancer, 
usually comes from observational studies [???, ???]. Even though experimental studies can 
be, and are carried out on animals, to study associations between risk factors and cancer, 
observational studies of humans are often considered superior to the animal studies. The 
argument being that sound conclusions about normal or pathological phenomenon in 
humans can only be made by studying humans [???, ???].  
Cohort and case-control designs are predominantly used in cancer epidemiology to assess 
associations. These studies are prone to the issues of bias and confounding [???], particularly 
in the case of case-control designs [???, ???]. Despite these issues, case-control studies are 
usually the first design choice in etiological research owing to their speed and efficiency and 
are especially indispensable in research of a rare disease like cancer [???]. In general, a 
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careful design, stringent quality control, thorough exposure assessment, and a sound 
analytical approach can all help in minimizing bias and confounding in case-control studies 
[???]. More specifically, an explicit definition of the selection criteria, and case 
ascertainment, full or at least partial blinding of the investigators to the case/control status 
of study participants/ study hypothesis, avoiding differential exposure assessment, and 
addressing confounding during study design or analysis are some of the measures that can 
be taken to increase confidence in the results of case-control studies [???, ???, ???]. In the 
absence of the evidence of confounding and bias, etiological inferences can be made from 
the results of adequately powered observational studies that address specific hypothesis 
[???]. Criteria such as the strength of association and its consistency, a dose-response 
relationship, and most importantly the evidence of temporality, can strengthen the 
argument for causality [???]. 
The aforementioned concepts of “causality” in cancer epidemiology have guided the various 
stages e.g. development of the study questionnaire, recruitment of the study subjects, data 
collection, and analysis (Fig ?.?), of a case-control study, carried out in the context of this 
body of work. Data collection methods, regarding the correct quantification and assessment 
of exposure at increasing levels of its duration, frequency, and intensity, were intended to 
establish the strength, temporality, and an exposure-response relationship, for a causal 
inference. Efforts to minimize bias and confounding in the study included recruitment of 
study participants from a single base population, partial blinding of interviewers and 
interviewees to the case/control status, and the use of causal diagrams.
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Figure ?.?. The conceptual framework for this dissertation 
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5 METHODS 
 
“To put everything in balance is good; to put everything in harmony is better.” 
                        - Victor Hugo 
This chapter provides a description of the research methods that were used to address the 
primary and secondary objectives of this body of work. The methods of the “Oral Cancer 
epidemiology in Khyber Pakhtunkhwa, Pakistan” (OraCEP), study (Article V and VI), are 
described in detail. The methods used to address the other objectives of this dissertation 
(Articles I-IV and VI-VIII) are described briefly as the detailed description of these, is given 
in the corresponding manuscripts. (See annexure). 
5.1 SPECIFIC OBJECTIVE I - NASWAR USE AND THE RISK OF ORAL CANCER IN KHYBER 
PAKHTUNKHWA, PAKISTAN- (ARTICLE V) 
5.1.1 Study design, setting, and participants. 
To assess the association between Naswar use and the risk of oral cancer in the Khyber 
Pakhtunkhwa province of Pakistan, we conducted a matched case-control study from 
September ???? until May ????, in two major cities of the province. Peshawar is the capital 
city of the province, while Abbottabad is a comparatively smaller city, serving as an 
educational hub for the whole of Pakistan. The Khyber Pakhtunkhwa province has an area 
of ??,??? km? and a total population of ??.? million. The population of Peshawar is 
?,???,???, while Abbottabad has ???,??? inhabitants. The majority of the population lives 
in rural areas, and agriculture and trade are the main earning resources [???]. A detailed 
description of the study centers is provided in “Article V”. 
Since primary and secondary healthcare facilities in the province do not have adequate 
means to diagnose and/or manage oral cancer patients, the included study centers are 
mainly responsible for the provision of both diagnostic and curative services for oral cancer. 
Moreover, the services provided by the study centers are not limited to oral cancer or 
dentistry, these centers are a part of large multi-specialty tertiary care hospitals. The 
catchment area of the study centers comprises the whole province, as well as the federally 
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administered tribal areas (FATA) of Pakistan. All study centers were selected based on expert 
opinion of local cancer physicians and dentists. 
A case was a person attending any of the study centers, who was clinically and histologically 
diagnosed with oral cancer, within the study period. For the purpose of this study, “oral 
cancer” was defined as, “squamous cell carcinoma of the buccal mucosa, lip, tongue and the 
oropharynx”. The ICD-?? classification was used to designate oral cancer sites to be included 
in the study. The eligible sites included lip, the base of tongue, other and unspecified parts 
of the tongue, gum, floor of mouth, palate, other and unspecified parts of the mouth, tonsil, 
and oropharynx (C?? - C??, C?? - C?? and C??). 
The recruitment of controls was guided by the principles of causal inference in observational 
epidemiology, i.e. (a.) the cases and controls should come from the same base population, 
that is to say, if a control in the study would have acquired the disease of interest, he/she 
would probably attend the same hospital as the cases, (b.) controls should be recruited 
irrespective of their exposure status [???]. The basic goal is to recruit subjects who are 
representative of the source population [???]. For the purpose of this study, a control was 
defined as “a subject attending any of the study centers during the study period, and having 
any disease with the exception of cancer, pulmonary disease, cardiovascular disease, 
gastrointestinal disease, and periodontal disease”. Given the breadth of conditions that are 
treated at the selected study centers, we excluded certain diagnoses, because they are related 
to different forms of tobacco use and might have produced biased results [???, ???]. It has 
been suggested in the literature that hospital controls being treated for conditions positively 
or negatively associated with the exposure should be excluded [???]. Detailed Eligibility 
criteria for both cases and controls are reported in “Article V”. We employed a frequency-
matching scheme based on variables, which have an established confounding role in the 
etiology of oral cancer, i.e. age and sex [???, ???]. Two matched controls were recruited per 
case from the outpatient and in-patient departments of the study centers.  
5.1.2 Sample size and recruitment of participants 
We calculated the minimum number of cases and controls to satisfy a power of ??% with a 
two-sided confidence interval of ??%, using the previous research findings on the 
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prevalence of Naswar use (exposure of interest) in oral cancer cases, and the general 
population of Khyber Pakhtunkhwa [??, ???-???]. Two sample sizes based on the case to 
control ratio of ?:? and ?:? were calculated, with the prevalence of exposure in cases set to 
??%, and that in controls set to ??%. The Fleiss method, with continuity correction factor 
[???], was used to calculate the sample size with the “StatCalc” function of Epi Info ? [???]. 
The estimated sample size of our study was ??? cases and ??? controls for a ?:? case/control 
ratio or ?? cases and ??? controls for a ?:? case/control ratio. The study started with a ?:? case 
to control ratio, but in December ????, Peshawar was subjected to a deadly terrorist attack 
that resulted in the death of more than ??? schoolchildren [???]. A state of emergency was 
declared in the province, with a very tight security situation in the following months. The 
strict measures taken by the armed forces as a part of an anti-terrorism operation led to a 
decrease in patient in-flow at most hospitals in Peshawar city, as both inter- and intra-city 
movement came to a halt. This decrease in patient in-flow hampered recruitment of cases 
in Peshawar, making it difficult to recruit the desired number of ??? cases for the study, 
within the stipulated time. Therefore, in February ????, we decided to recruit two controls 
per case in order to be able to achieve the desired power for the study. 
5.1.3 Ethical approval 
Ethical approval for the study was granted by the ethical review board of Khyber Medical 
University, and by the ethical review committee of Khyber College of Dentistry (Appendix 
XI). Written consent on a printed form was taken from each study participant before 
recruitment (Appendix XII). All study participants had the option to withdraw their consent 
at any stage of the study if they did not want to continue as a part of the study. To ensure 
maximum participation, histology charges for cases were paid from the study funds. These 
charges are normally paid out of pocket, by the patients. 
5.1.4 Data collection 
The data collection for this study was guided by apriori “DAG” analysis to identify important 
study variables for which data had to be collected. The main outcome variable of our study 
was dichotomous, i.e. absence or presence of oral cancer. The predictor variables, as 
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identified by the DAG analysis i.e. The Minimum Adjustment Set (MAS), included Naswar 
use, tobacco smoking, alcohol use, socioeconomic status (SES), age, and sex.  
The data collection tool for the study was adapted from the “Alcohol-related cancers and 
genetic susceptibility in Europe (ARCAGE)” study [?]. Additionally, questions from other 
previously validated questionnaires on sunlight exposure and SES [???, ???], were also 
incorporated in the study questionnaire (Appendix X). We conducted face-to-face 
interviews with the study subjects, abstracted data from their medical records and 
laboratory results, collected Naswar samples from the market, and Naswar pellet samples 
from the study subjects. We also collected biological samples for the detection of Human 
Papilloma Virus. The collection of blood, saliva, and the resection of tumor tissue for the 
biopsy was carried out by trained doctors and phlebotomists, as per the study hospital 
protocols. A detailed description of the study questionnaire, data collection, and variables 
is provided in “Articles V and VI”. 
5.1.5 Statistical Methods 
The data was double entered in Epi Info ? [???], and then transferred to SAS ?.?. Cary, NC: 
SAS Institute. Inc. [???] for analysis. Random frequency checks, identification of any 
missing or incomplete data, and outlier detection was carried out to clean the data. Due to 
the quality assurance measures observed during data collection, the data set was virtually 
devoid of any missing data. Descriptive analysis of the data was carried out in Epi Info ?, 
while more complex statistical analyses were carried out in SAS ?.?. Frequency distribution 
of the variables in the MAS, as well as socio-demographic variables was computed. We 
carried out both univariate and multivariate analysis to assess the association of the different 
risk factors in the MAS, with oral cancer. For the multivariate analysis, we conducted a 
conditional (conditioned for age and sex) logistic regression analysis using the “PROC 
LOGISTIC” function in SAS ?.?. We also conducted a simple logistic regression analysis, to 
compare its results with the conditional model, as there have been recent suggestions that 
an unconditional logistic regression analysis can occasionally be more efficient for the 
analysis of some matched case-control studies [???]. The outcome was defined as the 
presence or absence of oral cancer, and age, sex, any tobacco use, alcohol use, and 
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socioeconomic status were set as the predictor variables in the model. Proxy variables were 
used to categorize continuous variables, e.g. socioeconomic status, and Naswar pack-year. 
The main analysis included estimation of odds ratio (OR) for “Ever-users” compared to 
“Never-users”, of Naswar, other tobacco, and alcohol. ORs were also calculated for the 
exposure-response relationship between Naswar and oral cancer. Cumulative exposure to 
Naswar (Naswar pack-years) was used to assess this relationship. Both crude and adjusted 
odds ratios with their ??% confidence intervals were calculated. We also carried out a 
stratified analysis by sex using simple logistic regression. A more detailed description of the 
data analysis is provided in articles V and VI. 
5.2 SPECIFIC OBJECTIVE II - ORAL CANCER RESEARCH IN PAKISTAN (ARTICLE I) 
An electronic search in “Medline” via “PubMed”, “Science Citation Index” via “Web of 
Science” and “PakMedinet” databases, supplemented by a google search, was carried out in 
January and February ????. Publications were included in the review based on preset 
criteria. Data from the included articles were recorded and analyzed in Microsoft Excel. The 
analysis included estimation of yearly, as well as total research output in terms of 
publications. We computed the frequency of publications based on research study types, 
exposures, and outcomes, publication in indexed compared to non-indexed journals. We 
also performed a stratified analysis based on the research institute of the first author of the 
included studies, and by geographical region in Pakistan. 
5.3 SPECIFIC OBJECTIVE III – SMOKELESS TOBACCO AND ORAL CANCER IN SOUTH ASIA (ARTICLE II) 
An electronic search was carried out in “Medline” via “PubMed” and “Science Citation Index” 
via “Web of Science”, in August ???? using a combination of MeSH terms. This search was 
supplemented by a google search. Articles were included/excluded in the review using pre-
specified inclusion/exclusion criteria. The included articles were assessed for their quality 
using the “Effective Public Health Practice Project’s Quality Assessment Tool for 
Quantitative Studies” [???]. Data from the included articles were abstracted on a pre-
designed spreadsheet and later transferred the Cochrane RevMan ?.? software [???], for 
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analysis. We pooled the log risk estimates from the included studies to calculate a summary 
risk estimate, using the “inverse variance” method through a random effects meta-analysis. 
We also carried out a subgroup, and sensitivity analyses, to determine the effects of 
individual studies on the summary effect. Heterogeneity was quantified using the I? statistic. 
Publication bias was visually assessed via funnel plots. 
5.4 SPECIFIC OBJECTIVE IV - SMOKELESS TOBACCO AND ORAL POTENTIALLY MALIGNANT DISORDERS 
IN SOUTH ASIA (ARTICLE III AND IV) 
Article III reports the protocol of a systematic review. The protocol was guided by and was 
in accordance with, the “Preferred Reporting Items for Systematic Reviews and Meta-
Analysis - Protocol” (PRISMA-P) guidelines [???]. In Article IV, a systematic review and 
meta-analysis of the association of SLT with Oral Potentially Malignant Disorders (OPMDs) 
is reported. We undertook a systematic literature search, using MeSH terms and keywords 
in Medline via PubMed, the Science Citation Index (SCI) via Web of Science, Scopus, and 
CINAHL databases. Articles were excluded from or included in the review based on preset 
inclusion/exclusion criteria. The quality of the included studies was assessed by the 
““Effective Public Health Practice Project’s Quality Assessment Tool for Quantitative 
Studies” [???]. Data were abstracted and recorded on a spreadsheet. Effect estimates were 
calculated for the studies that had not explicitly reported them but had sufficient data to 
calculate them. Statistical analyses were carried out in Rev Man ?.?. Log effect estimates 
were combined using the inverse variance method in a random effects model, to obtain a 
meta-odds ratio (mOR). Subgroup analyses included estimation of an mOR for: (?) the risk 
of developing individual sub-type of OPMD associated with the use of any SLT; (?) the risk 
of developing any OPMD with the use of different subtypes of SLT; (?) the risk of developing 
OPMDs based on intensity and duration of SLT use; and (?) the risk of developing OPMDs 
between male and female SLT users. Country-specific estimates (Sri Lanka and India) were 
also calculated. We conducted sensitivity analyses to assess the causes of heterogeneity. 
Publication bias was assessed through the visual inspection of funnel plots. 
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5.5 SPECIFIC OBJECTIVE V - CUMULATIVE EVIDENCE OF THE ASSOCIATION OF NASWAR USE AND 
ORAL CANCER IN PAKISTAN (ARTICLE VIII) 
We conducted a systematic electronic search in “Medline” via “PubMed”, “Science Citation 
Index” via “Web of Science”, and “PakMedinet” using a combination of keywords and MeSH 
terms. Selection of articles was carried out according to a pre-set criteria. Data were 
abstracted from the included articles on a pre-designed spreadsheet. Adjusted odds ratios 
with their ??% confidence intervals were recorded. When these were not available, crude 
odds ratio were recorded or calculated from the given data. If possible, a stratified effect 
estimate (ORMH), using the Mantel-Haenszel method [???] was calculated. A pooled 
analysis was carried out using both random and fixed effects model in STATA. Heterogeneity 
was assessed by using the I? statistic and publication bias was assessed by a visual inspection 
of funnel plots. The Population attributable fractions of oral cancer with the use of Naswar 
were calculated for Pakistan as a whole and for the constituent provinces.  
5.6 SPECIFIC OBJECTIVE VI – GAPS IN SMOKELESS TOBACCO CONTROL POLICY IN PAKISTAN 
(ARTICLE VI) 
A systematic electronic search of documents pertaining to the Government of Pakistan’s 
tobacco control policies and strategies was carried out using keywords. The included 
documents were appraised for the presence or absence of laws, rulings, state orders, and 
statutes, regarding smokeless tobacco control in Pakistan. Data from the documents were 
recorded on a spreadsheet and the findings were presented in a research 
communication/short review. 
5.7 SPECIFIC OBJECTIVE VII – POLICY RECOMMENDATIONS (ARTICLE VII) 
Manuscript VII is a guest editorial on the use of Naswar in the Khyber Pakhtunkhwa 
Province of Pakistan. It reviews the evidence gathered from the other manuscripts in this 
dissertation and presents a case for policy revision.  
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6 KEY RESULTS 
 
“I pass with relief from the tossing sea of Cause and Theory to the firm ground of Result and 
Fact.” 
- Sir Winston S Churchill on facing an uprising, in what is the current Khyber 
Pakhtunkhwa province. ‘The Story of the Malakand Field Force’, ????. 
This chapter summarizes the key results pertaining to the objectives that guided this body 
of work. These results have been described in more detail in the related manuscripts (see 
appendices I - VIII).  
6.1 RISK OF ORAL CANCER ASSOCIATED WITH NASWAR USE IN KHYBER PAKHTUNKHWA, PAKISTAN. 
(ARTICLE V) 
We found a strong association between the use of Naswar and oral cancer in the Khyber 
Pakhtunkhwa province of Pakistan. “Ever-users” of Naswar had a more than ??-fold higher 
risk of oral cancer compared to “Never-users”, OR=??.? (??% CI, ?.?-??.?). Compared to 
“Never-users”, the risk was highest for “Current-users” of Naswar, OR=??.? (??% CI, ??.?-
??.?). “Past-users” had a ??-fold higher risk of developing oral cancer compared to “Never-
users”, OR=??.? (??% CI, ?.?-??.?). The risk of oral cancer for “Ever-users” compared to 
“Never-users” of Naswar was higher among women, OR=??.? (??% CI, ?.?-???.?), compared 
to men, OR=??.? (??% CI, ?.?-??.?) There was no difference in the risk of oral cancer 
incidence between the “green” and “black” varieties of Naswar. Spitting the saliva after 
Naswar use was associated with a lower risk for oral cancer compared to swallowing saliva, 
OR=?.? (??% CI, ?.?-?.?). Figures ?.? and ?.? describe the exposure-response relationship 
between Naswar use and oral cancer among both sexes. More than ??% of the primary 
tumors originated either from the gingiva (Alveolus) or from the buccal mucosa, which are 
the primary anatomical sites coming in direct contact with a Naswar pellet. Tobacco 
smoking was also significantly related to oral cancer  with “Ever-smokers” having a two fold 
elevated risk of oral cancer compared to “Never-smokers”, O.R=?.? (??% CI, ?.?-?.?). 
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Alcohol (p-value=?.??) and socioeconomic status (p-value=?.??) were not significantly 
associated with oral cancer in Khyber Pakhtunkhwa, Pakistan. 
 
Y-axis: Natural log of Odds Ratio, X-axis: Naswar pack-years 
 
 
Y-axis: Natural log of Odds Ratio, X-axis: Intensity of Naswar use (duration of single use in minutes) 
Figure ?.?. Relationship between the cumulative exposure to Naswar (Naswar pack-
years) and the risk of oral cancer in Khyber Pakhtunkhwa, Pakistan 
Figure ?.?. The relationship between the intensity of Naswar use and the risk of oral 
cancer in Khyber Pakhtunkhwa, Pakistan. 
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6.2 ORAL CANCER RESEARCH IN PAKISTAN (ARTICLE I) 
??? publications were included in the review. Important characteristics of the included 
studies along with their references are given in the Supplementary table ? (Annexure). ??% 
(n=??) of the publications were published before the year ????, ??% (n=??) were published 
between ???? and ????, while ??% (n=??) were published from ???? onwards. The 
majority of the studies were descriptive and case series was the most common study type 
(??%). There were only six epidemiological case-control studies to assess the association 
between lifestyle risk factors and oral cancer in Pakistan and none of them was carried out 
in the Khyber Pakhtunkhwa province. 
6.3 SMOKELESS TOBACCO AND ORAL CANCER (ARTICLE II) 
6.3.1 Chewing tobacco 
?? publications were included in this meta-analysis. Studies adjusting for alcohol and 
smoking, when combined, provided a pooled OR of ?.? (??% CI, ?.?-?.?). The pooled OR 
from combining only case-control studies was ?.? (??% CI, ?.?-?.?). Cohort studies, when 
combined, provided a pooled OR of ?.? (??% CI, ?.?-?.?). Studies carried out in men only 
when combined provided a pooled OR of ?.? (??% CI, ?.?-?.?). The risk among women (? 
studies) was in the range of ?.? (??% CI, ?.?-?.?) to ??.? (??% CI, ??.?-??.?). Studies that 
had adjusted for smoking and alcohol use, reported ORs varying from ?.? (??% CI, ?.?-?.?), 
for chewing tobacco or chewable products containing tobacco for less than ? times a day, to 
??.? (??% CI, ?.?-??.?), for more than ?? times a day, compared to non-chewers. 
6.3.2 Betel quid 
Nine studies were included in the meta-analysis of the risk of oral cancer associated with 
Betel-quid use. Studies that adjusted for alcohol and/or smoking, when pooled, provided an 
mOR of ?.? (??% CI, ?.?-??.??). Betel quid chewers who chewed for less than ? times/day 
had a ?-fold higher risk of oral cancer compared to non-chewers, the risk increased to ??-
fold with a chewing frequency of ?? times/day. The OR for chewing habit duration varied 
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from ?.? for a chewing habit of fewer than ?? years to ??.? for a chewing habit persisting for 
?? years or more. 
6.4 SMOKELESS TOBACCO AND ORAL POTENTIALLY MALIGNANT DISORDERS (ARTICLE IV) 
A total of ?? studies was included in this review. The pooled risk for OPMDs with the use of 
SLT was ??.? (??% CI, ?.?-??.?). Exclusion of studies that had not reported an effect estimate 
adjusted for alcohol and smoking provided a pooled OR of ??.? (??% CI, ?.?-??.?). The 
adjusted meta-risk for the development of Submucous fibrosis with the use of “all SLT” was 
??.? (??% CI, ??.?-??.?). Lower risks were observed for Leukoplakia, mOR=?.?? (??% CI 
?.?-??.?). The pooled risk for the development of “all OPMDs” with the use of betel quid with 
tobacco was ??.? (??% CI, ?.?-??.?). The corresponding risk, with the use of Gutkha, was 
much lower at ?.? (??% CI, ?.?-?.?). Compared to non-users, the pooled risk for developing 
an OPMD with up to ?? years of SLT use was ??.? (??% CI, ??.?-??.?). The risk increased to 
??.? (??% CI, ??.?-??.?), for an SLT habit of up to ?? years. The Population attributable 
fraction of SLT use for oral cancer in India was ??% and that for Sri Lanka was ??%. 
6.5 NASWAR USE AND THE RISK OF ORAL CANCER: POOLED EVIDENCE FROM PAKISTAN (ARTICLE 
VIII) 
Five studies were eligible for the review. Two studies each were carried out in Sindh and 
Khyber Pakhtunkhwa provinces and one study was from Punjab. Three studies had a 
moderate rating and two were rated low, based on the “Effective Public Health Practice 
Project’s Quality Assessment tool for Quantitative studies” [???]. Gender specific estimates 
were provided by two studies, and two studies provided data on the exposure-response 
relationship between Naswar use and the risk of oral cancer. 
The overall risk [Meta OR (mOR)] (five studies) for oral cancer associated with Naswar use 
was ??.? (??% CI, ?.?-??.?) and ??.? (??% CI, ?.?-??.?) with fixed and random effects, 
respectively. The I? statistic had a value of ??%. When only the studies with a moderate 
quality were included in the meta-analyses, the mOR was ??.? (??% CI, ??.?-??.?) in both 
random and fixed effects analysis, with an I? of ?%. Females [mOR ??.? (??% CI, ??.?-??.?)] 
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had a comparatively higher risk of oral cancer compared to males [mOR ??.? (??% CI, ??.?-
??.?)] but the confidence interval overlaps.  
6.6 SMOKELESS TOBACCO-RELATED GAPS IN TOBACCO CONTROL POLICY OF PAKISTAN (ARTICLE VI) 
Sale of “cigarettes” and other “smoking” substances to minors is banned in Pakistan, but 
smokeless tobacco has not been addressed specifically in the policy, on a national level. 
There is a selective prohibition, regarding some forms of SLT, in just one province of 
Pakistan, i.e. a ban on the sale of Gutkha in the Sindh province. On the national level, public 
sector buildings, educational institutions and hospitals have been declared “smoke-free” but 
not “tobacco-free”. 
The adjuvant laws that inform the tobacco control policy in Pakistan, ban children under 
the age of ?? years from selling or getting involved in the manufacture of tobacco related 
products. However, there are no such provisions for adolescents (??-?? years), except in 
Khyber Pakhtunkhwa province. There are no provisions in the national laws concerning 
regulation, taxation, or health warnings for smokeless tobacco. 
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7 DISCUSSION: A DISCOURSE ON CAUSALITY AND PREVENTION 
 
“New opinions often appear first as jokes and fancies, then as blasphemies and treason, then 
as questions open to discussion, and finally as established truths.” 
                  - George Bernard Shaw 
This chapter discusses the methods and findings pertaining to this dissertation, in the light 
of the theoretical constructs of “Chronic disease prevention” and “Causality”. More 
specifically, the focus will be on the triangulation of these methods and findings, and how 
they coalesce, to address the broader general objective of this body of work. 
7.1 SMOKELESS TOBACCO AND ORAL CANCER IN SOUTH ASIA (CONSIDERATIONS FOR CAUSALITY) 
7.1.1 Evidence from the systematic reviews 
7.1.1.1 Main findings 
Betel quid with tobacco (Paan) and other forms of SLT used in South Asia were associated 
with an elevated risk of oral cancer. Paan users had a seven-fold increase in the risk of oral 
cancer compared to non-users. The risk for oral cancer with the use of other forms of SLT 
was approximately five times higher compared to non-users. Compared to men, women had 
a higher risk of oral cancer associated with the use of SLT products. We found a direct 
exposure-response relationship between SLT use and oral cancer. Users of any SLT products 
had a ??-fold higher risk of developing OPMDs, compared to non-users. Women had a twice-
higher pooled risk of OPMDs associated with SLT use, compared to men. Betel quid with 
tobacco had the highest associated risk of OPMDs, among all SLT products. Submucous 
Fibrosis had the highest risk associated with SLT use, among all OPMDs. 
7.1.1.2 Interpretation 
The results from the two reviews point towards a potentially causal nature of the relationship 
between the use of SLT and oral cancer and OPMDs in South Asia. In both the reviews, we 
report a high magnitude of the pooled risk estimate and the presence of an exposure-
response relationship between SLT use and oral cancer and OPMDs. Our results were in 
accordance with the systematic reviews of SLT use and the associated risk of oral cancer in 
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South Asia carried out parallel to, or after the publication of our review [??-??]. An elevated 
risk of oral cancer associated with the use of different SLT products in South Asia was 
reported by all the reviews. Similarly, all the reviews found an exposure-response 
relationship between SLT use and the incidence of oral cancer. Moreover, our findings were 
in accordance with the findings of the reviews from other parts of the world [???, ???, ???, 
???]. The findings of the systematic review on OPMDs that an elevated risk of OPMDs is 
associated with SLT use and that an exposure-response relationship exists between the two, 
are comparable to individual studies on OPMD risk factors carried out around the world 
[???-???].  
7.1.1.3 Strengths and limitations 
The systematic reviews reported in this dissertation were the first reviews of South Asian 
literature on the risk of oral cancer and OPMDs, associated with the different forms of SLT 
products. Efforts were made to identify and include all the relevant publications, but some 
publications in local journals, which are not indexed in mainstream databases, may have 
been missed. The reviews were based on observational studies and hence bias e.g. selection 
and recall bias, as well as bias linked to retrospective exposure assessment in the included 
studies, may have influenced our reported risk estimate. We observed a high heterogeneity 
between the included studies. Efforts were made to minimize this through subgroup and 
sensitivity analysis. There was also a lack of studies addressing the less common OPMDs and 
as such, our findings are only applicable to the common OPMDs conditions such as 
Leukoplakia, Submucous Fibrosis, and Erythroplakia.  
7.1.2 Naswar use and the risk of oral cancer in Pakistan 
7.1.2.1 Main findings 
The case-control study (Article V and VI) carried out in Peshawar reports a ?? fold elevated 
risk of oral cancer in Ever-users of Naswar compared to Never-users. An increasing 
cumulative exposure to Naswar i.e. Naswar pack-years was associated with an increasing risk 
of oral cancer and vice versa. A similar relationship was observed between the intensity of 
Naswar use i.e. duration of each use and the risk of oral cancer. About ??% of incident oral 
cancers in Khyber Pakhtunkhwa are attributable to Naswar use. The systematic review 
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(Article VIII) Ever-users of Naswar had a ??-fold higher risk of oral cancer compared to 
Never-users. An increase in the frequency and duration of Naswar use was associated with a 
corresponding increase in oral cancer risk. 
7.1.2.2  Interpretation  
We observed an elevated risk of oral cancer associated with the use of Naswar in the case-
control study and the systematic review of Pakistani literature on Naswar use and the 
associated risk of oral cancer. The high magnitude of the risk estimate in both sexes, the 
presence of an exposure-response relationship, and the existing evidence of the potential 
carcinogenicity of Naswar due to its biochemical composition [???], all point towards a 
causal nature of the association between Naswar use and the elevated risk of oral cancer. 
This is further substantiated by the fact that approximately ??% of the primary tumors, 
reported in our study, developed from the gingival or the buccal mucosal tissue. These are 
the primary anatomical sites coming in direct contact with a Naswar pellet. 
Risk factors for oral cancer are an under-researched area in Pakistan [??]. The case-control 
study at the core of this body of work is the first adequately powered epidemiological study 
carried out in the Khyber Pakhtunkhwa province, to assess the risk of oral cancer associated 
with Naswar use. A previous study from the same region reported a high biochemical risk 
of cancer associated with the constituents of Naswar [???], adding to the plausibility of our 
findings. The prevalence of Naswar use among both cases and controls at ??% and ??% 
respectively, was comparable to the previously reported prevalence of Naswar use, in oral 
cancer cases from this region and the general population of Peshawar [???, ???, ???, ???]. 
The prevalence of Naswar use in controls, though, was much higher compared to the 
national prevalence of Naswar in Pakistan i.e. ?% [??].The difference can be explained by 
the difference in tobacco consumption practices between the different regions of Pakistan 
[??, ???]. The national figures are based on a representative sample of all the provinces of 
the country, our study sample is limited to Khyber Pakhtunkhwa province only, where 
Naswar use is observed as a cultural practice [???]. 
The high magnitude of the risk of oral cancer associated with the use of Naswar, observed 
in our study, is consistent with the existing literature on the risk of oral cancer associated 
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with the use of SLT products such as Gutkha and Betel quid, from India and Pakistan, [??, 
??, ???, ???]. However, in our study, the observed risk estimates are even higher compared to 
these SLT products. This can be explained by the higher amounts of “Tobacco-Specific 
Nitrosamines”, nicotine, and a higher alkalinity (pH) of Naswar, compared to the other SLT 
products used in India and Pakistan [??]. The high pH of Naswar facilitates rapid absorption 
of high amounts of Nicotine, leading to a nicotine dependence [??, ???]. A positive feedback 
cycle then ensues, with more frequent and longer uses of Naswar to curb the nicotine urge, 
and hence, a greater exposure to the carcinogens present in Naswar [??]. Additionally, there 
are suggestions that Naswar causes local tissue trauma by erosion [???], and chronic trauma 
is an independent risk factor for oral cancer [???].  
A previous case-control investigation by merchant et al. [???], from the South of Pakistan, 
reported an OR of ?.? (??% CI, ?.?-??.?), for the risk of oral cancer associated with Naswar 
use. Although of a high magnitude, this estimate is considerably lower than the risk estimate 
reported by us. A difference between SLT products used in different parts of Pakistan may 
be a possible explanation for the difference in the reported risk estimates. As noted earlier, 
Betel quid and Gutkha are the favored SLT products in the south of Pakistan, while in 
northern Pakistan and especially in the Khyber Pakhtunkhwa province, Naswar is the most 
common type of SLT [??, ???]. Betel quid was not significantly associated with an elevated 
risk of oral cancer in our study but Merchant et al reported a higher risk of oral cancer 
associated with the use of betel quid. This implies that the risk factor profile for oral cancer 
might be different in different regions of Pakistan, owing to varied tobacco use practices. 
Our findings though are comparable to a large case-control study (???? cases, ???? controls) 
carried out in the city of Karachi in the ????’s [???]. That study reported a ??-fold increase 
in the risk of oral cancer associated with the use of “Nass”, which is essentially the same 
product as Naswar. Although Karachi is also in the south of Pakistan, the large size of the 
study may have enabled the investigators to calculate more precise estimates regarding Nass, 
compared to Merchant et al., who had a much smaller sample size. 
In the case-control study, current users of Naswar had a higher risk for oral cancer compared 
to past users, similar to the findings reported by a cohort study from India [???]. The 
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exposure-response relationship between Naswar and oral cancer in our study are in 
accordance with the systematic reviews of SLT and the risk of oral cancer i.e. the risk of oral 
cancer increases with increasing frequency, duration and intensity of SLT products use [??, 
??]. Females had a higher risk of oral cancer associated with Naswar use in our study, which 
is similar to other findings from the Indian subcontinent [??, ???, ???]. This can be attributed 
to a lower background risk for oral cancer in women i.e. lower prevalence of smoking and 
alcohol use among women in the Indian subcontinent, compared to men. 
7.1.2.3 Strengths and Limitations 
A case-control study design was chosen to address one of the core objectives of this body of 
work. Although prospective study designs are better suited to establish epidemiological 
associations between putative risk factors and disease, they are sometimes not feasible to 
carry out, particularly when the outcome of interest is a rare disease like oral cancer [???]. 
Case-control studies are a suitable alternative in such situations, providing an efficient and 
cost-effective approach to study epidemiological associations between disease and their risk 
factors [???]. However, case-control designs due to their retrospective nature may be 
susceptible to a variety of biases [???, ???]. Our study was also susceptible to the biases 
inherent to case-control designs. This subsection provides an overview of the strengths and 
the limitations of our case-control study, which are necessary for a correct interpretation of 
our findings. 
Strengths 
? We were able to recruit the required number of participants despite unfavorable 
conditions in the wake of a deadly terrorist attack and the subsequent military 
operations against terrorism in Peshawar. Patient flow to the hospitals was severely 
hampered in the wake of these events, and as a result, we had to change our initial 
design of a ?:? case-control ratio to ?:?. We were successful in recruiting the required 
number of participants in a nine months period and could have possibly recruited 
more cases and controls, if not for the events that took place in Peshawar during the 
study period. 
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? Only incident cases of oral cancer were included in the study to avoid incidence-
prevalence bias [???]. Recruitment of incident cases can also potentially lead to a 
more accurate assessment of the pre-morbid exposure compared to prevalent cases 
[???]. 
? Interviews were carried out prior to the definitive diagnosis of oral cancer in the cases. 
This might have helped in avoiding the issue of differential recall between the cases 
and controls to some extent, as the potential cases were not aware of their disease 
status. The same holds true for interviewer bias as the Interviewers were not certain 
about the case or control status of the interviewee. 
? The hospitals that were chosen for this study have a catchment area that includes 
most of the Khyber Pakhtunkhwa province and the Federally Administered Tribal 
Areas. This can be validated by the district wise distribution of our study participants, 
with all but two of the ?? districts of the province being represented in our study 
sample. This adds to our confidence in the representativeness of the study sample, to 
the source population. 
? Reduction of bias was the focus while recruiting controls for the study. A variety of 
diagnoses was eligible to be recruited as controls to have a diverse selection of 
participants. To detect an effect estimate that is closer to the true effect, cancers and 
tobacco-related diagnoses were excluded,  
? The high response rates achieved by the study helped in minimizing selection bias, 
further adding to the representativeness of our study sample. It also ensured minimal 
missing data. 
? Exposure assessment was carried out with temporality as a consideration. Questions 
regarding lifestyle risk factors were aimed at assessing exposures over the life course 
rather than the near past, which might have been influenced by the present illness. 
This helped us in avoiding temporal ambiguity regarding exposure recall. 
? An effort was made to quantify the exposure of interest in the form of Naswar pack-
years. As has been suggested earlier (Chapter ?), exposure assessment regarding SLT 
products is very tricky, as their production is often unregulated i.e. various sizes and 
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compositions. Additionally, the serving size of Naswar is dependent on the user’s 
personal preference. Given the circumstances and the available resources, the novel 
exposure metric of Naswar pack-years facilitated a more precise calculation of the 
cumulative exposure to Naswar, than would have been possible otherwise. 
? We used a simple poverty scorecard that has been specifically tailored to the Pakistani 
context. To the best of our knowledge, the scorecard has never been used in health 
research before. The scorecard provides an efficient way to assess SES through ten 
simple questions. This considerably reduces the interview time with each participant, 
while providing a valid estimate of SES. 
? Appropriate statistical analyses, guided by apriori causal diagram analysis, were 
carried out to address the aims of the study. 
Limitations 
? Potential interviewer bias can be anticipated in our case-control study. Not all the 
interviewers were blinded to the main hypothesis of the study. Due to limited 
resources, independent interviewers could not be hired and the researcher (doctoral 
candidate), who was aware of the study hypothesis, was a part of the interviewing 
team. 
?  Theoretically, it can be assumed that the interviewers were not familiar with the 
case-control status of the participants, but the presence of the lesion in the oral cavity 
is sometimes obvious to the naked eye, and hence the “case” status. 
? While efforts were made to address the issue of differential recall and temporal 
ambiguity between the cases and controls, these cannot be ruled out completely. 
? Even though a representation of most districts of Khyber Pakhtunkhwa province was 
observed in our study sample, findings from a hospital-based study may not be 
generalizable to the whole population (of Khyber Pakhtunkhwa). The same is true 
for the Naswar-pack years metric, which was developed by using samples from the 
study participants. 
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? Although we were able to recruit more than the estimated number of participants, 
numbers were small for the subgroup and exposure-response analysis and are 
reflected in the precision of the risk estimates. 
? The risk estimates reported in our study have considerably wide confidence intervals. 
We carried out an unconditional analysis to compare the results with those of the 
conditional model and found out very similar results i.e. elevated ORs with wide 
confidence intervals, implying the absence of serious errors or an instability of the 
conditional model.  
? The imprecision of the risk estimates reported by our study point towards potential 
bias in these estimates. However, even if we assume the presence of residual and/or 
unmeasured confounding, the high magnitude of the risk estimates implies that a 
potential causal association between Naswar and oral cancer cannot be ruled out.  
? There may have been an underreporting of the prevalence of tobacco smoking, 
alcohol drinking, and Naswar use in the study participants, particularly the female 
controls. This is due to a social stigma attached to these habits in the Pakistani 
society. 
7.1.3 Smokeless tobacco (Naswar) and oral cancer, a causal association? 
In this subsection, I analyze the findings of the case-control study (Article V) in the light of 
the Bradford Hill criteria for causality [???], Rothman’s causal pies [???], and causal diagrams 
[???]. I do so, with the view that fulfillment of these criteria does not ESTABLISH or REFUTE 
causality between a risk factor and an outcome in absolute terms, but merely supports or 
opposes it [???], as Greenland and colleagues put it “…all causal inference is based on 
assumptions that cannot be drawn from observations alone” [???]. 
7.1.3.1 Bradford Hill criteria 
Although oral cancers have a multifactorial etiology, in the context of South Asia, smokeless 
tobacco plays perhaps the most important role in the causation of oral cancer [??, ???, ???]. 
We report a ??-fold increase in the risk of oral cancer associated with the use of Naswar 
among “Ever-users” compared to “Never-users”. While, the confidence interval around this 
risk estimate is wide, the whole interval lies well above unity, signifying a strong association 
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between Naswar use and incidence of oral cancer. In our study, an increase in the frequency 
of use, the total duration of the Naswar habit, and the duration of a single use, were 
associated with a corresponding increase in the risk of oral cancer. The risk estimates 
reported by our study have been adjusted for other known risk factors such as age, sex, 
alcohol use, tobacco smoking, and socioeconomic status, hence pointing towards a high 
specificity of oral cancer causation related to the use SLT products in South Asia. 
Although case-control studies are not ideal for the analysis of the temporal aspects of an 
association between two variables, the mean duration of Naswar exposure among the cases 
in our study (??.? years), suggests that Naswar use among these cases may well have 
preceded their current illness (oral cancer). The biological model of Naswar related oral 
carcinogenesis presented in chapter ? further validates this assertion (Fig ?.?). The model 
provides a plausible explanation, and the possible temporal sequence, of the events involved 
in the incidence of oral cancer associated with Naswar use. Our finding that more than ??% 
of the cases had a primary tumor arising from either the gums or the cheeks (sites of Naswar 
use), also provides evidence of a temporal succession of oral cancer to Naswar. 
“Article VIII” describes the results of previous case-control studies on the use of Naswar in 
other areas of Pakistan [???, ???, ???, ???]. These results show a strong association between 
the incidence of oral cancer and the use of Naswar. Our findings are thus, consistent with 
the previous findings. The pooled risk estimate reported in article VIII highlights the high 
risk of oral cancer associated with the use of Naswar. Our finding that a high risk of oral 
cancer is associated with the use of Naswar is coherent with previous findings from 
systematic reviews on SLT products used in South Asia [??, ???]. Pooled risk estimates 
reported in these reviews are of a high magnitude, which is in accordance with the risk 
estimates that we have reported. The risk of oral cancer associated with the use of Naswar 
and other SLT products is analogous to the risk of lung cancer associated with tobacco smoke 
i.e. the anatomical site primarily responsible for the absorption of the bioactive ingredients 
in tobacco, is the most susceptible to the development of a tumor [???]. 
Zakiullah et al. reported very high levels of carcinogens in the Naswar samples available in 
the Pakistani market [???].The model of Naswar related carcinogenesis presented in 
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Chapter ? (Figure ?.?) outlines the bio-epidemiological processes that are potentially 
involved in the causation of oral cancer associated with Naswar use. Experimental studies 
in humans for assessing health risks related to the use of Naswar are not practical due to 
ethical considerations. Experiments on animals are also seldom informative given the long 
latency period of cancers and a short life span of experimental animals, as few survive until 
the appearance of tumors [???, ???]. The IARC evaluated experimental studies carried out 
in animals, in the monograph on smokeless tobacco [???], the reviewed literature revealed 
no tumors at the site of application of Naswar but a variety of tumors developed in other 
organs.  
7.1.3.2 Smokeless tobacco (Naswar) as the component of a sufficient cause 
Rothman defines a sufficient cause as "...a complete causal mechanism" that "inevitably 
produces disease." Consequently, a "sufficient cause" is not a single factor, but a minimum 
set of factors and circumstances that, if present in a given individual, will produce the 
disease [???]. In the view of the available literature, the proposed bio-epidemiological model 
of Naswar related carcinogenesis in chapter III, and the research studies carried out in the 
context of this dissertation, a sufficient cause for oral cancer in the context of South Asia can 
be presented as the following pie chart 
 
  
 
 
Figure ?.?. Naswar as the component of a sufficient cause for oral cancer. 
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It is evident that smokeless tobacco (Naswar) plays an important role in the causation of oral 
cancer in the context of Pakistan, as a component sufficient cause. Other sufficient causes 
for oral cancer may also exist, especially in the presence of emerging risk factors such as HPV. 
Smokeless tobacco thus cannot be termed as a “necessary” component of all causal pies for 
oral cancer in South Asia, but when present, contributes to a large chunk of the pie. The role 
of Naswar in oral cancer causation in Pakistan cannot be underpinned enough, as is 
suggested by the high Naswar associated attributable fractions in articles V and VIII, and 
the Naswar attributable incident cases reported in article VIII.  
7.1.3.3 Naswar, oral cancer, and causal diagrams 
Data collection and the subsequent statistical analysis for the case-control study conducted 
in the context of this dissertation were guided by apriori DAG analysis (Article V). A 
“minimum adjustment set (MAS)” of variables was identified through this analysis. We 
observed both direct and indirect unblocked causal paths between Naswar use and the 
incidence of oral cancer. This implies that the relationship between Naswar and oral cancer 
can possibly be a causal one and that this association may be confounded by other variables, 
which would need adjustment during the analysis. Data regarding all the MAS variables was 
collected and the adjustment for the confounding variables was carried out in the logistic 
regression model to compute an unconfounded effect estimate.  
7.1.4 Confidence in cumulative evidence 
The evidence that informs this body of work is produced by systematic reviews of 
observational studies and a case-control study. Evidence generated by systematic reviews is 
usually placed high in the evidence hierarchy [???]. The validity and applicability of 
systematic reviews are often dependent on the quality of the included studies [???]. In 
theory, this could imply that systematic reviews of observational studies are less valid and 
applicable compared to systematic reviews of experimental studies. Observational studies 
have multiple biases inherently related to them, which can affect the quality of a study and 
may produce spurious results [???]. In practice, though, this is not the case, systematic 
reviews of observational studies, particularly those related to disease etiology are 
increasingly becoming popular, and are considered useful in informing policy and practice 
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[???]. Etiological observational studies are usually small and examining several such studies 
simultaneously can give us a deeper insight into real and spurious associations between 
disease and their risk factors [???]. Systematic reviews of observational studies are usually 
carried out to answer questions which cannot be answered by experimental studies due to 
ethical or practical concerns like an outcome being very rare or when there is a lack of 
adequate experimental evidence [???]. In such scenarios, evidence from observational 
studies constitutes the “Best available evidence” [???], that can be used to inform public 
policy and clinical practice [???, ???].  
Case-control studies form an integral part of cancer epidemiology because of their 
speediness, efficiency and cost-effectiveness [???]. Case-control studies are used to 
establish an association between an exposure and a disease (outcome) [???], and are 
invaluable in the studies of rare outcomes, where the causal pathway may span decades 
[???]. It is a refined method of observation that allows us to look back in time and establish 
associations between disease and their risk factors [???]. The case-control study designs are 
particularly important in the context of developing countries, where longer prospective 
studies are not feasible due to a lack of resources [???, ???, ???]. A well-designed and 
properly conducted case-control study can provide valid, informative and unbiased effect 
estimates, which may be comparable with those produced by cohort studies [???, ???]. 
In the context of the pooled analysis of evidence from Pakistan (Article VIII), two 
independent reviewers assessed the quality of the case-control study (Article V), that 
informs the core dissertation of this body of work, by using a validated quality assessment 
tool for quantitative studies [???], and found that the study was of “moderate” quality. The 
reason it did not get a “strong” rating was that the data collection tool for the study was not 
shown to be valid nor reliable. The data collection tool for our study was adapted from a large 
multicenter case-control study carried out in Europe under the umbrella of the IARC [?]. 
Owing to limited resources and time constraints, validity and reliability of the tool could not 
be established in the local context of Pakistan. However, the contents of the questionnaire 
were assessed by senior dentists at the study centers in Pakistan, who unanimously agreed 
that the all the questions were valid and exhaustive, to get the necessary information needed 
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to address the aims of the study. Detailed results of the quality assessment of the case-
control study are provided in as appendix VIII. 
In the light of the above discussion, it can be concluded that although the findings reported 
by this body of work are based on observational research designs, in the absence/infeasibility 
of experimental studies, it represents the “best available evidence”. It can be inferred from 
the evidence generated by this body of work that smokeless tobacco products are strongly 
associated with an increased risk of oral cancer and oral potentially malignant disorders in 
South Asia. It can also be inferred that Naswar use is strongly associated with a high risk of 
oral cancer in the Khyber Pakhtunkhwa province, Pakistan. The application of the Bradford 
Hill criteria to the association between Naswar use and the risk of oral cancer suggests that 
this association may potentially be a causal one. 
7.2 ORAL CANCER PREVENTION IN PAKISTAN 
7.2.1 The lack of epidemiological research 
The importance of research in tackling NCDs has been outlined in chapter ?. In the context 
of this dissertation, we carried out an electronic search of local (Pakistani) and international 
research databases to identify oral cancer literature produced from Pakistan (Article ?). The 
electronic search was supplemented by google searches and hand searches of bibliographies 
of the included publications. Oral cancer research in Pakistan is lagging in terms of 
quantitative output. Although the output has doubled post the year ????, as compared to 
the output from ???? until ????, the growth is only relative. A meager ??? publications from 
Pakistan, addressing oral cancer, were found through searches of national and International 
databases. Only six studies were epidemiological investigations fit to assess the modifiable 
risk factors for oral cancer. Our results are supported by previous findings from Mushtaq 
and colleagues, who observed a general lack of a research culture in Pakistan, which can be 
confirmed by its less than ?.?% share of the worlds’ research output [???]. To put it into 
perspective, Pakistan is the sixth most populous country in the world [???]. The pattern 
(not numbers) of oral cancer literature growth in Pakistan is comparable to findings from 
India [???, ???]. Both countries have seen a rapid growth in oral cancer research output in 
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recent years [???]. The lack of epidemiological studies from Pakistan on relevant risk factors 
for oral cancer is evident by an under-representation in the systematic reviews on the risk of 
oral cancer associated with smokeless tobacco products used in South Asia [??, ??, ???]. 
Although efforts were made to make our electronic searches as exhaustive as possible, 
studies published in journals with no or minimal presence on the world-wide-web might not 
have been included in our review. Citation analysis could not be carried out due to the 
unavailability of suitable data required for such an exercise.  
7.2.2 Gaps in tobacco control policy  
In the context of this body of work, I carried out a review of smokeless tobacco control 
policies in Pakistan (Article VII). Pakistan is a signatory to the WHO’s “Framework 
Convention for Tobacco control”. To date, the focus of tobacco control in Pakistan has 
primarily been on tobacco smoking. In the reviewed policy documents of the Tobacco 
Control Cell of Pakistan, SLT is seldom mentioned, and usually in vague terms, such as 
“other tobacco”. There are no formal regulations regarding the production of the various SLT 
products in Pakistan, neither are these products covered by the tobacco taxation net. Unlike 
cigarettes, there are no health related warnings on the packaging of SLT products produced 
in Pakistan. One of the most alarming gaps in tobacco control policy is perhaps the absence 
of any provisions regarding the prohibition of sale to, and by adolescents (??-?? years), an 
age group which is usually the most vulnerable to take up tobacco habits.  
The findings of the review were in accordance with a previous review of smokeless tobacco 
control policies in South Asia [???]. The finding that smokeless tobacco sale to and by 
minors is not explicitly prohibited by the tobacco control policy of Pakistan, is, however, in 
contrast to the findings of Khan et al. We have provided the grounds for this disagreement 
in the related manuscript (Article VI). Efforts were made to include all the related policy 
documents available on the national and provincial Government websites but there is a 
possibility that unpublished documents which have been recently approved or are in the 
process of getting approvals, and not yet available on the world-wide-web, might not have 
been included in this review. 
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8 CONCLUSIONS AND PERSPECTIVES 
 
“We are not going in circles, we are going upwards. The path is a spiral; we have already 
climbed many steps.”  
                 -Hermann Hesse 
 
Non-communicable diseases pose a great challenge to public health in the ??st century [???]. 
A key aspect in the prevention of NCDs is the generation of research evidence regarding the 
causes and risk factors of these diseases [???]. Sound research evidence, synthesized 
through rigorous methods, has a potential to drive both policy and practice [???]. It is 
imperative that such evidence is produced in the local context of the countries, as risk factor 
profiles and genetic make-up of the people differ in various geographical regions [???]. 
Findings from industrialized countries may not be applicable to developing countries and 
vice versa.  
The incidence of oral cancer is on the rise in Pakistan [?]. The excessive burden of oral cancer 
in Pakistan necessitates research into the causes and risk factors of this disease. A lack of a 
research culture and the non-availability of resources are obvious reasons for the scarcity of 
oral cancer research in Pakistan. However, researchers should also be shouldering the 
responsibility, their motivation for doing research should be the prevention and elimination 
of disease, rather than a satisfaction of the minimum number of publications required for 
promotion. 
Smokeless tobacco use presents a unique public health dilemma. The IARC has labeled SLT 
as a Group I carcinogen in humans [??], but aided by evidence from a few research studies 
conducted on Swedish SLT products, some tobacco control experts vouch for SLT use as 
means of tobacco harm reduction [???]. This further emphasizes the point made earlier 
about the importance of research in a local milieu. The two systematic reviews carried out 
in the context of this dissertation, show that the use of SLT is associated with an elevated 
risk of oral cancer and OPMDs in South Asia. The findings of this dissertation imply that 
approximately ??-??% of the oral cancers and about the same proportion of OPMDs in 
India, Pakistan, and Sri Lanka can be prevented with the elimination of SLT products in 
these countries. The review of tobacco control policies in Pakistan outlined a negligence 
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towards SLT control in the country. If Pakistan aims to relieve its public health system from 
the burden of oral cancer then SLT control policies need to be in place. The rising cigarette 
prices in Pakistan further necessitates this, as more people may potentially take up SLT 
products as cheaper substitutes to cigarettes.  
 On a more local level i.e. Khyber Pakhtunkhwa Province, the results of our case-control 
study suggest a strong association between oral cancer and the use of Naswar. The strength 
of the association, coupled with the exposure-response relationship, and the biochemical 
evidence of Naswar’s carcinogenicity, points towards the possibility of a causal relationship 
between Naswar and oral cancer. It certainly warrants larger studies to assess this association 
in more detail. Naswar is cheap, easily available all over the province and a lack of research 
on its deleterious effects means that potentially many Naswar users might not be aware of 
its health consequences. To add more insult to injury, there are no official regulations 
regarding the manufacture of Naswar, there are no health warnings, and it largely evades 
the tobacco tax-net. The Government of Khyber Pakhtunkhwa province needs to address 
these issues and in the light of the findings of this body of work and formulate a tobacco 
control policy for the province, which specifically targets Naswar.  
8.1 POLICY IMPLICATIONS 
“Smokeless Tobacco” is a recognized term by the WHO and hence, should be used as such 
in the public policy documents, rather than the use vague terms like “other tobacco”, which 
can be misleading and may be misinterpreted. The use of smokeless tobacco, explicitly citing 
“Naswar”, “Gutkha”, and “Paan”, shall be prohibited in public places, offices, and educational 
institutions, akin to the prohibition of tobacco smoking. Sale of all forms of tobacco 
(smoking and smokeless), to and by, a person who is younger than ?? years of age shall be 
prohibited. Health warnings should be made mandatory on the packaging of Naswar and 
other SLT products. As opposed to an absolute ban on SLT products, the government should 
try to introduce regulatory legislation regarding the composition of these products. The 
content of carcinogenic agents in Naswar and other SLT products could be reduced using 
the “Swedish Snus” model. This will ensure a security of the livelihoods and jobs of the 
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workers in the smokeless tobacco industry while reducing the harmful potential of the SLT 
products. These policy provisions should be supplemented by media, and school awareness 
campaigns on the deleterious effects of SLT products. 
 
9 AFTERWORD 
 
A cancer specialty hospital in Peshawar and two tertiary care dental teaching hospitals in 
two other large cities of Khyber Pakhtunkhwa have started working since the conclusion of 
the case-control study presented in this dissertation. This presents an ideal opportunity to 
carry out a larger study, involving more study centers and a larger number of participants, to 
confirm the findings presented in this dissertation.  
At the time of writing, detection of Human Papilloma Virus DNA in the blood and tissue 
samples of our study participants is underway at the Khyber Medical University, Peshawar. 
The Human Papilloma Virus analysis can potentially provide us new insights into the 
changing risk factor spectrum of oral cancer, as has been seen in developed countries. 
The Tobacco control cell of the Government of Khyber Pakhtunkhwa province has shown a 
keen interest in our study findings and have asked them to be shared. We intend to write a 
policy brief in the light of our findings with the aim that these findings would influence 
tobacco control policies in the Khyber Pakhtunkhwa province. As a practice implication, we 
intend to further refine the Naswar pack-year exposure metric, so that it can be used 
clinically akin to the smoking pack-years. This could involve the replication of our original 
methods on a larger scale and a randomly selected sample from the population of Khyber 
Pakhtunkhwa. 
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Introduction
Oral cancer affects around 14.1 million people, 
making it one of the most prevalent cancers in the world 
(Warnakulasuriya, 2009). Developing countries, especially 
those from the South Asian region, have a higher burden 
of oral cancer compared to developed countries (Cancela 
et al., 2010; Krishna Rao et al., 2013; Mishra abd 
Meherohtra, 2014)). With an estimated increase of 13,000 
new cases each year, oral cancer is the most common 
cancer among men and second only to breast cancer among 
women in Pakistan. It also has the second highest cancer 
related mortality rates in the country (IARC, 2012). Oral 
cancer thus warrants immediate public health attention 
and evidence based consorted efforts for its control and 
prevention in Pakistan.
Research into non-communicable oral disease such 
as oral cancer is high on the agenda of the World Health 
Organization’s (WHO) “Oral health program” (Petersen, 
2005). Research is considered to be a central component 
of any cancer control strategy (Sullivan et al., 2014) and 
efforts made to reduce cancer burden involve plans and 
actions based on sound intervention and surveillance 
research, which are important for knowledge synthesis 
(Best et al., 2003). The application of such knowledge 
1Leibniz Institute for Prevention Research and Epidemiology, BIPS, Bremen, Germany, 2Khyber Medical University, 4Institute of 
Management Sciences, Peshawar, 3Multan Medical and Dental College, Multan, Pakistan  *For correspondence: khan@bips.ini-
bremen.de
Abstract
 Background: Oral cancer is the most common cancer among men and second only to breast cancer among 
women in Pakistan. For the effective control and prevention of oral cancer, Pakistan needs to recognize the 
importance of research and generation of the evidence-base which can inform policy making and planning and 
implementation of intervention programs. The objective of this review was to quantify oral cancer research 
output in Pakistan. Materials and Methods: A systematic electronic search in “Medline”, “ISI-Web of Science” 
and “Pakmedinet”, supplemented by a Google search, was carried out in January and February, 2014, to identify 
literature from Pakistan relevant to oral cancer. The selection of publications for the review was carried out 
according to preset criteria. Data were recorded and analyzed using Microsoft Excel. Results: A total of 166 
publications comprising 62 case series, 36 cross sectional, 31 case control, 10 basic laboratory research, eleven 
reviews and two trials, were included in this review. Some 35 % of the publications focused on risk factors for 
oral cancer. COMSATS Institute of Information Technology was the institution with the highest contribution. 
Conclusions??????????????????????????????????????????????????????????????????????????????????????????????????????
be put in place to improve both quality and quantity of oral cancer research in the country.
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and current results of research can help in tackling 
cancer mortality and morbidity in low and middle income 
countries (Sankaranarayanan and Boffetta, 2010). Global 
cancer research priorities exist (National Cancer Institute, 
2012) and new trends are emerging in oral cancer research 
in developed countries. However, for developing countries 
it is imperative that they set their own cancer research 
priorities, based on their needs rather than following an 
agenda set up by high income countries (Sullivan et al., 
2014). The setting up of research priorities and agenda is 
a process that should be founded on available evidence 
and information. However, often it is a problem for policy 
makers to identify and collect such information (Nuyens, 
2007). 
The aim of this paper is to provide an overview, 
including a quantitative analysis of published literature 
?????????????? ??? ????????? ??? ????? ???????????? ????????
objectives are: i) to analyze the growth pattern of oral 
cancer literature from Pakistan, ii) to examine the types 
of research studies, iii) to assess the focus of oral cancer 
publications in Pakistan, and iv) to identify institutions 
contributing literature on oral cancer and the core journals 
publishing this literature. This information can be useful 
for policy makers, future researchers and other stake 
holders.
Zohaib Khan et al
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Materials and Methods
Literature search
A systematic search was conducted in the following 
electronic databases: “PubMed”, “ISI-Web of Science” 
and “Pak Medinet”, using various combinations of the 
words “oral cancer”, “oral carcinoma”, “head and neck 
cancer”, “oral neoplasia”, “squamous cell carcinoma of 
the oral cavity” and “Pakistan”, from January 7, 2014 till 
??????????????????????????????????????? ???? ???????????
process. A supplementary search in the web search engine 
www.google.com.pk and choosing the option “Pages 
from Pakistan” was also carried out to minimize the 
possibility of missing potential literature. Bibliographies 
of the selected publications were additionally searched to 
identify any further relevant studies. 
For the purpose of this literature search, oral cancer 
????????????????????????????????????????????????????????
cavity (the mouth) or the oropharynx (the part of the 
throat at the back of the mouth)” (National Institute of 
Health, 2014) 
Inclusion criteria
Publications were included in the review if they 
?????????????????????????????????i) With the exemption of 
review articles, the research described in the publication 
was carried out in Pakistan or was in the context of 
Pakistan. ii) Oral cancer was the main focus or one of the 
foci of the publication. iii) Manuscript published in an 
indexed or non-indexed journal up to 29.02.2014
Exclusion criteria
iv) Publications focusing solely on salivary glands or 
laryngeal or oesophageal cancers. v) Publications (except 
???????????????????????????????????????????????????????????
Pakistan but not carried out in Pakistan or in the context 
of Pakistan. 
Selection of publications
The selection of the publications for this review 
was carried out in three stages: i) Screening of titles of 
??????????????????????????????????????????????????????ii)
scrutiny of abstracts of the publications selected after the 
????????????????????????????????????????????????????????????
abstracts and i) selection of publications to be included in 
this review based on the scrutiny of full texts (Figure 1).
Data abstraction
Two authors (Z.K and J.T) separately abstracted 
the following data from the selected publications on a 
??????????????? ????????? ?????? ??????????????????????????
year of publication, study type, sample size, main focus 
?????????????????????????????????????????????????????????????
The data were later compared and any discrepancies 
or differences were assessed and dealt with by mutual 
agreement.
The assessment of institutional research output was 
????? ?????? ????????? ????????? ?????????????? ??????????? ???
stated in the publication. Research output on the basis 
of geographical location (District or Division taken as 
an administrative unit) was ascertained by the district or 
???????????????????????????????????????????????????????????
???????????????????????
Publications were also divided into two groups: those 
which were published in indexed journals and those in 
non-indexed journals. Journals indexed in “Medline” 
??? ?????????????? ?????????? ??? ????????? ??????????? ???
addition, the WHO database “Index Medicus for the 
Eastern Mediterranean region” was searched to identify 
journals that are indexed with it. However, these were 
?????????????????????????????????????????????????????????
Medline or Embase.
Data analysis
Analyses involving the calculation of frequencies 
and percentages were carried out using Microsoft Excel. 
The institutions and geographical administrative units 
in Pakistan with the most number of publications, as 
?????????????????????????????????????????????????????????
????? ???????????????? ??????????????????? ??????????????
was also assessed on the basis of the presence of an 
author belonging to an institute/body outside Pakistan. A 
quantitative summation of the different research foci and 
study designs of the included publications was carried 
out. The cumulative number of research publications 
was plotted against the corresponding year to analyze 
research productivity over time. To identify the core 
journals, Bradford-Zipf plotting (Tsay and Yang, 2005) 
was carried out.
Results 
The search in the three electronic databases returned 
a total of 1692 publications, including duplications. 1196 
publications were left after the exclusion of duplications. 
After application of the selection criteria, a total of 151 
?????????????????? ????????? ??? ??? ????????? ??? ???? ?????
???????? ??????????????????????????????????? ??????????????
???????????????????????????????????? ???? ??????????????
through a search of the bibliographies of the selected 
?????????????????????????????????? ???????????????????? ????
review (Figure 1). Important characteristics of the included 
studies, such as author and publication year, along with 
their references are given in the supplemental Table 1. Full 
texts/abstracts of a further six papers selected after the 
???????????????????????????????????????????????????????????
The titles of these papers were however suggestive of oral 
cancer being the main focus and thus have been included 
in the supplemental table for reference. These publications 
were also incorporated in the “Journal, geographical and 
????????????????????????????????????????????????????????????
could be extracted.
Oral cancer literature growth in Pakistan
???????????????????????????????????????????????????
published in 1972, while the latest publication at the time 
of writing this review was from April 2014 (“Article in 
press” version was available at the time of our electronic 
search). The cumulative growth of oral cancer research 
?????????????????????? ????????????????????????????????????
?????????????????????????????????????????????????????
?????????? ????????????? ???????????????? ???? ???????
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were published from 2010 till February, 2014. There 
were no publications in the years 1973 to 1975, 1978 to 
1985, 1988 to 1991 and 1993. The most productive year, 
in terms of publications, was 2013. The average number 
??????????????????????????????? ??????????????????????????
1972 up to 2000 was less than one. The average number 
of publications increased to 7.5 per year between 2001 
and 2010, and to 20 per year between 2011 and 2013.
Type of research
???? ???????????? ????? ??????? ????????? ???? ???????
???????????????????????????????????????????????????????
???????????????????????????????????????????????????????
???????????????????????????????????????????????????????
?????????????????????????????????????????????????????????
the rest were molecular, chemical, viral and genetic 
????????????? ????????????? ???????????? ??????????????
?????????????????? ???????????????????????????????????????
???????????????????????????????????????????????????????
trials among the included studies.
Foci of research
??????????????????????????????????????????????????????????
for oral cancer, among which 31 studies were of case 
control and two of cross sectional comparative design. 
Among these studies 12 focused on genetic risk factors, 
13 on viral, chemical or molecular risk factors and six on 
lifestyle risk factors. Most of the publications focusing on 
genetic epidemiology were published from 2010 onwards. 
There was only one epidemiological case control study 
focusing on lifestyle risk factors post year 2000.
?????????????????????????????????????????????????????
distribution and hospital/clinic based frequencies of oral 
?????????????????????????????????????????????? ??????????
???? ????? ???????? ??? ?????????? ?????? ??? ???????????
????????????????? ??? ????? ???????? ???????? ??? ??????
pathological characteristics of oral cancer cases. Seven 
studies assessed knowledge and/or attitudes of different 
population groups regarding oral cancer. Four studies 
reported on follow up outcomes of oral cancer. Three 
studies were about quality of life in oral cancer patients 
and two studies focused on cancer care.
Core journals
The included publications were published in a total 
of 65 journals, 39 of which were indexed with “Medline” 
??????????????????????????????????????????????????????
Figure 1. Flow Chart of Publication Selection Process
Figure 2. Cumulative Growth of Oral Cancer 
Literature in Pakistan from 1972 till February 2014
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Figure 3. Distribution of Oral Cancer Publications 
from Pakistan Over Research Journals
Table 1.  Top Ranked Journals According to the Number of Oral Cancer Publications from Pakistan
Rank Journal Name Number of  Cumulative  Impact  Indexed  Indexed  Subject area
  publications number of  factor of  with  with  
? ? ? ????????????????? ???????? ???????? ???????
?? ?????? ??? ????? ??? ???????? ???? ?? ?? ??????????????????????
?? ???????????????????????? ??? ???????? ???? ?? ?? ??????
?? ??????????????????????????????????????? ??? ???????? ???? ?? ?? ??????????????????????
4 J Pakistan Dental Assoc 9 54 (31) N/A X X Dentistry
5 Pakistan J Otolaryngol, Head and Neck Surg 8 62 (36) N/A X X Otolaryngology and head
       and neck surgery
?? ?? ???? ??????????? ?? ???????? ???? ?? ?? ??????????????????????
5 Pakistan Oral and Dent J 8 78 (46) N/A X X Dentistry
5 Ann King Edward Med University 8 86 (51) N/A X X Medicine and Dentistry
Zohaib Khan et al
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in this review were published in journals indexed with 
?????????????????????????????????????????????????????
in journals that are currently not indexed with them. 
However, 44 of the latter were published in journals that 
are currently indexed with the WHO Index Medicus for 
the Eastern Mediterranean region. Three journals were 
indexed with all three databases, while 18 of the “non-
indexed” journals were indexed in the WHO database.
More than half of the included articles were published 
in eight of the 65 journals (Figure 3), with three journals 
publishing more than a third of the articles: the Journal 
???????????? ??????? ??????????????????????? ????????????
????????????????????????????????????????????????????????
???????????????????????????????????? ??????????????????????
1). These select few journals can be termed as “Core 
journals” for oral cancer publications from Pakistan.
Geographical distribution of included publications
Karachi has the highest number of publications with 
????????????????????????????? ????????????????????????
?????????????????????????????????????????????????????
?????????????? ???????????????????????????????????????????
and Abbottabad with 5 publications each. Only two 
publications were from Quetta. Provincially, Sindh has 
???????????? ??????? ???? ?????? ?????????????? ??????? ????
???????????????????????????????????????????? ????
???? ???????? ???????? ?????????? ???????????? ??????? ????
total included studies. There were no publications from 
Gilgit/Baltistan or the federally administered tribal areas.
Institutional output
A total of 63 institutions contributed to oral cancer 
research output in Pakistan. Table 2 includes the major 
institutional oral cancer research producers in Pakistan. 
Other notable contributors include Liaquat university of 
medical and health sciences and Armed forces institute 
?????????????????????????????????????????????????????
memorial cancer hospital, Ayub medical college and 
University of Karachi (four publications each).
Discussion
Historically, in Pakistan, Government policies 
including those in the field of health, have neither 
??????????????????????????????????????????????????????????
(Government of Pakistan, 2001; Government of Pakistan, 
2011), thus underscoring the importance of research. 
This, among many factors, has contributed to a lack of 
research culture in the country, evidenced by Pakistan’s 
????????????????? ??? ???????????? ???????????????? ???????
?????????????????????????????????? ????????????????????????
including health research (Mushtaq et al., 2012). Our study 
shows that the scarcity of research output in Pakistan 
???????????????????????????????????????????????????????????
one of the most prevalent non-communicable diseases in 
the country.
????????????????????????????????????????????????????????
appears to have grown exponentially over time. This 
growth is however relative rather than absolute, since 
publication numbers were very small at the beginning. 
The growth trend in oral cancer research is in contrast to 
???? ????????????????????????????? ?????????????????? ???????
????????????????????????????????????????????????????????
out. No differences in clinical radiology research output 
were seen before or after the year 2000 (Akhtar et al., 
2009). The general pattern of oral cancer literature growth 
in Pakistan however is comparable to the Indian cancer 
research output (Sullivan et al., 2014; Lewison and Roe, 
2012), where oral cancer is one of the most researched 
cancers due to its huge burden of disease. Oral cancer 
research output in both countries has seen a rapid growth 
post year 2000 (Ghaffar et al., 2013). 
The numerical increase in research output in Pakistan 
post year 2000 can be contributed to the emergence of the 
Higher Education Commission (HEC) in the early 2000s 
(Qureshi et al., 2013). The commission issued a directive 
that educational institutions be more research oriented and 
also introduced schemes for students to pursue research 
degrees such as Master and Doctoral programs, where 
publications are a requirement. Additionally, a minimum 
number of research publications are now required for 
promotion to a higher post in academia. The latter 
was implemented in the medical/dental colleges and 
universities by the Pakistan Medical and Dental Council 
(PMDC) and the HEC (Ghaffar et al., 2013). Although 
these steps have contributed to the total number of 
publications, there is a lack of good quality output with 
meaningful impact.
An essential aim of cancer research in low and middle 
income countries should be to understand the social, 
environmental, behavioral and biological determinants 
of the disease in a local context, so as to be able to assess 
???????????????????????????????????????????????????????????
(Sankaranarayanan and Boffetta, 2010). Epidemiological 
case control and cohort studies are effective research 
approaches to understand various risk factors or 
determinants of disease (Song and Chung, 2010). Our 
?????? ?????? ????????? ?????? ?? ??????????? ????? ??? ?????
epidemiological studies in Pakistan. Although an increase 
in genetic epidemiological studies was observed, we did 
????????????????????????????????????????????????????????
factors published after the year 2000. More importantly, 
all the case control studies on lifestyle risk factors were 
carried out in one single city and are therefore most 
likely not generalizable to the whole of Pakistan. Further, 
the majority of the included case control studies were 
laboratory based and investigated molecular and genetic 
risk factors. The practical implementation of such studies 
???????????????????????????????????????????????????????????
Pakistan’s restricted resources. Overall, case series 
studies were the primary study form, reporting simple 
Table 2. Major Oral Cancer Research Producing 
Institutions in Pakistan
Institution City No. of 
  publications
Comsats institute for information technology Islamabad 16
Jinnah post graduate medical centre Karachi 12
Karachi cancer registry Karachi 11
Aga Khan university Karachi 11
King Edward medical university Lahore 10
Dow university of health sciences Karachi 10
Khyber college of dentistry Peshawar 8
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descriptions of oral cancer cases or histo-pathological 
??????????????????????????????????????????????????????
added new knowledge to, nor aided the prevention and 
control of oral cancer in Pakistan. There is also a distinct 
lack of clinical trials on oral cancer in Pakistan, with 
just two trials being conducted, both of which were not 
randomized (Shaharyar et al., 2006; Masud et al., 2007). 
Trials are an important tool for establishing cost effective 
treatment and prevention measures, and should be the 
priority of cancer research in low and middle income 
countries (Sankaranarayanan and Boffetta, 2010; Magrath, 
2010). In contrast, in India cancer research, including oral 
cancer, comprises of a number of case control studies. 
Although these studies might not be up to the standards 
of those in developed countries, this is the right approach 
to assess risk factors (Sullivan et al., 2014). In addition 
to these, focusing on established lifestyle factors (Gupta 
and Johnson, 2014), a few cohort and interventional 
studies have also been well documented (Gupta et al., 
1986; Muwonge et al., 2008; Jayalekshmi et al., 2009; 
Jayalekshmi et al., 2011). 
?????????????????????????????????????????????????????
included in this review were published in just eight of 
the 65 journals which published oral cancer research 
from Pakistan, is comparable to similar studies in cancer 
??????????????????????????????????? ???????????????? ????
world (Tsay and Yang, 2005; Patra and Bhattachariya, 
2005). These journals can therefore be regarded as core 
journals which form the literature basis for oral cancer 
????????? ??? ????????? ?????????? ??????????? ???????????
mentioned directive by the governing bodies of medicine 
and education on having a certain number of publications 
for promotion purposes resulted in authors publishing 
in certain journals, which are recognized by the HEC 
and PMDC, but are often non-indexed with the globally 
recognized Indices (Ghaffar et al., 2013; Mushtaq et al., 
2012). These journals have limited circulation and often 
????? ??????????? ????????????????? ??? ????????? ??? ??????
potential stakeholders and policy makers. In conducting 
????? ???????????????? ??????????? ???????????? ??????????
articles from some of these non-indexed journals. This 
???????????????????????????????????????????????????????????
these journals may have little impact if they fail to reach 
the intended audience.
Karachi is the biggest metropolis in Pakistan 
(World Population Statistics, 2013) and has the highest 
concentration of medical universities in Pakistan. Hence 
it is not surprising that it has the highest research output 
among all the Pakistani cities. The point of concern 
however is the lack of oral cancer research output from 
the bigger cities such as Quetta and Peshawar, which, 
despite having a heavy burden of oral cancer, have 
contributed very little to its research (Begum et al., 2009; 
Roohullah et al., 2012). Also of concern is the lack of 
research from the FATA and Gilgit Baltistan provinces. 
There are no epidemiological data whatsoever available 
on the prevalence or incidence of oral cancer in these 
areas. There appears to be a gradient of inequality in oral 
cancer research carried out in Pakistan, with less research 
being done in areas with poorer access to healthcare. 
This scenario as a whole is comparable to oral health 
improvement and disease prevention on a global level, 
where marked inequalities exist both inter and intra 
regionally (Sgan-Cohen et al., 2013). Oral cancer research 
output appears to be associated with the regional human 
development index of Pakistan (Jamal and Khan, 2007) , 
with, as observed in our study, districts which score high 
on the human development scale having more research 
output and vice versa. 
With regards to institutions, the trend is similar to that 
of the geographical distribution, with institutions based 
in larger cities producing more research publications 
than those in smaller, less developed cities. The Comsats 
institute of information technology is a relatively new 
academic institution which is principally non-medical. 
Despite this, it has produced the most number of 
publications, and along with Karachi cancer registry 
and King Edward medical university, has collaborative 
????????????? ?????????????????????????????????? ????????
of this review which is of great concern is the lack of 
recent publications from the Karachi cancer registry. A 
possible explanation could be the death of its founder who 
was the principal author in most studies produced from 
the registry. This is a possible indication that research 
in Pakistan is generally not institutionalised, but rather 
depends on personal motivation, and in some cases, is an 
activity imposed by the respective authorities (15).
???????????????????????????? ??? ???? ???????? ?????????
output from the cancer specialty hospitals of the Pakistan 
atomic energy commission (PAEC) and the biggest cancer 
hospital in the country, Shaukat Khanum memorial cancer 
hospital (SKMCH). There are just three publications by 
????? ???????? ?????????? ??? ???????????????????? ???? ?????
publications from the SKMCH.
In conclusions, oral cancer is a big public health 
problem in Pakistan and as such needs a serious 
commitment and a holistic approach to tackle it. The 
lack of timely and quality research informing policy and 
practice can be a hindrance to such an approach. This study 
highlights the fact that oral cancer research output from 
Pakistan is lacking in both relative and absolute terms, 
and also that the type of research studies carried out may 
not be in line with the cancer research needs of Pakistan.
Cancer is a heterogeneous disease. Hence, the 
strategies needed for its prevention as well as the research 
needed to devise such strategies should be heterogeneous. 
Although the publications on oral cancer from Pakistan 
reviewed in this paper do tackle various topics regarding 
oral cancer, much of the research done is of a very basic 
level. Most publications are based on institutional records 
and there is a lack of population based studies.
???????????????????????????????? ???????????????????????
which has been made to collect and summarize all the 
oral cancer research done in Pakistan for future use by 
researchers and other relevant stakeholders. This review 
was based entirely on electronic search, and though we 
tried to include all relevant studies, it cannot be ruled out 
that we missed some of the literature. Citation analysis, 
which is sometimes used in such publications could not 
be carried out due to the incompleteness of suitable data 
required for such an exercise. This was due to the presence 
of a considerable number of studies that are unfortunatley 
Zohaib Khan et al
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not included in ISI-Web of Science or Scopus databases, 
where data is available for more complex bibliometric 
analysis.
The government needs to look into setting up a national 
oral cancer research agenda based on local needs. This 
should be done in collaboration with the various stake 
holders such as the Pakistan Medical Research Council, 
PAEC, academia, SKMCH, the Karachi and Punjab cancer 
registries, the pharmaceutical industry and provincial 
health departments. Once an agenda and research 
priorities are set, research projects in the area of need, 
should be commissioned to the educational and research 
institutes. These in turn should carry out these projects 
in collaboration with clinicians and hospital staff, who 
otherwise are unable to conduct research on their own, 
due to a heavy patient load. 
Although communicable diseases are often on the 
priority list of policy makers in Pakistan, the importance 
of non-communicable diseases such as oral cancer need to 
be realized and more concerted efforts should be made for 
their prevention and control. Strategies should be devised 
to combat the high incidence of oral cancer in the country 
???????????????????????????????????????????????????????
research. A holistic approach to cancer research, bringing 
together both medical and non-medical institutions 
with relevant expertise, should be implemented, so that 
researchers with different skills complement each other. 
Research linkages between institutes working on oral 
cancer research should be established. The Pakistan 
???????? ????????? ???????? ????????????? ??????? ??? ????
major cites of Pakistan, can act as a liaison among these 
institutions. The Offices of research, innovation and 
commercialization (ORIC) at the medical and general 
universities, which are responsible for research related 
activities in these universities and also coordinate with 
the HEC on research related funding, can help PMRC in 
bringing together these institutions.
At an institutional level, efforts should be made to 
forge links with international cancer research institutes, 
which can provide technical assistance in carrying out 
novel research projects. Collaborative research with these 
partners and the resultant publications can help increase 
the research understanding of local researchers, resulting 
in well executed research projects and high quality 
publications having an impact on oral cancer prevention, 
treatment and control. 
At the individual level, authors should strive to publish 
research which has a direct impact on disease prevention 
????????????????????????????? ???????????????????????????
methods for the control of oral cancer, keeping the local 
context in mind. In choosing journals for publication, 
authors should try and publish their research work in 
????????? ??????????????????????????????????????????????
cancer research community and are easily accessible to 
potential stake holders, so that their research reaches its 
intended audience.
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Supplementary table: Salient characteristics of the included studies 
 
Study Reference 
Year of 
Publicatio
n 
Journal Type of Study Location 
Institutional 
affiliation Sample size (n) 
Primary focus of 
the study 
(Vahidy et al., 1972) 1972 Surgical oncology Case series Karachi 
Jinnah 
postgraduate 
medical 
centre 
1192 
Diagnosis / 
Accuracy of 
toluidine blue 
(Jafarey & Zaidi, 
1976a) 
1976 Tropical doctor Case control Karachi 
Jinnah 
postgraduate 
medical 
centre. 
1,192/3,562
* 
Lifestyle risk factors 
for oral cancer 
(Jafarey & Zaidi, 
1976b) 1976 
Journal of Pakistan 
medical association Cross sectional Karachi 
Jinnah 
postgraduate 
medical 
centre 
24,784 
Distribution of  oral 
cancer 
(Jafarey et al., 1977) 1977 
Journal of Pakistan 
medical association 
Case control Karachi 
Jinnah 
postgraduate 
medical 
centre 
1,192 
Lifestyle risk factors 
for oral cancer 
(Frequency of 
malignant tumours in 
seven centres of 
pakistan. pakistan 
medical research 
council cancer study 
group.1977) 
1977 
Journal of Pakistan 
medical association 
Cross sectional Islamabad PMRC - 
Distribution of  oral 
cancer 
(Ibrahim et al., 1977) 1977 Clinical oncology Case control Karachi 
Jinnah 
postgraduate 
medical 
centre 
203/112* 
Nutritional 
risk/protective 
factors for oral 
cancer 
(Aziz-ur-Rehman & 
Jafarey, 1986) 
1986 
Journal of Pakistan 
medical association 
Case control Karachi 
Jinnah 
postgraduate 
medical 
centre 
50 / 100* 
Viral risk factors for 
oral cancer 
(Jafarey & Zaidi, 1987) 1987 
Journal of Pakistan 
medical association Cross sectional Karachi 
Jinnah 
postgraduate 
medical 
centre  
6,192 
Distribution of oral 
cancer 
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(Shah & Khan, 1992) 1992 
Journal of 
environmental, 
pathology, 
toxicology and 
oncology 
Case series Abbottabad 
 
Ayub 
medical 
college 
186 
Risk factors for oral 
cancer 
(Khan & Ahmad, 1994) 1994 British dental journal Report Karachi - - 
Report of a dental 
elective 
(Ahmed & Jafarey, 
1995) 
1995 
Journal of 
environmental, 
pathology, 
toxicology and 
oncology 
Case control Abbottabad 
Ayub 
medical 
college 
 
56/156 * 
Viral risk factors for 
oral cancer 
(Khan et al., 1995) 1995 Cancer Case control London 
 
St. Thomas 
Hospital 
24 /24* 
Lifestyle risk factors 
for oral cancer 
(Khurshid & Baseer, 
1995) 
1995 
Pakistan armed 
forces medical 
journal 
Case series Lahore 
Fatima 
Jinnah 
medical 
college 
50  
Risk factors for oral 
cancer 
(Mirza, 1996)** 1996 
Pakistan journal of 
otolaryngology and 
head and neck 
surgery 
- Karachi 
Dow 
university of 
health 
sciences 
N/A 
Distribution of oral 
cancer  
(Khan et al., 1997) 1997 
Journal of Pakistan 
medical association 
Cross sectional Peshawar 
Institute of 
radiotherapy 
and nuclear 
medicine 
13,359  
Distribution of oral 
cancer 
(Mirza et al.,1997)**` 1997 
Pakistan journal of 
otolaryngology and 
head and neck 
surgery 
- Karachi 
Dow 
university of 
health 
sciences 
N/A 
Protective/risk 
factors for oral 
cancer 
(Mirza, 1997)** 1997 
Pakistan journal of 
otolaryngology and 
head and neck 
surgery 
- Karachi 
Dow 
university of 
health 
sciences 
N/A 
Molecular risk 
factors for oral 
cancer 
(Bhurgri et al., 1998) 1998 
Journal of Pakistan 
medical association 
Cross sectional Karachi 
Karachi 
cancer 
registry 
3,500,000 
Oral cancer 
incidence/ 
distribution 
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(Haider, 1998) 1998 
Journal of Baqai 
medical university Review article Karachi 
Baqai 
medical 
university 
N/A 
Care for cancer 
patients 
(Mirza et al., 1998) 1998 
Pakistan journal of 
otolaryngology and 
head and neck 
surgery 
Case control Karachi 
Dow 
university of 
health 
sciences 
130/25 
Viral risk factors for 
oral cancer 
(Mirza, 1998)** 1998 N/A 
Basic laboratory 
research 
Karachi 
University of 
Karachi 
N/A 
Viral risk factors for 
oral cancer 
(Ali et al., 1998) 1998 Biomedica Case series Lahore 
Mayo 
hospital 
202  
Distribution patterns 
and characteristics 
of the cases. 
(Bhurgri et al., 1999) 1999 Journal of Pakistan 
medical association 
Cross Sectional Karachi 
Karachi 
cancer 
registry 
1253  
Oral cancer 
incidence/Distributio
n 
(Latif et al., 1999) 1999 
Journal of 
Rawalpindi medical 
college 
Case control Rawalpindi 
Rawalpindi 
medical 
college 
60/30* 
Chemical risk 
factors 
(Shah & Malik, 
1999)** 
1999 
Annals of King 
Edward medical 
university 
Case series Lahore 
Shaukat 
Khanum 
memorial 
cancer 
hospital 
- 
Treatment/Surgical 
techniques  
(Latif et al., 1999) 1999 
Journal of 
Rawalpindi medical 
college 
Case control Rawalpindi 
Rawalpindi 
medical 
college 
60 /30*  
Chemical risk 
factors 
(Bhurgri et al., 2000) 2000 
International journal 
of cancer 
Cross sectional Karachi 
Karachi 
cancer 
registry 
4268  
Cancer incidence 
including oral 
cancer/Distribution 
(Merchant et al., 2000) 2000 
International journal 
of cancer 
Case control 
Karachi / U S 
A 
Harvard 
school of 
public health 
79/149* 
Lifestyle risk factors 
for oral cancer 
(Latif et al., 2000) 2000 
Pakistan armed 
forces medical 
journal 
Case control Rawalpindi 
Rawalpindi 
medical 
college 
60/30*  
Chemical risk 
factors 
(Asif & Muzafar, 2000) 2000 
Journal of college of 
Physicians and 
surgeons Pakistan 
Case series Abbottabad 
Ayub 
medical 
college 
10  
Patterns and 
characteristics of the 
cases/ Distribution 
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(Shah, 2001) 2001 
Annals of King 
Edward medical 
university 
Review  Lahore 
De’ Mont 
Morency 
college of 
dentistry 
N/A Care for cancer 
patients 
(Cheema & Cheema, 
2001) ** 
2001 
Annals of King 
Edward medical 
university 
Case series Lahore 
Mayo 
Hospital 
Lahore 
- 
Treatment/ Surgical 
technique 
(Aziz et al., 2001) 2001 
Journal of college of 
Physicians and 
surgeons Pakistan 
Case series Lahore 
Allama Iqbal 
medical 
college  
375  
Histopathological 
patterns and 
characteristics of the 
cases. 
(Ali et al., 2002) 2002 Journal of Ayub 
medical college 
Review  Lahore 
Shaukat 
Khanum 
cancer 
memorial 
hospital 
N/A Treatment/ 
Radiation technique 
(Bhurgri et al., 2002) 2002 
Journal of Pakistan 
medical association 
Cross sectional Karachi 
Karachi 
cancer 
registry 
14,243  
Cancer incidence 
including oral 
cancer/ Distribution 
(Zakai et al. , 2002) 2002 
Annals of Abbasi 
Shaheed hospital and 
Karachi medical and 
dental college 
Case series Karachi 
Abbasi 
Shaheed 
hospital 
66  
Pattern of oral 
cancer /Distribution 
(Husein & Husein, 
2002) 
2002 
Journal of Pakistan 
dental association 
Review  Karachi 
Fatima 
Jinnah dental 
college. 
N/A 
Role of general 
dentists in oral 
cancer prevention. 
(Malik, 2002) 2002 
Pakistan journal of 
pathology Review Rawalpindi 
Armed forces 
institute of 
dentistry 
N/A 
Treatment / 
Screening methods 
for oral cancer 
(Ghani, 2002) 2002 
Journal of Pakistan 
association of 
dermatologists 
Case report Karachi 
Liaquat 
national 
postgraduate 
centre 
One 
Lip cancer with 
verrucoid features 
(Kadar & Maher, 2002) 2002 
Journal of surgery 
Pakistan 
Basic laboratory 
research 
Karachi 
Jinnah 
postgraduate 
medical 
centre 
30  
Diagnosis / 
Histological grading 
of oral cancer 
developing from sub 
mucous fibrosis 
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(Bhurgri et al., 2003) 2003 
Asian Pacific journal 
of cancer prevention Case series /Overview Karachi 
Karachi 
cancer 
registry 
1153  
Review of risk 
factors 
(Zakai et al., 2003) 2003 
Annals of Abbasi 
Shaheed hospital and 
Karachi medical and 
dental college 
Case series Karachi 
Abbasi 
Shaheed 
hospital 
60  
Risk factors for oral 
cancer 
(Isaac et al., 2003) 2003 
Journal of Pakistan 
dental association 
Case series Jamshoro 
Liaquat 
university of 
medical and 
health 
sciences 
43  
Patterns and 
characteristics of the 
cases / Distribution 
(Memon et al., 2003) 2003 
Pakistan journal of 
surgery 
Case series Jamshoro 
Liaquat 
university of 
medical and 
health 
sciences 
76  
Treatment 
modalities for oral 
cancer 
(Isaac et al., 2004) 2004 
Pakistan oral and 
dental journal 
Case series Jamshoro 
Liaquat 
university of 
medical and 
health 
sciences 
27  
Histopathological 
features of oral 
cancer. 
(Haider & Mehdi, 
2004) 
2004 
Journal of Pakistan 
dental association 
Case series Karachi 
Abbasi 
Shaheed 
hospital 
70  
Diagnosis 
/Ascertainment of 
referral source. 
(Rashid et al., 2004) 2004 
Journal of college of 
physicians and 
surgeons Pakistan 
Case series Rawalpindi 
Combined 
military 
hospital 
63  
Treatment 
techniques 
(Khurram et al., 2004) 2004 
Journal of Pakistan 
dental association Review article Islamabad 
Margalla 
institute of 
health 
sciences 
N/A 
Molecular risk 
factors 
(Kadar & Hashmi, 
2004) 
2004 Medical channel Case series Karachi 
Jinnah 
postgraduate 
medical 
centre 
25  
Patterns and 
characteristics of the 
cases/ Distribution 
(Lehri et al., 2004) 2004 
Journal of Pakistan 
dental association 
Basic laboratory 
research 
Quetta 
Bolan 
medical 
college 
40  
Diagnosis / 
Evaluation of a 
diagnostic technique 
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(Khan et al., 2004) 2004 
Federation dentaire 
international report 
Pathfinder cross 
sectional survey 
Nationwide N/A N/A 
Distribution of oral 
disease 
(Anwar et al., 2005) 2005 
Journal of clinical 
and experimental 
cancer research. 
Case series Japan 
Kagoshima 
University 56  
Viral risk factors for 
oral cancer  
(Bhurgri et al., 2005) 2005 
Asian Pacific journal 
of cancer prevention 
Cross sectional Hyderabad 
Karachi 
cancer 
registry 
2,840,653 
Oral cancer age 
standardized rates / 
Distribution 
(Hussain et al., 2005) 2005 
Journal of college of 
Physicians and 
surgeons Pakistan 
Cross sectional 
comparative 
Islamabad 
Pakistan 
institute of 
medical 
sciences 
60 
Risk factors for oral 
cancer 
(Wahid et al., 2005) 2005 
Journal of Ayub 
medical college 
Case series Abbottabad 
Ayub 
medical 
college 
60  
Pattern of oral 
cancer/ Distribution 
(Khan et al., 2005) 2005 
Journal of college of 
physicians and 
surgeons Pakistan 
Case report Kohat 
Combined 
military 
hospital 
One 
Treatment Modality 
for oral cancer. 
(Khan & Khitab, 2005) 2005 
Pakistan oral and 
dental journal 
Case series Peshawar 
Khyber 
college of 
dentistry 
80  
Diagnosis / 
Histopathological 
grading of oral 
cancer 
(Khawaja et al., 2005) 2005 
Asian Pacific journal 
of cancer prevention 
Letter to the 
editor/Review Rawalpindi 
Rawalpindi 
General 
hospital 
N/A 
Review of risk 
factors and 
preventive measures 
(Khurram, 2005) 2005 Journal of Pakistan 
dental association 
Basic laboratory 
research 
United 
Kingdom/Isla
mabad 
Margalla 
institute of 
health 
sciences. 
N/A 
Molecular risk 
factors for oral 
cancer 
(Jamil et al., 2005) 2005 
Annals of King 
Edward medical 
university 
Case control Lahore 
Postgraduate 
medical 
institute  
50/50*  
Molecular risk 
factors for oral 
cancer  
(M. Tahir, Ullah, & 
Khan, 2005) 
2005 
Journal of 
postgraduate medical 
Institute 
Case series Peshawar 
Hayatabad 
medical 
complex 
20  
Treatment / Surgical 
technique 
(Bhurgri, Pervez et al., 
2006) 
2006 
Asian Pacific journal 
of cancer prevention 
Cross sectional Karachi 
Karachi 
cancer 
registry 
1,724,915 
Oral cancer age 
standardized rates / 
Distribution 
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(Bhurgri et al., 2006) 2006 
Asian Pacific journal 
of cancer prevention Cross sectional Karachi 
Karachi 
cancer 
registry 
552,509 
Oral cancer age 
standardized rates / 
Distribution 
(Najeeb, 2006) 2006 
Journal of college of 
physicians and 
surgeons Pakistan 
Case series Islamabad 
Pakistan 
institute of 
medical 
sciences 
67  
Patterns of oral  
cancer and treatment 
/ Distribution 
(Khan et al., 2006) 2006 
Pakistan oral and 
dental journal 
Case series Peshawar 
Khyber 
college of 
dentistry 
23  
Diagnosis / 
Histopathological 
grading of tongue 
cancer 
(Jamal et al., 2006) 2006 
Pakistan armed 
forces medical 
journal 
Case series Rawalpindi 
Armed forces 
Institute of 
pathology 
723  
Patterns and 
characteristics of the 
cases /  
(Bhurgri et al., 2006) 2006 
Journal of Pakistan 
medical association 
Review Karachi 
Karachi 
cancer 
registry N/A 
Burden of different 
types of cancers in 
Pakistan including 
oral cancer / 
Distribution 
(Ahmed, 2006) 2006 
Journal of Pakistan 
dental association 
Review  Karachi 
Jinnah 
postgraduate 
medical 
centre 
N/A 
Treatment 
modalities for oral 
cancer 
(Shaharyar et al., 2006) 2006 
Pakistan journal of 
medical sciences Clinical trial Lahore 
King Edward 
medical 
college 
39  
Treatment 
modalities for oral 
cancer 
(Ikram et al., 2006) 2006 
Journal of Pakistan 
medical association 
Case series Karachi 
Aga Khan 
University 80  
Follow up / 
Recurrence of oral 
cancer 
(Jamil et al., 2006) 2006 
Annals of King 
Edward medical 
university 
Case control Lahore 
Ghurki 
hospital 50/50* 
Molecular risk 
factors for oral 
cancer 
(Ahmed et al., 2007) 2007 
Journal of college of 
Physicians and 
surgeons Pakistan 
Case series Wah 
Wah medical 
college 37 
Diagnosis / Occult 
metastasis in oral 
cancer 
(Z. Ahmed et al., 2007) 2007 
Journal of Ayub 
medical college 
Cross sectional Karachi 
Aga khan 
university 
20,000  
Oral cancer 
prevalence and 
decade of life / 
Distribution 
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(Ahmed et al., 2007) 2007 
Journal of surgery 
Pakistan Case series Wah 
Wah medical 
college 714  
Patterns and 
characteristics of the 
cases / Distribution 
(Khan et al., 2007) 2007 
Journal of Pakistan 
dental association 
Case series Peshawar 
Khyber 
college of 
dentistry 
100 
Niswar as a risk 
factor for oral cancer 
(Masud et al., 2007) 2007 Professional medical 
journal 
Clinical Trial Multan 
Nishtar 
hospital 200  
Treatment 
modalities for oral 
cancer 
(Akhtar et al., 2007) 2007 
Journal of Pakistan 
medical association 
Case series Karachi 
Aga Khan 
university 
32  
Treatment / Surgical 
technique 
(Butt et al., 2007) 2007 
Annals of King 
Edward medical 
university 
Review article Lahore 
King Edward 
medical 
university 
N/A 
Viral risk factor for 
oral cancer. 
(Chaudhry et al., 2008) 2008 
Asian Pacific journal 
of cancer prevention 
Cross sectional Lahore 
Sheikh Zayed 
federal post 
graduate 
institute 
41,4017 
Institution based 
prevalence of head 
and neck cancers / 
Distribution 
(Ali et al., 2008) 2008 Oral surgery Case series Karachi 
Aga Khan 
University 140 
Viral risk factors for 
oral cancer 
(Sharif et al., 2008) 2008 
Journal of college of 
Physicians and 
surgeons Pakistan 
Case report Rawalpindi 
Armed forces 
institute of 
pathology 
One  
Rare biphasic 
synovial sarcoma of 
oral cavity 
(Mirza et al., 2008) 2008 
Pakistan journal of 
otolaryngology and 
head and neck 
surgery 
Case control Karachi 
Dow 
university of 
health 
sciences 
130/65*  Diagnosis 
(Ahmed et al., 2008) 2008 
Rawal medical 
journal 
Case series Islamabad 
Pakistan 
institute of 
medical 
sciences 
37  
Treatment / Surgical 
technique 
(Panjwani & Sadiq, 
2008) 
2008 
Pakistan journal of 
medical sciences 
Basic laboratory 
research 
Karachi 
Jinnah 
postgraduate 
medical 
centre 
423 
Genetic risk factors 
for oral cancer  
(Abid et al., 2008) 2008 
Annals of King 
Edward medical 
university 
Case series Lahore 
King Edward 
medical 
university 
30 
Treatment / Surgical 
technique 
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(Musani et al., 2009) 2009 
Journal of Ayub 
medical college Case series Karachi 
Abbasi 
Shaheed 
hospital 
45 
Patterns of oral 
(cheek) cancer / 
Distribution 
(Khan et al., 2009) 2009 
Journal of Dow 
university of health 
sciences 
Case series Karachi 
Civil hospital 
50 
Prevalence of risk 
factors for oral 
cancer among cases. 
(Begum et al., 2009) 2009 
Journal of 
postgraduate medical 
Institute 
Case series Peshawar 
Institute of 
radiology and 
nuclear 
medicine 
628 
Patterns of oral 
(cheek) cancer / 
Distribution 
(Hanif et al., 2009) 2009 
Asian pacific journal 
of cancer prevention 
Case series Karachi 
University of 
Karachi 
16351 
Cancer trends 
including head and 
neck cancers / 
Distribution 
(Isaac et al., 2009) 2009 
Journal of Liaquat 
University of 
medical and health 
sciences 
Case series Jamshoro  
Liaquat 
university of 
medical and 
health 
sciences 
106  
Histopathological 
grading of oral 
cancer 
(Rizvi et al., 2009) 2009 
Journal of college of 
Physicians and 
surgeons Pakistan 
Cross sectional Rawalpindi 
Combined 
military 
hospital 
37  
Quality of life with 
surgical prostheses 
(Cancela et al., 2010) 2010 Head and Neck  Cross sectional 
Worldwide 
including 
Pakistan 
Karachi 
cancer 
registry 
108,780  
Oral cancer age 
standardized rates/ 
Distribution 
(Alamgir et al., 2010) 2010 
Pakistan journal of 
otolaryngology and 
head and neck 
surgery 
Review Karachi 
Bahria 
University 
N/A Genetic risk factors 
(Bile et al., 2010) 2010 
Eastern 
Mediterranean health 
journal 
Cross sectional Islamabad 
World health 
organization 
regional 
office 
29,307  
Prevalence and risk 
factors for oral 
cancers 
(Fadoo et al., 2010) 2010 
Journal of Pediatric 
Hematology 
Oncology 
Case report Karachi 
Aga Khan 
university One  
Squamous cell 
carcinoma in young 
age. 
(Zaidi et al., 2010) 2010 
Journal of Pakistan 
medical association 
Review/Short 
communication 
Karachi 
Aga Khan 
university N/A 
Prevention / Head 
and neck cancer 
control 
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(Kazi et al., 2010) 2010 
Journal of hazardous 
material Case control Jamshoro 
University of 
Sindh 96/110* 
Chemical risk factor 
for oral cancer 
(Kazi et al., 2010) 2010 
Human and 
experimental 
toxicology 
Case control Jamshoro 
University of 
Sindh 92/78 * 
Chemical risk factor 
for oral cancer 
(Liaqat et al., 2010) 2010 
Journal of Ayub 
medical college Case series Rawalpindi 
Armed forces 
institute of 
dentistry 
24  Treatment technique 
(Nosheen et al., 2010) 2010 
Asian Pacific journal 
of cancer prevention 
Case control Islamabad 
Comsats 
institute of 
information 
technology 
388/150*  
Genetic risk factors 
for head and neck 
cancer 
(Shah et al., 2010) 2010 
Journal of Ayub 
medical college 
Case series Rawalpindi 
Armed forces 
Institute of 
dentistry 
334  
Stages of oral cancer 
at diagnosis 
(Shahid et al., 2010) 2010 
Journal of basic and 
applied sciences 
Basic laboratory 
research 
Karachi 
Dow 
university of 
health 
sciences 
518 
Diagnostic 
procedure  
(Akram et al., 2010) 2010 
Pakistan journal of 
otolaryngology and 
head and neck 
surgery 
Basic laboratory 
research 
Karachi 
Dow 
university of 
health 
sciences 
301 
Histopathological 
features of oral 
cancer. 
(Shafique et al., 2010) 2010 
Journal of Pakistan 
dental association 
Case series Karachi 
Civil hospital  
60  
Patterns and 
characteristics of the 
cases. / Distribution 
(Ali et al., 2010) 2010 Oral surgery Case series Karachi 
Aga Khan 
university 140  
Histpathological 
characteristics of 
oral cancer. 
(Khan et al., 2010) 2010 
Anesthesia, pain and 
intensive care 
Case report Lahore 
Shaukat 
Khanum 
memorial 
cancer 
hospital 
One  
Follow 
up/Glossopharyngea
l neuralgia after 
radiation treatment 
for tongue cancer 
(Riaz & Warriach, 
2010) 
2010 Journal of Ayub 
medical college 
Cross sectional Lahore 
King Edward 
medical 
university 
30  Quality of life with 
surgical prostheses 
Supplementary table: Salient characteristics of the included studies 
 
(Ayaz et al., 2011) 2011 Biomedica Case series Karachi 
Armed forces 
institute of 
pathology 
268  
Patterns and 
characteristics of the 
cases. / Distribution 
(Nazir et al., 2011) 2011 
Asian Pacific journal 
of cancer prevention 
Case series/Lab Islamabad 
Comsats 
institute of 
information 
technology 
120 Genetic risk factors 
(Mehboob et al., 2011) 2011 
Pakistan oral and 
dental journal 
Cross sectional Peshawar 
Khyber 
college of 
dentistry 
236  
Oral cancer 
knowledge 
assessment. 
(Urooj et al., 2011) 2011 
Journal of Dow 
university of health 
sciences 
Cross sectional Karachi 
Dow 
university of 
health 
sciences 
399  
Frequency of oral 
cancer/ Distribution 
(Bashir et al., 2011) 2011 
Journal of Ayub 
medical college 
Cross sectional 
comparative 
Lahore 
Shaukat 
khanum 
memorial 
cancer 
hospital 
28  
Diagnosis / 
Reliability of MRI to 
gauge thickness of 
tumor 
(Bhurgri, 2011) 2011 
IARC scientific 
publications 
Case series Karachi 
Karachi 
cancer 
registry 
413  
Five year survival 
rate for oral cancer 
cases / Follow up 
(Castillo et al., 2011) 2011 
World journal of 
gastroenterology Cross sectional 
Multiple 
countries 
including 
Pakistan/ 
Lahore 
Kagoshima 
university/ 
King Edward 
medical 
university 
71  
Viral risk factors for 
oral cancer 
(Mahjabeen et al., 
2011) 
2011 
Asian Pacific journal 
of cancer prevention 
Case control Islamabad 
Comsats 
institute of 
information 
technology 
300/ 300* 
Genetic risk factors 
for head and neck 
cancer 
(Masood et al., 2011) 2011 
Asian Pacific journal 
of cancer prevention 
Case control Islamabad 
Comsats 
institute of 
information 
technology 
228/150* 
Genetic risk factors 
for head and neck 
cancer 
(Rana et al., 2011) 2011 
Head and neck 
oncology 
Cross sectional 
comparative 
Lahore 
Hannover 
medical 
school / King 
Edward 
398  
Treatment / 
Retrospective 
comparison between 
surgical techniques 
for Ca tongue. 
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medical 
university 
(Sobani et al., 2011) 2011 
Journal of Pakistan 
medical association 
Cross sectional 
comparative 
Karachi 
Aga khan 
university 
29 
Care / Comparison 
of feeding methods 
in oral cancer 
patients 
(Sobani et al., 2011) 2011 Journal of Pakistan 
medical association 
Case report Karachi Aga khan 
university 
One  Mucoepidermoid 
carcinoma of tongue 
(Kazmi et al., 2011) 2011 
Pakistan oral and 
dental journal 
Cross sectional KAP 
survey 
Lahore 
University of 
Lahore 
760  
Knowledge about 
oral cancer, its 
prevention and 
screening etc. 
(Haq et al., 2011) 2011 
Journal of college of 
Physicians and 
surgeons Pakistan 
Case series Lahore 
King Edward 
medical 
university 
50  
Histopathological 
findings. 
(Riaz, 2011) 2011 
Pakistan journal of 
medical health 
sciences 
Case series Lahore 
King Edward 
medical 
university 
237  
Treatment / Surgical 
technique 
(Khan et al., 2011) 2011 
Professional medical 
journal 
Case series Peshawar 
Khyber 
college of 
dentistry 
25  
Treatment / Surgical 
technique 
(Malik et al., 2011) 2011 
Pakistan journal of 
medical health 
sciences 
Case series Lahore/ 
Allama Iqbal 
medical 
college/ King 
Faisal 
Hospital 
Riyadh 
25  Treatment / Surgical 
technique 
(Ahmed et al., 2011) 2011 
Journal of college of 
Physicians and 
surgeons Pakistan 
Case report Lahore 
University of 
Faisalabad 
One 
Treatment 
modalities for oral 
cancer 
(Riaz & Warraich, 
2011) 
2011 
Annals of King 
Edward medical 
university 
Case series Lahore 
King Edward 
medical 
university 
64  
Patterns and 
characteristics of the 
cases. / Distribution 
(Masood et al., 2011) 2011 
Asian Pacific journal 
of cancer prevention Review  Rawalpindi 
Comsats 
institute for 
information 
technology 
49/49* 
Genetic risk factors 
for head and neck 
cancer 
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(Masood & Kayani, 
2011) 
2011 Genetics and 
molecular biology 
Case control Islamabad 
Comsats 
institute for 
information 
technology 
388/150* 
Genetic risk factors 
for head and neck 
cancer 
(Gillani et al., 2012) 2012 
Asian Pacific journal 
of cancer prevention 
Case series Rawalpindi 
Armed forces 
institute of 
pathology 
40 
Diagnosis / 
Diagnostic accuracy 
of a technique 
(Janjua & Qureshi, 
2012) 
2012 
Journal of skin 
cancer 
Cross sectional Faisalabad 
Punjab 
medical 
college 
171  
Basal cell carcinoma 
of head and neck / 
Distribution 
(Junaid et al., 2012) 2012 
World Journal of 
surgical oncology 
Basic laboratory 
research 
Karachi 
Jinnah 
medical and 
dental 
college 
280  
Diagnosis / 
Diagnostic accuracy 
of toluidine blue 
(Kazmi et al., 2012) 2012 
Journal of Pakistan 
medical association 
Case series Karachi 
Aga Khan 
university 
72  
Follow up/ Size of 
tumor as a 
prognostic factor for 
recurrence 
(Kazmi et al., 2012) 2012 
Pakistan oral and 
dental journal 
Cross sectional Lahore 
University of 
Lahore 
75  
Knowledge about 
oral cancer, its 
prevention and 
screening etc. 
(Roohullah. et al., 
2012) 
2012 
Annals of Punjab 
medical college 
Cross sectional Quetta 
CENAR 
270  
Cancer Prevalence 
including oral cancer 
/ Distribution 
(Zaib et al., 2012) 2012 
Pakistan oral and 
dental journal 
Case series Islamabad 
Islamic 
international 
medical and 
dental 
college 
114 
Histopathological 
findings 
(Mangi et al., 2012) 2012 
Pakistan journal of 
surgery 
Case series Karachi 
Jinnah 
postgraduate 
medical 
centre 
28  
Treatment 
modalities for oral 
cancer 
(Khan, 2012) 2012 Webmed central Review Abbottabad 
NIMS 
medical 
college  
N/A 
Oral cancer 
prevention 
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(Makhdoom & Ullah, 
2012) 
2012 Journal of Khyber 
college of dentistry 
Cross sectional 
Knowledge 
assessment  survey 
Peshawar 
Khyber 
college of 
dentistry 
200 
Knowledge about 
oral cancer, its 
prevention and 
screening etc. 
(Rehman & Khan, 
2012) 
2012 
Pakistan oral and 
dental journal 
Cross sectional 
Knowledge 
assessment  survey 
Peshawar 
Khyber 
college of 
dentistry 
100 
Knowledge about 
oral cancer, its 
prevention and 
screening etc. 
(Rehman et al., 2012) 2012 
Journal of khyber 
college of dentistry 
Case series Peshawar 
Khyber 
college of 
dentistry 
102  
Assessment of 
quality of life among 
oral cancer patients. 
(Akhtar et al., 2012) 2012 
Annals of Pakistan 
institute of medical 
sciences 
Case series Rawalpindi 
Armed forces 
institute of 
pathology 
240  
Histopathological 
features of oral 
cancer. 
(Ahmed et al, 2012) 2012 
Pakistan journal of 
medical health 
sciences 
Cross sectional Multan 
Combined 
military 
hospital 
88  
Diagnostic delay as 
a risk factor 
(Masood et al., 2012) 2012 Asian Pacific journal 
of cancer prevention 
Case control Islamabad 
Comsats 
institute of 
information 
technology 
49/49*  Genetic risk factors 
(Mahjabeen et al., 
2012) 
2012 Medical oncology Case control Islamabad 
Comsats 
institute of 
information 
technology 
50** Genetic risk factors 
(Sabir et al., 2012) 2012 
Hereditary cancer in 
clinical practice 
Case control Islamabad 
Comsats 
institute of 
information 
technology 
380/350* Genetic risk factors 
(Maqsood et al., 2012) 2012 
Medical forum 
monthly 
cross sectional Karachi 
Dow 
university of 
health 
sciences 
279  
Diagnostic delay as 
a risk factor  
(Mahjabeen et al., 
2013) 
2013 Mutagenesis Case control Islamabad 
Comsats 
institute of 
information 
technology 
300/300* Genetic risk factors 
(Junaid et al., 2013) 2013 
Journal of Pakistan 
medical association 
Basic lab research Karachi 
Jinnah 
medical 
56 
Diagnostic accuracy 
of toluidine blue. 
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college 
hospital 
(Sabir et al., 2013) 2013 
International journal 
of biological 
markers 
Case control Islamabad 
Comsats 
institute of 
information 
technology 
380/350*  Genetic risk factors 
(Akram et al., 2013 2013 Pakistan journal of 
medical sciences 
Case control Karachi 
Sindh 
medical 
college 
100/100* 
Multiple lifestyle 
risk factors for oral 
cancer 
(Iqbal et al., 2013) 2013 Oral disease 
Basic laboratory 
research 
Lahore 
King Edward 
medical 
university 
80  
Viral risk factors for 
oral cancer 
(Mahjabeen et al., 
2013) 
2013 
Pathology oncology 
research 
Case control Islamabad 
Comsats 
institute of 
information 
technology 
300/150*  
Genetic risk factors 
for head and neck 
cancer 
(Saleem et al., 2013) 2013 Oral oncology Case control Karachi 
University of 
Karachi 
260/260* 
Genetic risk factors, 
related with 
smokeless tobacco 
use, for head and 
neck cancer. 
(Tahir et al., 2013) 2013 
Journal of cancer 
research and 
therapeutics 
cross sectional 
comparative 
Bhawalpur 
Quaid e 
Azam 
medical 
college 
37  
Chemical risk 
factors for oral 
cancer 
(Ikram et al., 2013) 2013 
Journal of Pakistan 
medical association 
Case series Karachi 
Aga Khan 
university 42  
Treatment 
modalities for oral 
cancer 
(Siddiqui, 2013) 2013 
Pakistan journal of 
medicine and 
dentistry 
Review Karachi 
Ziauddin 
University N/A 
Prevention of oral 
cancer. 
(Ashfaq et al., 2013) 2013 
Journal of 
Rawalpindi medical 
college 
Case series  Rawalpindi 
Combined 
military 
hospital 95  
Patterns, 
characteristics and 
treatment procedures 
for carcinoma 
tongue 
(Chaudhary et al., 
2013) 
2013 
Rawal medical 
journal 
Case series Bhawalpur 
Quaid e 
Azam 
medical 
college  
184  
Patterns and 
characteristics of the 
cases. / Distribution 
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(Rasool et al., 2013) 2013 Isra medical journal Cross sectional Islamabad 
Islamic 
international 
university 
140  
knowledge about 
oral cancer, its 
prevention and 
screening etc. 
(Hassan et al., 2013) 2013 
Medical forum 
monthly 
Cross sectional 
knowledge 
assessment  survey 
Jamshoro 
Liaquat 
university of 
medical and 
health 
sciences 
50  
Knowledge about 
oral cancer, its 
prevention and 
screening etc. 
(Alamgir et al., 2013) 2013 
Pakistan journal of 
medicine and 
dentistry 
Case series Karachi 
Bahria 
university 50  
Patterns and 
characteristics of the 
cases / Distribution 
(Zulfiqar et al., 2013) 2013 Biomedica Case series Lahore  
University of 
health 
sciences  
39  
Histopathological 
patterns and 
characteristics of the 
cases. 
(Janjua et al., 2013) 2013 
Journal of college of 
Physicians and 
surgeons Pakistan 
Case series Faisalabad 
Punjab 
medical 
college 
319  
Histopathological 
patterns and 
characteristics of the 
cases. 
(Rubab et al., 2013) 2013 
Journal of Pakistan 
medical association 
Review  Karachi 
Ziauddin 
university 
N/A 
Viral risk factor for 
oral cancer. 
(Khyani et al., 2013) 2013 
Pakistan journal of 
otolaryngology and 
head and neck 
surgery. 
Review Karachi 
Dow 
university of 
health 
sciences 
N/A 
Diagnostic 
techniques. 
(Tahir et al., 2013) 2013 
Theoretical biology 
and medical 
modelling 
Basic laboratory 
research 
Islamabad 
Islamic 
international 
university 
N/A 
The role of a 
specific tumor 
necrosis factor in 
development of an 
anti-cancer drug. 
(Khaliq et al., 2013) 2013 Springer plus Case series Karachi 
University of 
Karachi 
5134  
Ethnicity as a risk 
factor. 
(Masood & Kayani, 
2013) 
2013 
Pathology oncology 
research 
Case control Islamabad 
Comsats 
institute of 
information 
technology 
192  Genetic risk factors 
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(Sabir et al., 2013) 2013 Molecular biology 
reports 
Case control Islamabad 
Comsats 
institute of 
information 
technology 
300 / 270* Genetic risk factors 
(Masood et al., 2013) 2013 
Asian Pacific journal 
of cancer prevention 
Review Islamabad 
Comsats 
institute of 
information 
technology 
N/A Genetic risk factors 
(Malik et al., 2014) 2014 
International journal 
of clinical chemistry 
Case control Karachi 
University of 
Karachi 45/30* 
Chemical risk 
factors for oral 
cancers 
(Masood et al., 2014) 2014 
Molecular biology 
reports Review article Rawalpindi 
Comsats 
institute of 
information 
technology 
N/A Genetic risk factors 
*number of cases/number of controls, **abstract and/or full text not accessed, included in the supplemental table but not in the review, 
*** both cases and controls included, N/A: Not applicable.
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1
Introduction
Oral Potentially Malignant Disorders (OPMDs) are chronic lesions 
or conditions of the oral cavity characterized by a potential for 
malignant transformation.1 More specifically, “It is a group of disor-
ders of varying etiologies, usually tobacco; characterized by muta-
gen associated, spontaneous or hereditary alterations or mutations 
in the genetic material of oral epithelial cells with or without clinical 
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Abstract
Oral Potentially Malignant Disorders (OPMDs) are chronic lesions or conditions characterized by a 
potential for malignant transformation. While recent meta-analyses show that smokeless tobacco (SLT) 
use is a risk factor for oral cancer in South Asia, there is a lack of pooled evidence regarding SLT use and 
the development of OPMDs. We searched Medline via PubMed, the Science Citation Index (SCI) via Web 
of Science, Scopus, CINAHL, Global Index Medicus and Google Scholar databases for relevant literature 
using a combination of keywords and MeSH terms. Eighteen case-control studies were included in the 
review, all of which reported significantly elevated risk estimates for OPMDs associated with SLT use. 
Overall and subgroup, Meta Odds Ratios (mOR) were calculated through a random effects analysis 
using “generic inverse variance” method in Rev Man 5.3. Heterogeneity was quantified by calculating 
the I2 statistic. The mOR for any OPMD with the use of any SLT product was 15.5 [95% Confidence Interval 
(CI), 9.9–24.2]. Women had a higher risk, mOR = 22.2 (95% CI, 9.1–54.1) compared to men, mOR = 8.7 
(95% CI, 2.1–34.8). Betel quid with tobacco carried the highest risk for OPMD, mOR = 16.1 (95% CI, 7.8–
33.5). Although the cumulative evidence is informed by case-control studies only, the magnitude of the 
pooled estimates and the presence of exposure-response indicate a very strong association between 
OPMDs and SLT use. In addition to tobacco control, results of this review may help in informing oral 
cancer control policies in South Asia, since OPMDs lie on the causal pathway for oral cancer.
Implications: More than 250 million South and South East Asians use SLT in some form. As cigarettes 
prices climb up all over the world, more people could potentially take up SLT, particularly in the absence 
of epidemiological evidence regarding the harmful effects of these products, and SLT being advocated as 
a means of tobacco harm reduction. Our findings are thus relevant and timely in highlighting the harm-
ful effects of SLT use, with a potential of influencing tobacco control policies in South Asia and beyond.
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and histomorphological alterations that may lead to oral squamous 
cell carcinoma transformation.”2 Leukoplakia (LKP), Erythroplakia 
(EP), Oral Sub-Mucous Fibrosis (OSMF), Lichen Planus (LP), 
Actinic Keratosis (AK), Discoid Lupus Erythematosus (DLE) and 
Palatal lesions among reverse smokers, constitute OPMDs.3 The 
prevalence of OPMDs worldwide varies between 1% and 5%.4 
The potential for malignant transformation among these condi-
tions varies considerably,5 ranging from less than 1% to as high 
as 36%.6 Further, it is often influenced by the post-diagnosis ces-
sation or continuity of the high-risk behaviors such as tobacco and 
alcohol use, as well as clinical intervention.7–9 LP, EP, and OSMF 
have a higher potential for malignant transformation compared to 
the other conditions.10 Apart from being possible precursors to oral 
cancer, OPMDs themselves, are potentially painful and debilitating 
conditions and influence the quality of life, both in terms of pain 
and social disability.11,12
Smokeless Tobacco (SLT) that is, the forms of tobacco that are 
used without burning the product, is considered to be a risk factor 
for OPMDs,13 with SLT being estimated to contain more than 30 
carcinogenic agents.14 SLT use is a culturally and socially acceptable 
habit in South Asia15 and according to a recent WHO report, 90% 
of the SLT burden of the whole world lies in South Asian countries.16 
These countries include Pakistan, India, Sri Lanka, Bangladesh, 
Bhutan, Nepal, Afghanistan, and Maldives. According to the 
WHO,13 a variety of SLT products are used in South Asian coun-
tries, with the habits often being dictated by regional and cultural 
influences.17 The most widely used products include Betel quid or 
PAAN with tobacco, Gutkha, Naswar, Khaini, Misri, and chewable 
tobacco leaves. All these products have carcinogenic agents, usually 
the “Tobacco Specific Nitrosamines” that act by inducing changes 
at both genetic level and locally. Regarding the latter, they provide a 
conducive local environment for the hyperplastic transformation of 
the buccal cells.18 The SLT products used in South Asia usually have 
a high pH, aimed at a rapid and extensive absorption of Nicotine,19 
resulting in stronger Nicotine urges and addiction. A strong Nicotine 
urge, in turn, induces more frequent and prolonged use of the SLT 
product,18 resulting in a prolonged exposure to the carcinogenic 
agents in SLT.
While recent evidence shows that SLT use is a major risk factor 
for the high incidence of oral cancer in South Asia,14,20 there is, how-
ever, a lack of pooled evidence with regards to SLT use and the devel-
opment of OPMDs, the precursor lesions for oral cancer. The dearth 
of pooled evidence regarding the association between SLT use and 
OPMDs is apparent from a 2014 comprehensive report on SLT by 
the National Cancer Institute, United States21 and a 2015 study on 
the global burden of disease attributable to SLT,22 where summary 
risk estimates and SLT attributable burden for cancers and cardio-
vascular disease have been provided but estimates for OPMDs have 
not been included. Systematic reviews on the association of cancers 
with SLT use by Sinha and colleagues,23 and Critchley and Unal,24 
have also pointed out the need for future studies on the assessment 
of the burden of precancerous conditions attributable to SLT use. 
In an effort to provide evidence that may inform both tobacco con-
trol policies and public opinion regarding the deleterious effects of 
SLT use in South Asian countries, we conducted a systematic review 
focusing on literature on the relationship between SLT and OPMDs. 
We aimed to assess the risk of developing OPMDs among SLT users 
and non-users by systematically reviewing, and if possible pooling 
effect estimates from, epidemiological studies carried out in South 
Asia.
Methods
Eligibility Criteria
Study Design, Participants/Population, and Setting
This review includes observational studies on the use of SLT and the 
risk of developing OPMDs carried out in the human population of 
the eight countries of South Asia. Studies carried out among both 
males and females irrespective of age, socio-economic, physical, or 
dental status, who were residents of South Asia were eligible for the 
review. Studies carried out among expatriate populations of South 
Asia were not eligible. Studies were included irrespective of the study 
setting, that is, hospital-based (private and public) or community-
based, the only exception being laboratory based genetic epidemiol-
ogy studies. Studies focusing on animals were also not eligible.
A pre-review scoping exercise had identified a lack of experimen-
tal studies on the topic, a fact further substantiated by existing sys-
tematic reviews of South Asian literature on the association of SLT 
with oral cancer, where all the included studies were case-control 
or cohort design.14,21,25 Therefore, we only focused on observational 
studies of case-control and/or cohort design, as these are the most 
appropriate observational study designs to establish epidemiological 
associations.26 However, in order to avoid missing any potentially 
eligible study, we did not limit our search to specific study types.
Exposure
Studies in which exposure to any form of SLT had been ascertained 
through written records, for example, medical history, structured 
interviews or written self-reports and in which SLT was the main or 
one of the main exposures of the study were included in the review. 
For the purpose of this review, an “ever” exposed participant is 
defined as someone who might have used an SLT product at least 
once in life. Exposure was quantified in years and daily frequencies 
for the assessment of the exposure–response relationship between 
OPMD and SLT. Only the studies reporting daily frequencies and 
total duration of exposure or reporting data to calculate these were 
included for the exposure-response analysis. Studies in which expo-
sure of interest was areca nut only were excluded.
Comparator(s)/Control
For case-control studies, the control group had to have subjects who 
had no history of OPMDs. Case-control studies where SLT was used 
as an inclusion criterion for both the case and control groups were 
hence excluded. In order to include maximum studies, matching for 
age, sex, and other potential confounders were not used as inclusion 
criteria. The source of controls, that is, hospital or community-based 
did not affect the inclusion/exclusion of a study from the review. 
For cohort studies, the use of any unexposed comparison group for 
example, internal comparison group, external comparison group, or 
population comparison group, was eligible as a comparator.
Outcome
Studies were eligible to be included in the review only when the cases 
had been ascertained to have an OPMD through histological confir-
mation. Studies reporting an OPMD as a primary or secondary out-
come were eligible for this review. Studies with multiple outcomes 
(OPMDs), were included in the meta-analysis as separate studies 
with the corresponding data related to each specific OPMD. Articles 
reporting estimates of relative risk for example, Odds Ratio (OR) 
or Relative Risk (RR) with their 95% confidence intervals (CI) for 
SLT users versus non-users, or those reporting data from which these 
effect estimates could be computed were included in the review.
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Language
No filters were used during the search process and hence studies 
published in any language were eligible for inclusion in this review.
Search Methods
A detailed search strategy is provided in Supplementary Table  1. 
Briefly, we searched Medline via PubMed, the Science citation Index 
(SCI) via Web of Science, Scopus, and CINAHL databases from their 
inception till Feb 15, 2016, for relevant literature using a combination 
of keywords and MeSH terms. In order to include all relevant litera-
ture, no filters were used during the electronic search. Additionally, 
we also searched the Global Index Medicus and Google Scholar 
databases to identify relevant studies that might have been missed 
from our primary search. The electronic search was supplemented 
by a hand search of the bibliographies of selected articles. We also 
searched SLT related reports22,13,27 of the International Agency for 
Research on Cancer and the National Cancer Institute of the United 
States to identify studies that might be eligible for the review.
Selection of Studies
One author (LC) ran the search query in the electronic databases. After 
removal of duplicate articles, the remaining records were stored in an 
independent folder in a reference management software (Endnote). 
Two authors (SR, SK) separately went through the titles of all the 
records and selected the relevant studies. This was followed by the 
reading of the abstracts of the selected studies and exclusion of irrel-
evant ones, also carried out by SK and SR. Full texts of the selected 
studies were then obtained and screened independently by two authors 
(SK and ZK) for inclusion or exclusion in the final review. Any differ-
ences/discrepancies during the study selection process were resolved 
in consultation with a third author (OE). Finally, the bibliographies of 
the selected studies were screened by SR, SK, and ZK for any relevant 
studies that might have been missed by the search process.
Assessment of the Quality of Included Studies
Two authors (ZK, SR) assessed the quality of the included studies by 
applying the National Collaborating Centre for Methods and Tools, 
McMaster University’s “Effective Public Health Practice Project 
Quality Assessment Tool for Quantitative Studies.”28 Studies were 
ranked as “strong,” “moderate,” or “weak” based on six parameters 
that is, selection bias, study design, confounding, blinding, data col-
lection methods, and withdrawals and dropouts (Supplementary 
Table 3).
Data Extraction and Management
Two authors (ZK, OE) separately carried out data extraction using 
a pre-designed spreadsheet. Data regarding study type, publica-
tion year, authors, place of study, sample size, type/s of exposure, 
exposure intensity, outcome/s and overall as well as stratum-spe-
cific effect estimates (OR and RR) were extracted. ORs and RRs 
were calculated for studies that did not report an OR or RR but 
had sufficient data for their calculation. Wherever possible, efforts 
were made to calculate an adjusted or a Mantel–Haenszel odds ratio 
(ORMH). However, crude estimates were used for the meta-analysis 
when the available data were insufficient to calculate an adjusted or 
MH estimate. Both authors compared their spreadsheets to rule out 
heterogeneity, which when present, were resolved in the presence of 
a third author. The extracted data were then entered into Cochrane 
Rev Man 5.3. software.29
Statistical Analysis and Data Synthesis
Statistical analyses were carried out in Rev Man 5.0. Natural logs of 
individual ORs along with their corresponding standard errors were 
calculated. These log effect estimates were combined by the inverse 
variance method using a random effects model to get a summary 
meta- odds ratio (mOR). An mOR was calculated for the risk of 
developing any OPMD associated with the use of any SLT. Subgroup 
analyses included estimation of an mOR for: (1) Stratified risk for 
each subtype of OPMDs, associated with the use of any SLT; (2) 
risk of developing any OPMD with the use of different subtypes of 
SLT; (3) risk of developing OPMDs based on intensity and duration 
of SLT use; and (4) risk of developing OPMDs among male versus 
female SLT users. Country-specific estimates were also calculated. 
Heterogeneity among the studies regarding the stratification of dura-
tion and intensity of exposure were dealt with by collapsing strata 
and by calculating an ORMH for the combined strata. Subgroup anal-
yses were also carried out for studies reporting an estimate, which 
had been adjusted for smoking and alcohol use, and those reporting 
crude estimates or estimates calculated by the authors. Additional 
sensitivity analyses were carried out by excluding studies that had 
reported very high ORs (>20).
Where applicable we also calculated the country specific 
Population Attributable Fraction (PAF%) using the formula, signify-
ing the proportion of OPMDs in a population that can be attributed 
to the use of SLT products. Following the “rare disease assump-
tion,”30 we substituted OR for RR and country-specific exposure 
prevalence (p) estimates for India and Pakistan were derived from 
the most recent Global Adult Tobacco Survey (age 15 and above, 
both sexes) estimates of the WHO,31 for Sri Lanka the estimates 
were drawn from the most recent estimates of the (STEPS) NCD 
risk Factor Survey (age 15–64, both sexes) provided in the Tobacco 
Atlas.32
Heterogeneity among the studies was detected by visually inspect-
ing forest plots. The I2 statistic was calculated for the quantification 
of heterogeneity and assessment of the effects of heterogeneity on the 
pooled analysis. From our pre-review scoping exercise, we expected 
a high heterogeneity. However, we felt that the knowledge gap with 
regards to the risk of OPMDs associated with the use of SLT makes 
it pertinent and worthwhile to undertake meta-analyses and calcula-
tion of pooled effect estimates, with a view to point out the mag-
nitude of the heterogeneity to the readers along with each pooled 
estimate. Causes of heterogeneity were explored through subgroup 
analysis based on geographical location, the type of SLT, gender, and 
exposure-response categories. To determine the effect of each study 
on the overall estimate, one study was dropped at a time. Reporting 
bias was assessed by visually inspecting the funnel plot.
This study is reported in accordance with the “Meta-analysis Of 
Observational Studies in Epidemiology (MOOSE) guidelines.”
Results
Characteristics of Included Studies
The electronic search returned 712 articles, all in the English lan-
guage. One additional study was identified through a search of the 
bibliographies of the included studies. Fifteen articles corresponding 
to 18 studies were included in the final review after the removal 
of duplicates and application of the inclusion/exclusion criteria. 
Figure 1 describes the various steps of the study selection process.
The majority (n = 12) of the included articles were from India, 
two were from Sri Lanka and only one was from Pakistan. All 
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of the included studies were of a case-control design. Important 
features of the included studies are given in Table 1. The major-
ity of the studies (n  = 12) were of “moderate” quality, while six 
studies were rated as “weak.” None of the studies were rated as 
“strong.” Two studies exclusively reported LP as an outcome, while 
OSMF was a primary outcome in 12 studies. A further two studies 
focused on any OPMD without specifying the subtype, one study 
had multiple OPMDs and another, EP, as an outcome. Betel quid 
was reported as the main exposure in five studies, Gutkha was the 
primary exposure in three studies while the remaining 10 studies 
reported SLT as the primary exposure without specifying the sub-
type. Seven studies reported or provided data on overall duration of 
exposure, while six studies reported or provided data on exposure 
frequency. Gender specific estimates or data to calculate them were 
reported by five studies. Twelve studies reported an effect estimate 
which was adjusted for smoking and alcohol, one study reported 
an effect estimate adjusted for smoking only, while a crude or an 
MH effect estimate was calculated for five studies from the data 
provided in the article. Six of the included studies, five from India 
and one from Sri Lanka, had population-based controls, while the 
remaining used hospital-based controls. All studies reported an OR 
with a magnitude higher than one.
Prior to carrying out the meta-analyses, we assessed publica-
tion bias by a visual inspection of the funnel plot. The funnel plot 
(Supplementary Figure 1) was skewed, indicating an underrepresen-
tation of studies with smaller effect estimates. Exclusion of individ-
ual studies from the analysis did not have any effect on the funnel 
symmetry.
Risk of OPMDs with SLT Use
The mOR for any OPMDs with the use of any SLT products 
(All included studies, n = 18) was 15.5 (95% CI, 9.9–24.2), with 
a high heterogeneity of I2 = 89% (Figure 2). The mOR for stud-
ies (n = 15) from India was 14.5 (95% CI, 8.9–23.5), I2 = 90%. 
The pooled OR for studies from Sri Lanka was 15.5 (95% CI, 
7.2–33.6), I2 = 0%. An mOR for Pakistan could not be calculated 
because only one study reported an adjusted OR of 64.0 (95% 
CI, 15–273.2). Sensitivity Analysis revealed that exclusion of stud-
ies (6/18) that had not reported an effect estimate adjusted for 
both alcohol and smoking decreased the magnitude of the effect 
estimate, mOR = 13.1 (95% CI, 8.3–20.7), I2 = 86%, these were 
the same studies which had a “weak” rating. Exclusion of studies 
(7/18), which had reported a very high effect estimate (OR > 20), 
resulted in an mOR of 8.0 (95% CI, 5.5–11.7), I2 = 84%. After 
excluding the India-based studies (6/15) in which the effect esti-
mate was not adjusted for smoking and alcohol, the mOR for India 
decreased to 11.4 (95% CI, 6.9–18.8), I2  =  89%. The mOR for 
the six studies with population-based controls was 15.0 (95% CI, 
9.1–24.8), I2 = 88%.
Risk of OPMDs Subtypes with SLT Use
The mOR for the development of OSMF with the use of any SLT 
product was 20.0 (95% CI, 12.3–32.5), I2  =  79%. After exclud-
ing the studies (5/12) with unadjusted risk estimates, the resultant 
mOR was 16.2(95% CI, 8.7–30.0), I2 = 74% (Figure 3). The risk for 
LKP was much lower, mOR = 4.33 (95% CI 1.4–13.2), I2 = 81%. 
Multiple OPMDs and EP were reported as primary outcomes in one 
study each. The OR for Multiple OPMDs was 37.8 (95% CI, 16.8–
88.1), while that for EP was 19.8 (95% CI, 9.8–40.0). The pooled 
risk estimate from the studies (n = 2) that reported on OPMDs with-
out specifying any subtype was mOR of 20.4 (95% CI, 7.6–54.3), 
I2 = 0%.
Risk of OPMDs with Different SLT Types
The pooled risk for the development of any OPMDs with the use of 
betel quid with tobacco was 16.1 (95% CI, 7.8–33.5), I2 = 47%. The 
mOR for OPMDs with the use of Gutkha was much lower at 4.9 
(95% CI, 2.6–9.4), I2 = 33%. For studies (n = 10), which reported 
SLT as a primary exposure without specifying the subtype, the cor-
responding risk was 23.1 (95% CI, 10.6–50.2), I2  =  93%, after 
dropping studies (4/10) with unadjusted effect estimates, the mOR 
decreased to 13.8 (95% CI, 5.5–34.9), I2 = 93%.
Figure 1. Flow chart of the study selection process.
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Risk in Males Versus Females (Five Studies)
Females had a considerably elevated risk of developing a OPMDs 
with the use of SLT, mOR = 22.2 (95% CI, 9.1–54.1), compared to 
men, mOR = 8.7 (95% CI, 2.1–34.8), I2 = 79%.
Exposure–Response Relationship
The magnitude of risk was directly related to the total dura-
tion of exposure. Compared to non-users, the mOR for devel-
oping an OPMDs with the total duration of an SLT habit of 
up to 20  years was 67.5 (95% CI, 25.6–177.7), I2  =  83%. 
After excluding studies (2/7) that did not adjust for alcohol or 
smoking, the mOR came down to 29.3 (95% CI, 20.3–42.1), 
I2  =  0%. Compared to a non-user, the risk for persons having 
an SLT habit for up to 40 years increased to mOR = 95.2 (95% 
CI, 36.5–247.8), I2  =  78% for smoking and alcohol adjusted 
and non-adjusted studies (n = 7) combined, and 41.9 (95% CI, 
27.4–64.1), I2 = 9%, when only adjusted estimates were pooled 
(5/7). Similarly, the frequency of SLT use was directly related 
to the magnitude of the risk estimates. Compared to non-users, 
the mOR for developing an OPMDs was 38.1 (95% CI, 24.6, 
59.2), I2  = 27%, for persons using SLT up to 10 times per day 
(six studies). The pooled estimate slightly decreased when alco-
hol and smoke adjusted ORs were pooled, mOR  =  33.7(95% 
CI, 23.6–48), I2  =  0% (five studies). The pooled risk increased 
to 65.5 (95% CI, 39.2–109.5), I2  =  13%, for persons using an 
SLT product up to 20 times a day, when combining both adjusted 
and non-adjusted studies (n  =  6). The mOR after dropping the 
study (1/6), which had not adjusted for alcohol and smoking was 
55.7(95% CI, 35.2–88.3), I2 = 0%.
Population Attributable Fraction
Utilizing the country specific results from our meta-analysis, we cal-
culated the PAF for India, Sri Lanka, and Pakistan. The PAF for India 
(SLT prevalence = 25.9%) was 74% while that for Sri Lanka (SLT 
prevalence = 15.8%) was 69%, the PAF for Pakistan (SLT preva-
lence = 11.4%) was 88%.
Discussion
The results of our review point towards a strong association 
between SLT use and OPMDs in South Asia. Although there is 
evidence of high heterogeneity among the studies included in this 
systematic review, the magnitude of risk of developing OPMDs 
with the use of SLT products was consistently high across all the 
included studies. The pooled risk was elevated for most types of the 
OPMDS, but was particularly high for OSMF (16-fold). In compar-
ison, LKP had a 4-fold increased risk among SLT users compared 
to non-users. The high effect estimates and I2 values in our study 
Figure 2. Risk of Oral Potentially Malignant Disorders (OPMDs) associated with the use of smokeless tobacco (SLT).
Figure 3. Risk of Oral Sub-Mucous Fibrosis (OSMF) associated with smokeless tobacco (SLT) use (Sensitivity analysis). 
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are in line with those reported by previous systematic reviews on 
oral cancer risk with the use of SLT in the South Asian region.14,21,48 
The magnitude of the pooled OR in our study was higher than the 
mORs reported by the meta-analysis of studies on oral cancer. This 
can be explained by the fact that OPMDs is an intermediate out-
come, lying on the pathway of the development of oral cancer, and 
not all OPMDs progress to malignancy.4 Country specific analy-
sis revealed high mORs for India and Sri Lanka, albeit a higher 
heterogeneity in the case of India. The latter might be due to the 
difference in the number of studies pooled together that is, two 
for Sri Lanka and 11 for India. Pooling of effect estimates which 
were adjusted for smoking and alcohol revealed a decrease in the 
magnitude of the pooled OR and also a slight decrease in the het-
erogeneity. These findings are similar to those of previous reviews 
on SLT and the risk of oral cancer and are suggestive of alcohol 
and smoking as factors in the etiology of OPMDs.21,49–52 The strong 
association between OPMDS and the use of SLT in South Asia that 
we are reporting is in accordance with results of independent stud-
ies carried out in other parts of the world. A study of 1569 men 
from Uzbekistan reported an OR of 5.1 (95% CI, 3.1–8.6) for oral 
and esophageal precancer among users of SLT compared to non-
users.53 An OR of 60 (95% CI, 40.5–88.8) for LKP among tobacco 
chewers compared to no-chewers, was reported by a study of 1109 
baseball players in the United States.54 A  large study of 20 333 
adults in Sweden revealed a 15.4% prevalence of Snuff-induced 
lesions in the study sample.55
Our finding that there is a higher risk of developing OSMF 
compared to LKP, with the use of SLT, is supported by the fact 
that OSMF has a higher prevalence compared to any other 
OPMDs in South Asia,56–59 where SLT use is reaching an epidemic 
level.60 Although the mOR decreased significantly after exclusion 
of studies which did not report an adjusted risk estimate, it was 
still significantly higher than the corresponding estimate for all 
OPMDs combined. Although the risk of OSMF progressing to 
malignancy is considered lower than LKP, OSMF is a very restric-
tive and debilitating condition with considerable implications 
on the quality of life.61 The lack of studies on EP and multiple 
OPMDs did not allow for the calculation of a pooled risk esti-
mate for these conditions; however, the studies reporting EP and 
multiple OPMDs show highly elevated risks for these conditions 
with the use of SLT.
The stratified analysis by SLT products revealed a much lower 
heterogeneity among the studies. Among studies, which had adjusted 
for smoking and alcohol use, the combination of Betel quid with 
tobacco had the highest risk for developing OPMDs compared to 
other products. This finding is similar to the results reported by sys-
tematic reviews on oral cancer risk with the use of SLT products.14,21 
All tobacco products induce carcinogenesis at the cellular level. The 
Tobacco Specific Nitrosamines in SLT help in the formation of DNA 
adducts, which if remain unrepaired, bring about abnormal cellu-
lar proliferation and the subsequent tumor formation.62 The higher 
risk associated with betel quid plus tobacco can be explained by the 
additional constituents of betel quid. Areca nut, which in itself is 
considered carcinogenic63 is combined with slaked lime and tobacco 
in the preparation of betel quid. The slaked lime works 2-fold: (1) it 
helps in the release of Arecoline and its conversion into Arecaidine, 
which in turn trigger fibroblast proliferation and increase collagen 
synthesis in the oral mucosa, and (2) it also facilitates the produc-
tion of Reactive Oxygen Species, which causes oxidative stress by 
increasing the pH of the oral microenvironment. This, combined 
with the carcinogens in tobacco,13 may thus pose a higher risk of oral 
premalignancy and malignancy due to a synergistic effect, compared 
to other SLT products.64–67
The results of our review suggest a considerably elevated risk of 
development of OPMDs among females compared to males associ-
ated with the use of SLT products. This finding is similar to previ-
ous findings on SLT use and the risk of oral cancer.14 This might be 
explained by a lower background risk of OPMDs among females as 
compared to males. The prevalence of other risk factors for OPMDs 
such as alcohol and smoking tobacco is considerably higher among 
men as compared to women in the countries of origin of the included 
studies.21 There might also be differences in the pattern of use of 
SLT products among males and females.68,69 Females in South Asia 
predominantly stay indoors, with very few going out for work, while 
most men go out for work etc. This may result in women chewing 
more and/or for a longer duration as compared to men, thus increas-
ing their risk of development of OPMDs.70,71
Our study reports a strong exposure–response relationship with 
regards to the frequency and duration of use of SLT products and 
development of OPMDs. The risk increases with increasing duration 
as well as the intensity of SLT use. This finding is in agreement with 
the results of a meta-analysis on the risk of oral cancer associated 
with SLT use14,54 and further suggests a strong association between 
OPMDs and SLT use. Future prospective studies are needed to assess 
the nature of this association for causal inference.
Strengths and Limitations
To the best of our knowledge, this is the first systematic review 
assessing the risk of OMPDs associated with the use of SLT prod-
ucts in South Asia and we believe it will help in informing tobacco 
control policies in South Asia, where control of SLT control has sel-
dom been the main focus of tobacco control policies and actions.72 
As pointed earlier a recent study on the global burden of disease 
attributable to SLT use has reported the burden of cancers and car-
diovascular disease that are attributable to SLT use, however, that 
study did not report the OPMD burden attributable to SLT use.23 
As such this review adds to the body of knowledge on the burden 
of disease attributable to SLT use. The high heterogeneity among 
the included studies might negatively affect the pooled risk estimate 
reported by our study. Efforts were however made to minimize this 
through stratified analysis. Further, the magnitude of the heteroge-
neity was presented with every effect estimate that is reported in 
our review.
Another potential limitation of our study was the inherent bias 
related to observational study designs that might have been present 
in the included studies. This includes selection and recall bias, as 
well as bias linked to retrospective exposure assessment and under 
or over reporting of exposure status. There was a lack of a precise 
definition of what constituted “ever exposed,” in quantitative terms, 
in the included studies. Therefore, we had to use broad criteria for 
“ever exposed” that is, A person who had used SLT only once in 
their life and a person who had used it for 20 years were both con-
sidered as ever-exposed. This might have resulted in an overestima-
tion of the true risk estimate.
Additionally, under-reporting of smaller effect estimates and pub-
lication bias may also have affected the results of our study. There 
was also a lack of studies addressing the less common OPMDs such 
as LP, DLE, and AK and as such, our findings are only applicable 
to the more common OPMDs conditions such as LKP, OSMF, and 
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EP. Moreover, we did not include studies carried out in expat South 
Asian populations which might have resulted in an under or over 
estimation of the true risk estimate. We excluded studies carried out 
in expat populations on the grounds that there may be differences in 
the composition of the SLT products used in South Asia and those 
used elsewhere. Another reason for excluding the expat populations 
was the potential difference in lifestyle related factors, such as diet 
and exercise, which are considered modifying factors for the risk of 
various disease. It may be worthwhile to conduct future reviews of 
studies carried out in expat populations.
It is also pertinent to mention that the biochemical composition, 
methods of use, and the duration of use vary among different SLT 
products. Additionally, the composition and the method of use of a 
similar product may vary among different geographical regions,19 
which might have a bearing on the generalizability of our results. We 
have tried to address this issue by stratified analysis of the different 
SLT products to provide risk estimates associated with individual SLT 
products. Despite these limitations, we tried to address some of them 
through stratified analysis and provide the most robust risk estimates 
possible to quantify the relationship between OPMDs and SLT use.
Confidence in Cumulative Evidence
We used the “Grading of Recommendations, Assessment, 
Development and Evaluation (GRADE) Working Group methodol-
ogy”73 to assess the quality of the cumulative evidence (summary 
OR for the association of SLT use vs. no use, and OPMDs) reported 
in our study, via the GRADEpro GDT Software.74 The reported evi-
dence was downgraded on the basis of the high heterogeneity, risk 
of bias inherent to case-control studies, imprecision that is, increased 
the width of the confidence interval and presence of publication 
bias. The evidence was upgraded on the basis of the elevated mag-
nitude of the risk estimate, plausible residual confounding lowering 
the demonstrated risk and the presence of a dose-response relation-
ship. Application of the aforementioned parameters resulted in an 
overall quality of evidence that was rated as “Weak” (Supplementary 
Table 2).
There are plenty of reasons for the “weak” rating of the reported 
cumulative evidence, first and foremost is that GRADE methodology 
automatically assigns a “weak” rating to evidence from case-control 
studies, which, depending upon the methodological robustness and 
the validity of the reported effect estimates, of the pooled studies, 
may be upgraded to “Moderate” or very rarely to “High” strength.75 
There are indications of high heterogeneity and publication bias in 
addition to the usual methodological biases associated with case-
control studies.76 Although the quality of the cumulative evidence 
is “Weak,” it may be noted that the inappropriateness to conduct 
experimental studies for the assessment of the association between 
SLT and OPMDs on ethical grounds, renders the reported evidence 
as the “best evidence” available77 and hence may be used to inform 
tobacco control policies in South Asia.
Conclusion and Implications
The findings of our study point towards a strong association 
between some forms of OPMDs and SLT use in South Asia. The risk 
estimates are high, irrespective of controlling for confounders such 
as smoking and alcohol or stratification by sex, country or source of 
controls. There is also an exposure–response relationship between 
OPMDs and SLT use. The high prevalence of both OPMDs and 
SLT use in South Asia is a public health problem and this review 
provides the “best available” evidence on the association of OPMDs 
and SLT use, which can be used to educate the general public about 
the deleterious effects of SLT use and help inform both cancer and 
SLT control policies in South Asia as well as countries where SLT 
products of South Asian origin are used. Since OPMDs lie on the 
causal pathway to oral malignancy, preventing their development 
can potentially lead to a reduction in the incidence of oral cancer.
Differences Between Review and Protocol
We have tried our best to stay true to the published protocol for 
this review and hence report no significant differences between the 
review and the published protocol.78
Supplementary Material
Supplementary Tables 1–3 and Figure  1 can be found online at 
http://www.ntr.oxfordjournals.org
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ABSTRACT 1 
In the wake of smokeless tobacco (SLT) being advocated as a mean of tobacco harm 2 
reduction, it is pertinent to establish individual health risks associated with each SLT 3 
product. This case-control study was aimed at assessing the risk of oral cancer associated 4 
with a smokeless tobacco product (Naswar). The study was conducted from September 5 
???? till May ???? in Khyber Pakhtunkhwa, Pakistan. Exposure and covariate information 6 
was collected through a structured questionnaire. Conditional logistic regression was used 7 
to calculate odds ratios (OR) along with their ??% confidence intervals (CI). ?? oral cancer 8 
cases (??% males) and ??? age- and sex-matched controls were recruited. Ever users of 9 
Naswar had more than a ??-fold higher risk of oral cancer compared to never-users (OR 10 
??.?, ??% CI ?.?-??.?). Females had a higher risk of oral cancer with the use of Naswar (OR 11 
??.?, ??% CI ?.?-???.?) as compared to males (OR ??.?, ??% CI ?.?-??.?). Based on this 12 
result, ??% (men) and ??% (women) of the oral cancer burden in Pakistan is attributable 13 
to Naswar. The risk estimates observed in this study are comparable to risk estimates 14 
reported by previous studies on other forms of SLT use and the risk of oral cancer in 15 
Pakistan. The exposure-response relationship also supports a strong role of Naswar in the 16 
etiology of oral cancer in Pakistan. Although still requiring further validation through 17 
independent studies, these findings may be used for smokeless tobacco control in countries 18 
where Naswar use is common. 19 
 20 
 21 
ABBREVIATIONS 1 
CI  Confidence Interval 2 
DAG  Directed Acyclical Graph 3 
KPK  Khyber Pakhtunkhwa province 4 
MAS  Minimum Adjustment Set 5 
NPY  Naswar Pack-Year 6 
OR  Odds Ratio 7 
SLT   Smokeless Tobacco 8 
INTRODUCTION 9 
Oral cancer is one of the most common cancers in the world with approximately ???,??? 10 
incident cases each year [?]. Pakistan has one of the highest prevalence of oral cancer in the 11 
world [?]. With an age-standardized incidence rate of ?.?/???,???, oral cancer has become 12 
the most frequent cancer among males and the second most common cancer among both 13 
sexes in Pakistan [?]. A variety of risk factors like diet, alcohol, tobacco use, infections, 14 
genetic and environmental factors are associated with oral cancer. Among these, tobacco 15 
smoking and alcohol use have been widely researched and are universally considered as 16 
causal factors [?]. Smokeless tobacco (SLT) is labeled as carcinogenic by the World Health 17 
Organization [?]. Studies from South Asia have established SLT as a risk factor for oral 18 
cancer [?,?], but some investigations from industrialized countries, particularly Sweden, 19 
where SLT use is common, do not show an increased risk of oral cancer linked to the use 20 
of some SLT products [?,?]. These conflicting results become particularly important in the 21 
light of SLT products being considered as an alternative to smoking [?], and as means of 22 
harm reduction [?-??]. 23 
An estimated ??? million people use smokeless tobacco in South Asia [??]. Research on 24 
SLT products and the risk of oral cancer in South Asia has traditionally focused on Betel-25 
quid and Gutkha [?,?]. This is understandable, as the majority of SLT research has been 26 
carried out in India, where the most common forms of SLT are Gutkha and Betel-quid [??]. 1 
Naswar is a mixture of dried tobacco leaves, ash, lime and flavoring agents [??]. It is kept 2 
in the buccal sulcus of the mouth and the active agents are absorbed through the oral 3 
mucosa. Naswar use is often associated with the Pashtun tribes of Afghanistan and Pakistan 4 
but is also used in Central Asia, India, Bangladesh and by expat communities of these 5 
countries across the world [??]. 6 
Naswar is a much cheaper product compared to cigarettes. An average pack of Naswar costs 7 
approximately a ??th of the price of a cigarette pack in Pakistan and as such is gaining 8 
popularity as a cheap alternative to smoking [??]. It is also being advocated as a cheaper 9 
nicotine replacement therapy for people trying to quit smoking [??]. The sale and 10 
manufacture of Naswar in Pakistan are not regulated [??], and the sizing of the package 11 
and the constituents vary from one manufacturer to the other. Thus, the amount of 12 
carcinogenic agents also differs among the different brands available on the market [??]. 13 
Unlike cigarettes, the individual serving size also varies and is dependent upon personal 14 
preferences. This renders the correct establishment of the magnitude of the risk of oral 15 
cancer associated with a discernable Naswar “dose”, particularly challenging. A few studies 16 
from the south of Pakistan, where other forms of SLT are more popular [??,??], have 17 
reported risk estimates for oral cancer associated with Naswar, but there is scanty evidence 18 
from the Khyber Pakhtunkhwa province (KPK), which has the highest number of Naswar 19 
users in Pakistan [??]. The dearth of evidence needed to establish Naswar as carcinogenic 20 
for humans has also been acknowledged by the International Agency for Research on 21 
Cancer in its monograph on smokeless tobacco [??]. 22 
Given the conflicting research findings on the risks of SLT use and the scarcity of research 23 
on assessment of Naswar as being carcinogenic to humans, we carried out a case-control 24 
study in the KPK to assess the association between Naswar and the risk of oral cancer. We 25 
particularly focused on exposure quantification by using a novel method of Naswar pack-26 
years (NPY), assessment of exposure-response relationships and gender stratified risks. We 27 
also assessed the fraction of incident oral cancer among the study population that can be 28 
attributed to Naswar. 29 
METHODS 1 
Study design and setting 2 
A multi-center matched case-control study was carried out in two major cities of the 3 
Khyber Pakhtunkhwa province of Pakistan between September ???? and May ????. 4 
Peshawar is the capital city of the province; while Abbottabad is considered as the summer 5 
capital. The province has an area of ??,??? sq km and a total population of ??.? million. The 6 
population of Peshawar is ?,???,??? while that of Abbottabad is ?,???,??? [??]. The 7 
majority of the population lives in rural areas and agriculture and trade are the main 8 
earning resources. Cases were recruited at three tertiary care centers (Maxillofacial Surgery 9 
department of Khyber College of Dentistry, Peshawar, Ear, Nose, and Throat department 10 
of the Khyber Teaching hospital, Peshawar and the Maxillofacial Surgery Department of 11 
Rehmat Memorial Hospital, Abbottabad). Since primary and secondary healthcare facilities 12 
in the province do not have adequate means to diagnose and/or manage oral cancer 13 
patients, the included study centers are mainly responsible for the provision of both 14 
diagnostic and curative services for oral cancer. The catchment area of the study centers 15 
includes the whole province along with the Federally Administered Tribal Areas (FATA) of 16 
Pakistan. Controls were recruited from the same centers as well as from two additional 17 
health facilities in Peshawar (Pakistan Paraplegic Center, Peshawar and Institute for 18 
Physical Medicine and Rehabilitation, Khyber Medical University, Peshawar). These 19 
facilities also provide health services to the population of the whole province. All study 20 
centers were selected based on expert opinions from local cancer physicians and dentists. 21 
The recruitment was carried out for a nine-month period starting September ???? and 22 
ending in the first week of June ????. 23 
Power calculation 24 
The study size for a case-control ratio of a ?:? and ?:?, was calculated in Epi Info ? by using 25 
the Fliess method with continuity correction factor. The prevalence of Naswar (??%) among 26 
the general population (controls) was derived from a nationally representative 27 
survey[??,??]. To detect an OR of ?.? with a two-sided ??% confidence level and a power 1 
of ??%, we had to recruit ?? cases and ??? controls. 2 
Ethical approval 3 
Ethical approval for the study was granted by the ethical review board of Khyber Medical 4 
University and also by the ethical review committee of Khyber College of Dentistry. Written 5 
approvals to carry out the study were also obtained from the heads of the participating 6 
centers. Written consent was taken from each study participant before the interview and 7 
subsequent collection of biosamples. All study participants had the option to retract their 8 
consent at any stage of the study if they did not want to be a part of the study. To ensure 9 
maximum participation, laboratory charges related to the histopathological diagnosis and 10 
confirmation of the presence of oral cancer were borne from the study fund. These charges 11 
are normally paid out of pocket by the patients. 12 
Recruitment of cases and controls 13 
Cases 14 
Potential cases were recruited based on a clinical differential diagnosis of oral cancer. For 15 
the purpose of this study, “oral cancer” was defined as squamous cell carcinoma of the 16 
buccal mucosa, lip, tongue and the oropharynx: The ICD-?? classification was used to 17 
designate oral cancer sites to be included in the study. The eligible sites included lip, the 18 
base of tongue, other and unspecified parts of the tongue, gum, floor of mouth, palate, 19 
other and unspecified parts of the mouth, tonsil, and oropharynx (C?? - C?? and C?? - 20 
C??). A potential case was confirmed as a “definitive case”, only after the histopathological 21 
confirmation of the presence of squamous cell carcinoma at one of the above-mentioned 22 
sites.  23 
Controls 24 
Subjects with any condition, except for cancer, pulmonary disease, cardiovascular disease, 25 
gastrointestinal disease and periodontal disease, were eligible to be recruited as controls 26 
because these diseases are known to be related to tobacco use. Two age (??-year bands) 27 
and sex-matched controls were recruited per case from the out-patient and in-patient 1 
departments of the study centers. Following are the inclusion and exclusion criteria for 2 
recruitment: 3 
Inclusion criteria  4 
? Only incident cases who had not yet undergone any treatment for oral cancer were 5 
included as cases;  6 
? all included cases and controls were permanent residents and/or living in KPK or 7 
FATA for at least twelve months prior to the interview; 8 
? a case or control was only included if he/she could provide an informed consent and 9 
was deemed physically fit to be interviewed by the resident doctor/s.  10 
Exclusion criteria  11 
? Subjects with tumors/malignancy of the hypopharynx, nasopharynx, and salivary 12 
glands, or who had previous treatment for oral cancer before the interview; 13 
? subjects who were not permanent residents and/or had not been living in the 14 
Khyber Pakhtunkhwa province or the federally administered tribal areas for at least 15 
?? months prior to the interview; 16 
? unable to provide informed consent due to illness or deemed “physically not fit” for 17 
interview by a resident doctor. 18 
Matching 19 
Two controls per case, frequency-matched for age (??-year bands) and sex, were recruited 20 
for the study. 21 
Exposure variables 22 
 A Directed Acyclical Graph (DAG) analysis (Supplementary figures I an II) was carried out 23 
to ascertain study variables for which data needed to be collected. Oral cancer was the main 24 
outcome and Naswar was the primary exposure variable. Age, sex, socioeconomic status 25 
(SES), tobacco smoking and alcohol use were determined as the Minimum Adjustment Set 26 
(MAS) i.e. confounding exposures. Additionally, data were collected for Betel-quid 1 
chewing, sunlight exposure, diet, oral hygiene habits and history of the systemic and oral 2 
disease. 3 
Data Sources/ Measurement 4 
Data on the study variables was collected through a structured questionnaire adapted from 5 
a large European case-control study on upper aero-digestive tract cancers [??]. Face to face, 6 
interviews were conducted with both cases and controls. Apart from questions about the 7 
“current illness”, the questionnaire used for both groups was the same. 8 
Naswar use 9 
Data on ever use, daily frequency, total duration in years, duration of single use and type 10 
of Naswar were recorded. To determine the cumulative exposure to Naswar, we developed 11 
a novel measure of “Naswar pack-year (NPY)” 12 
Tobacco smoking 13 
Data regarding ever smoking, past smoking, current smoking, frequency and total duration 14 
of use in years for cigarettes and/or water pipe were recorded.  15 
Alcohol drinking 16 
Although alcohol is an established risk factor for oral cancer and can modify or confound 17 
the effects of other risk factors, the section of the questionnaire on alcohol use was 18 
considerably shortened from the one in the ARCAGE study and had only six questions. This 19 
was because alcohol use is forbidden in Islam, the main religion in this region, and is also 20 
a culturally and socially unacceptable habit in Pakistan. This renders any talk about alcohol 21 
as a taboo. However, we still collected data on ever and never use of alcohol and total 22 
duration of alcohol use in order to account for the effects of alcohol use, if any, during 23 
analysis.  24 
 25 
 26 
Socioeconomic status 1 
SES was assessed using a simple poverty scorecard developed for Pakistan[??]. The 2 
scorecard is used to determine the probability of a household to be situated above the 3 
national poverty line i.e. a higher score means a higher probability of being placed above 4 
the national poverty line and vice versa. This method has been previously used in social 5 
science research in Pakistan but never in health research. The scorecard consists of ten 6 
close-ended questions pertaining to assets, education, job type, the number of children, 7 
and source of drinking water. The responses are marked and scored according to pre-8 
determined scores. The overall score is then translated into the likelihood of a household 9 
being below or above the national poverty line. The advantage of this approach is that it is 10 
based on household-level data, which is cognizant of the Pakistani culture of joint families. 11 
Dietary habits were assessed using a food frequency questionnaire, containing questions 12 
about meat, vegetables, fruit and tea intake. The intake was recorded in terms of frequency 13 
per month. The oral health section included questions regarding frequency and mode of 14 
mouth and/or teeth cleaning along with the presence of oral disease and the use of 15 
dentures. History of disease, such as candidiasis, herpes, warts and regurgitation, was 16 
recorded in the systemic disease section. Pictures were used to aid the memory of 17 
participants. Sun exposure was assessed by asking questions about the average time spent 18 
in the sun during a day. Questions regarding any means of sun protection used by the 19 
participants were also included.  20 
Exposure quantification 21 
Age 22 
Age was categorized into ten-year bands. 23 
SES 24 
Based on the probability of lying above the national poverty line, we assigned our study 25 
participants into three categories: high (probability > ??%), medium (??% - ??% 26 
probability) and low (probability < ??%). 27 
Habits 1 
An “Ever user” of Naswar, cigarette, betel-quid, water pipe, or alcohol was defined as a 2 
person who had practiced the habit at least once per week for one year in his life. A “current 3 
user” of Naswar was defined as someone who has been using Naswar at least once per week 4 
in the ?? months preceding the interview, including those who had stopped the habit 5 
within those ?? months. A “past user” was defined as a person who had used Naswar at least 6 
once a week for a year but had quit the habit before the ?? months preceding the interview.  7 
Naswar-pack-years 8 
Naswar production is not regulated in Pakistan and therefore the correct assessment of 9 
exposure categories and dose-responses is very difficult. Usually, the packages come in 10 
different sizes and the size of individual serving depends on users and varies to a great 11 
extent based on personal preference. To address this issue, a selected sample of ?? case and 12 
control participants, who were Naswar users, were asked to make a serving of Naswar, 13 
similar in size, to what these participants had been or were currently using. These servings 14 
were weighed and the average weight of a single serving was calculated. We also acquired 15 
?? different Naswar packages from the ?? districts of the KPK, the capital city of Pakistan 16 
and the five provincial capitals, and calculated the average weight of these Naswar 17 
packages. The number of servings/package was computed by dividing the average weight 18 
of a package by the average weight of a serving. From these data, NPY were calculated by 19 
using the formula (ܰݑܾ݉݁ݎ ݋݂ ݏ݁ݎݒ݅݊݃ݏ ݌݁ݎ ݀ܽݕ ×20 
ܶ݋ݐ݈ܽ ݀ݑݎܽݐ݅݋݊ ݋݂ ܰܽݏݓܽݎ ℎܾܽ݅ݐ ݅݊ ݕ݁ܽݎݏ) /(ܰݑܾ݉݁ݎ ݋݂ ݏ݁ݎݒ݅݊݃ݏ ݌݁ݎ ܰܽݏݓܽݎ ݌ܽܿ݇݁ݐ) 21 
The average weight of a Naswar pack was ??.? g (??% CI: ??.?-??.? g).. The average weight 22 
of a Naswar pellet was ?.? g (??% CI: ?.?-?.? g). The number of pellets per Naswar package 23 
was ??.?. Conservatively, a Naswar pack-year was thus defined as ?? pellets of Naswar used 24 
per day for one year. For the conditional model, NPY was categorized into ? categories i.e. 25 
None, ?-??, ??-?? and more than ??, the intensity of Naswar use (in minutes) was 26 
categorized into None, ?-?, ?-?? and greater than ??. 27 
 28 
Bias reduction 1 
The study participants were blind to the main research hypothesis. Interviewers and cases 2 
were partially blind to the case status of the participants, as interviews with the cases took 3 
place when a definitive diagnosis had not been established. This approach helped us reduce 4 
temporal ambiguity and of the interviewer and differential recall bias among cases and 5 
controls. Recruitment of incident only cases was aimed at avoiding problems of recall of 6 
pre-morbid history. 7 
Statistical methods 8 
Data were entered and stored in Epi Info ? [??]. The analysis was carried out in SAS version 9 
?.? [??]. Crude odds ratios (OR?) along with their ??% CI were calculated using conditional 10 
logistic regression (conditioned for age and sex). Moreover, adjusted odds ratios were 11 
derived (OR?), taking simultaneously into account the MAS of variables. We also calculated 12 
the population attributable fraction (PAF) for KPK and Pakistan, using the OR from the 13 
conditional logistic regression model and prevalence of Naswar (p) use from a nationally 14 
representative tobacco prevalence survey from Pakistan [??] by using the formula: ۾ۯ۴ =15 
[p(OR-1)]
[p(OR-1)+1]. The total number of attributable incident cases (AC) of oral cancer was 16 
obtained by the formula AC = PAF * TC, TC is the total number of annual incident cases of 17 
oral cancer. The estimated annual number of incident cases of oral cancer in Pakistan was 18 
extracted from Globocan, ???? [?]. 19 
RESULTS 20 
Participants profile 21 
Based on our initial sample size calculation, we had to recruit ??? cases and ??? controls 22 
for a ?:? case/control ratio, or ?? cases and ??? controls for a ?:? case/control ratio. The study 23 
initially started with a ratio of ?:? among cases and controls. However, in December ????, 24 
Peshawar saw a deadly terrorist attack killing almost ??? children and resulting in a very 25 
tight security situation in the whole province. The uncertain security situation led to a 26 
decrease in patient in-flow at most hospitals in Peshawar city as both inter and intra-city 1 
movement came to a halt. The security situation and the resulting decrease in patient in-2 
flow hampered recruitment of cases in Peshawar making it difficult to reach the desired 3 
number of ??? cases for the study. Therefore, in February ????, it was decided to recruit 4 
two controls per case in order to be able to achieve the desired power for the study.  5 
A total of ?? potential cases and ??? age and sex-matched controls were asked to participate 6 
in the study. ?? cases and ??? controls agreed to participate, The participation rate was 7 
??% for cases and ?? % for controls. The final sample included ?? cases and ??? age and 8 
sex-matched controls (Table ?) as two cases were excluded from the analysis because they 9 
had a cancer type other than squamous cell carcinoma. The majority of cases were males 10 
(n= ??). The mean age of male cases and controls was ??.? (±??.?) and ??.? (±??.?) years, 11 
respectively. Among females, the mean age of cases and controls was ??.? (±??.?) and ??. ? 12 
(±??.?) years, respectively. The male to female ratio was ?.?: ? and about ??% (?? males, ?? 13 
females) of the cases were ?? years of age or younger ??. 14 
The most common primary sites of oral carcinoma tumors were the gums (n=??) and the 15 
buccal mucosa (n=??). Histologically, ??% of the tumors were “well-differentiated”, ??% 16 
were “moderately differentiated”, and the remaining tumors either poorly differentiated or 17 
“undifferentiated”. From a total of ?? districts in the Khyber Pakhtunkhwa province, only 18 
two were not represented among the cases. Peshawar being the most populous city of the 19 
province had the highest number of cases. Six cases originated from the federally 20 
administered tribal areas. The distribution of MAS variables among the participants overall 21 
and stratified by sex is provided in Table ?. Naswar was the most prevalent habit among 22 
both cases (??.?%) and controls (??.?%). The majority of the participants (?? % cases, ?? 23 
% controls) belonged to the low or medium SES strata. Initial univariate analysis (chi-24 
square tests) revealed that Naswar use, smoking, and sex were significantly (p<?.??) 25 
associated with oral cancer.  26 
 27 
Table  1: Distribution of cases and controls by study recruitment center 
 
Study status 
 
 
KCD 
 
KTH 
 
RMH 
 
PPC 
 
KMU 
 
Total 
 
Cases n (%) 
 
57 (67.8) 
 
9 (10.7) 
 
18 (21.4) 
  
 
  84 
 
 
Controls n (%) 
 
63 (36.2) 
 
36 (20.6) 
 
20 (11.4) 
 
28 (16) 
 
26 (14.9) 
 
174 
 
 1 
KCD: Khyber College of Dentistry, KTH: Khyber Teaching Hospital, RMH: Rehmat Memorial Hospital, PPC. Pakistan Paraplegic Center, 2 
KMU: Khyber Medical University 3 
 4 
  5 
Table 2: Distribution of the lifestyle risk factors for oral cancer, by sex, among cases (n=84) and controls 1 
(n=174) in Khyber Pakhtunkhwa, Pakistan.  2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
  28 
Risk Factors 
Males Females Total 
Cases Controls Cases Controls Cases Controls 
n (%) n (%) n (%) n (%) n (%) n (%) 
Naswar 
Never 3 (5.7) 64 (59.2) 14 (43.7) 62 (93.9) 17(20.2) 126 (72.4) 
Ever 49 (94.2) 44 (40.7) 18 (56.2) 4 (6.1) 67 (79.7) 48 (27.5) 
Current 34 (65.3) 28 (25.9) 12 (37.5) 0 (0.0) 46 (54.6) 28 (16.1) 
Past 15 (28.8) 16 (14.8) 6 (18.7) 4 (6.1) 21 (25.1) 20 (11.4) 
Cigarette Smoking 
Never 29 (55.7) 82 (75.9) 27 (84.3) 65 (98.4) 56 (66.6) 147 (84.4) 
Ever 23 (44.3) 26 (24.1) 5 (15.6) 1 (1.6) 28 (33.3) 27 (15.5) 
Betel-quid Chewing 
Never 50 (96.1) 108 (100.0) 30 (93.7) 66(100) 80 (95.2) 174 (100) 
Ever 2 (3.8) 0 (0.0) 3 (6.2) 0 (0.0) 4 (4.7 0 (0.0) 
Water-pipe smoking 
Never 48 (90.3) 107 (99.1) 30 (93.7) 66 (100) 77 (91.6) 173 (99.4) 
Ever 4 (9.69) 1 (0.9) 3 (6.2) 0 (0.0) 7 (8.3) 1 (0.6) 
Alcohol 
Never 49 (94.2) 105 (97.2) 31(96.8) 66 (100.0) 80 (95.2) 171 (98.2) 
Ever 3 (5.7) 3 (2.7) 1 (3.1) 0 (0.0) 4 (4.7) 3 (1.7) 
Socio-economic status 
Low 26 (50.0) 50 (47.2) 13 (40.6) 16 (22.7) 39 (46.4) 66 (37.9) 
Medium 24 (46.1) 51 (48.1) 17 (53.1) 43 (63.6) 41 (48.8) 94 (54.0) 
High 2 (3.8) 7 (5.6) 2 (6.2) 7 (13.6) 4 (4.7) 14 (8.0) 
Main Results 1 
Table ?. shows the univariate as well as the simultaneously adjusted risk estimates for 2 
different risk factors among the study participants. Ever and current Naswar users had a 3 
more than ??-fold risk increase of oral cancer compared to non-users (ever: OR ??.?, ??% 4 
CI ?.?-??.?), (current: OR ??.?, ??% CI ??.?-??.?). Ever smoking also doubled the risk of 5 
oral cancer, compared to non-smokers (OR ?.?, ??% CI ?.?-?.?), while alcohol consumption 6 
was not significantly related to the risk of oral cancer (p-value= ?.??). In general, a higher 7 
SES was associated with a lower risk for oral cancer; however, this finding was also not 8 
significant (p-value= ?.??).Tables ? and ? provide an overview of the risk of oral cancer 9 
associated with Naswar stratified by males and females, respectively.  10 
The overall PAF of Naswar for oral cancer in Pakistan was ??%. The sex-specific PAF of 11 
Naswar for oral cancer in Pakistan was ??% and ??% for males and females, respectively. 12 
The PAF was ??% for KPK. Sex-specific PAF for KPK was not calculated due to lack of data. 13 
The total number incident cases of oral cancer in both sexes in Pakistan attributable to 14 
Naswar (AC) was ?,??? (??,??? total incident oral cancer cases in Pakistan. 15 
 16 
 17 
 18 
Table 3:  Risk of oral cancer associated with the lifestyle risk factors among both sexes (84 cases, 174 controls) in 
Khyber Pakhtunkhwa, Pakistan, derived from conditional logistic regression (conditioned on age and sex). 
 
*Ever users only; OR
1
: Basic model conditioned for age and sex; OR
2
: Basic model adjusted for other MAS variables.
Risk Factors Cases n (%) 
Controls 
n (%) OR
1 (95 % CI) 
 
OR2 (95 % CI) 
 
Socio-Economic Status 
Low 39  (46.4) 66  (37.9) 1.0 1.0 
Medium 41  (48.8) 94  (54.1) 0.7 (0.4-1.2) 0.7 (0.4-1.3) 
High 4    (4.8)        14   (8.0) 0.5 (0.1-1.5) 0.5 (0.1-1.7) 
Smoking 
Never 56  (66.6) 147 (84.4) 1.0 1.0 
Ever 28  (33.3) 27  (15.5) 3.0 (1.5-5.8) 2.2 (1.4-4.9) 
Alcohol 
Never 80  (95.2) 171 (98.2) 1.0 1.0 
Ever 4    (4.7) 3      (1.8) 2.7 (0.6-12.1) 0.7 (0.1-4.1) 
Naswar 
Never 17  (20.2) 126 (72.4) 1.0 1.0 
Ever 67  (79.7) 48   (27.5) 22.9 (9.2-57.4) 21.2 (8.4-53.8) 
Current 46  (54.7) 28   (16.1) 28.0 (10.5-74.0) 27.4 (10.0-74.7) 
Past 21  (25.0) 20   (11.4) 16.4 (5.8-46.7) 14.3 (4.9-41.2) 
Naswar Pack Years 
0 17  (20.2) 126  (72.4) 1.0 1.0 
1-10 16  (19.0) 16    (9.1) 15.3 (5.2-44.9) 12.5 (4.1-38.0) 
11-20 27  (32.1) 15    (8.6) 28.7 (9.9-82.8) 26.5 (9.0-78.2) 
>20 24  (28.5) 17    (9.7) 28.3 (9.3-86.2) 28.9 (9.3-90.2) 
Naswar dip duration (minutes) 
0 17  (20.2) 126  (72.4) 1.0 1.0 
1-5 19  (22.6) 39    (22.2) 8.5 (3.1-23.3) 7.2 (  2.5-20.4) 
6-10 23  (27.3) 6      (3.4) 67.6 (18.6-245.6) 61.8 (16.6-229.5) 
>10 25  (29.7) 3      (1.8) 142.2 (31.1-650.5) 136.2 (29.1-638.2) 
Naswar Saliva * 
Swallow 20  (29.8) 8     (20.8) 1.0 1.0 
Spit 47  (70.1) 40   (79.1) 0.4 (0.1-1.3) 0.4 (0.1-1.4) 
Naswar Type 
Non-user 17  (20.2) 126  (72.4) 1.0 1.0 
Black 50  (59.5) 37    (21.2) 22.2 (8.6-56.7) 21.3 (8.2-55.4) 
Green 17  (20.2) 11    (6.3) 25.9 (8.0-83.0) 21.0 (6.4-68.9) 
?? 
 
?? 
 
Table 4:  Naswar use and the risk of oral cancer among men (52 cases,108 controls) in Khyber Pakhtunkhwa, 
Pakistan, crude and adjusted risk estimates from simple logistic regression. 
 
*, **Includes “Never users”, *** Ever users only, OR1: Crude Odds Ratio, OR2: Adjusted for age, SES, smoking, and alcohol, CI: Confidence 
Interval 
 
 
 
 
Table 5. Crude and adjusted risk estimates for oral cancer associated with Naswar use among women (32 cases, 66 
controls) in Khyber Pakhtunkhwa, Pakistan, derived from simple logistic regression 
Risk Factor 
Cases Controls 
OR1 (95 % CI) OR2 (95 % CI) 
n % n % 
Naswar habit 
Never 3 5.8 64 59.3 1.0 1.0 
Ever 49 94.2 44 40.7 23.7 (6.9-81.0) 21.0 (6.1-72.1) 
Current 34 65.4 28 25.9 25.9 (7.3- 91.4) 23.4 (6.6-82.1) 
Past 15 28.8 16 14.8 20.0 (5.1-77.5) 16.4 (4.1-65.4) 
Naswar Pack Years 
0-10* 12 23.1 78 72.2 1.0 1.0 
11-20 20 38.5 13 12.0 9.9 (3.9-25.2) 9.6 (3.6-25.5) 
>20 20 38.5 17 15.7 7.6 (3.1-18.5) 8.7 (3.3-22.6) 
Dip duration (minutes) 
0-5** 14 26.9 100 92.6 1.0 1.0 
6-10 20 38.5 5 4.6 28.5 (9.2-88.3) 23.0 (7.4-71.5) 
>10 18 34.6 3 2.8 42.8 (11.1-164.3) 39.7 (9.9-158.5) 
Naswar type 
Green 11 21.2*** 10 9.3 1.0 1.0 
Black 38 73.1*** 34 31.5 1.0 (0.3-2.6) 1.0 (0.3-2.8) 
?? 
 
?? 
 
. 
*Includes “Never users”, **Ever users only, OR1: Crude Odds Ratio, OR2: Adjusted for age, SES, smoking and alcohol, CI: Confidence Interval 
 
 
 
DISCUSSION 
Statement of main findings 
Naswar contributes to about ??% of oral cancers in the study region. Ever users of Naswar 
were more than ?? times likely to develop oral cancer compared to non-users. Compared 
to non-users and participants with a comparatively low cumulative exposure (NPY) to 
Naswar (<??), both male and female ever-users with a higher NPY count had a significantly 
higher risk of oral cancer. A similar relationship was seen with the intensity of exposure 
between both sexes, with a significant increase in risk among Naswar users who kept 
Variables 
Cases Controls 
OR1 (95 % CI) OR2 (95 % CI) 
N % n % 
Naswar habit 
Never 14 44.1 62 93.9 1.0 1.0 
Ever 18 55.9 4 6.1 19.9 (5.8-68.1) 29.0 (5.4-153.9) 
Naswar Pack Years 
0-10* 21 65.6 64 97.0 1.0 1.0 
>10 11 34.4 2 3.0 16.7 (3.4-81.8) 16.0 (2.7-93.7) 
Dip duration (minutes) 
0 14 43.5 62 93.5 1.0 1.0 
1-5 8 25.0 3 4.5 11.8 (2.7-50.2) 16.7 (2.2-124.1) 
>5 10 31.3 1 1.6 44.2 (5.2-374.8) 50.2 (5.1-495.9) 
Naswar type 
Green 6** 18.8 1 1.5 1.0 1.0 
Black 12 37.5 3 4.5 0.6 (0.1-11.5) 0.8 (0.1-11.5) 
?? 
 
?? 
 
Naswar in the mouth for more than five minutes as compared to non-users and participants 
who kept Naswar in their mouth for a shorter duration.  
Interpretation and generalizability 
Smokeless tobacco is considered as a risk factor for oral cancer and its use is on a rise 
globally and in particular in South Asian countries [??,??]. Naswar has not been researched 
extensively, particularly in the context of cancer risk. A previous study from the KPK 
reported a high biochemical risk of cancer associated with the constituents of Naswar [??], 
the present study conducted in the same region provides epidemiological evidence to 
further strengthen that argument. A more than ??% prevalence of Naswar use among the 
oral cancer cases in our study is comparable to previous findings from the same region 
[??,??]. The prevalence of Naswar use among the controls at ??% is comparable to previous 
findings (??%) about Naswar use in Peshawar [??], yet substantially higher than the 
national figure of ?.?% [??]. The difference can be explained by the stark disparity in 
tobacco consumption practices among the different provinces of Pakistan. While the 
national figures are based on a representative sample of all the provinces of the country, 
our sample consists of subjects belonging to KPK only, where Naswar use is almost like a 
cultural practice [??]. 
We report a very high magnitude of risk for oral cancer associated with the use of Naswar. 
This finding is consistent with that of other studies from India and Pakistan on the risk of 
oral cancer associated with the use of other forms of SLT such as Gutkha and Betel-quid 
[?,?]. However, in our study, the observed risk estimates are even higher compared to those 
associated SLT products. A plausible explanation for this risk difference might be a 
comparatively higher amount of “Tobacco-Specific Nitrosamines” and nicotine, and a 
higher alkalinity (pH) of Naswar compared to Gutkha and Betel-quid [??]. Nicotine causes 
dependence and a higher nicotine level coupled with a high pH can cause stronger cravings 
and more frequent and/or prolonged use of the SLT products [??], leading to a stronger 
exposure to the carcinogenic agents. There are also suggestions that Naswar causes local 
?? 
 
?? 
 
tissue trauma by erosion [??], and chronic tissue trauma is an independent risk factor for 
cancer [??]. The ash and lime used in the preparation of Naswar may also be contributing 
a high level of toxins and heavy metals to the composition, thus adding to its potential 
toxicity [??]. 
Some previous studies from Southern Pakistan have reported risk estimates for oral cancer 
and Naswar which are lower in magnitude than the risk estimates we report [??,??]. This 
difference may be attributed to the diverse SLT consumption practices in different parts of 
Pakistan. Betel--quid use is very common in the south, while Naswar is mostly used in the 
north of Pakistan, including our study region [??]. In our study, Betel-quid use was not 
significantly related to an elevated risk of oral cancer and the prevalence of Betel-quid use 
was much lower than previous reports [??,??]. Furthermore, a large case-control study 
from Pakistan carried out in the ????s [??], reported a relative risk of ?? for oral cancer 
with the use of Nass (= Naswar), consistent with our findings. However, this study had 
some methodological limitations [??].  
Our results show that current users of Naswar had a higher risk compared to past users. 
This finding is in line with those of a cohort study on SLT use and the risk of oral carcinoma 
from India [??]. The results of our exposure-response analysis are in accordance with those 
reported in independent studies as well as systematic reviews of literature from South Asia, 
where an increasing frequency, duration, and intensity of exposure were all related to a 
subsequent increase in the risk of oral cancer [?,?]. We have reported a higher adjusted OR 
for the risk of oral cancer with the use of Naswar among females as compared to males. 
Other studies of SLT and its effects on oral cancer reported similar findings that may be 
explained by lower background risk of oral cancer among females and a greater potential 
for oral mucosal damage among women as compared to men [?,??]. Our study reports 
population attributable risks of Naswar for oral cancer comparable to those reported for 
other forms of SLT from other South Asian countries [?]. Notably, the PAF for KPK is 
considerably higher than the national PAF due to a higher prevalence of Naswar use in the 
?? 
 
?? 
 
province and signifies the importance of Naswar as a major risk factor for oral cancer in 
this population. 
Strengths and limitations of this study 
This study may suffer from drawbacks inherent to retrospective study designs. The study 
sample, particularly the hospital controls, may not be representative of the general 
population of KPK. However, we adopted wide eligibility criteria for the inclusion of 
controls with regard to their diagnosed disease to avoid recruitment of subjects who might 
be very similar to each other in terms of exposure and belonging to a narrow subset of the 
whole population. For recruitment of the participants, we chose the largest tertiary care 
facilities and in the case of oral cancer patients, the only public sector centers where 
diagnosis and treatment of oral cancer are carried out. We obtained a high response rate 
among potential study subjects, which may be attributed to the payment of laboratory 
charges on behalf of the case subjects as an incentive, and cooperation from the hospital 
staff at the study centers, who motivated control subjects to participate. We managed to 
exceed the number of cases and controls estimated during the sample size calculation. 
However, we still had to collapse a few exposure-response categories during the sex-
stratified analysis, due to a small number of participants. This shortcoming warrants larger 
epidemiological studies to strengthen the evidence provided by this study. 
Although we frequency-matched each case to at least two controls, there have been recent 
suggestions in the literature that an unconditional logistic regression analysis may yield 
equal or more robust and efficient results for matched studies [??]. We did not find any 
large differences between the effect estimates yielded by the conditional and the 
unconditional analysis, both being highly elevated and suggestive of a causal link between 
Naswar and oral cancer. This is the first adequately powered case-control study to be 
carried out on the risk factors for oral cancer in the Khyber Pakhtunkhwa province and the 
use of a “simple poverty card”, utilization of causal diagrams and “Naswar pack-years” gives 
it novelty among other similarly designed studies on use of smokeless tobacco and the risk 
?? 
 
?? 
 
of oral cancer. Another important feature of the study was the partial blinding of the study 
cases, as they were only differentially diagnosed at the time of interview and hence not fully 
aware of their condition. This may have diminished selective recall bias among the cases. 
 
Policy and practice Implications 
These findings are highly relevant for South and Central Asia, where Naswar use is 
common. As prices of cigarettes soar, more people might take up products like naswar, 
because of their lower prices [??]. The lack of published evidence on health risks associated 
with SLT, such as Naswar, may also contribute to this. It is, therefore, pertinent to produce 
further local evidence to inform public policy, as findings from developed countries may 
not be applicable in the local context because of a difference in composition of SLT 
products, which may be responsible for the observed differences in risk of oral cancer and 
other diseases between industrialized and developing countries [??]. To the best of our 
knowledge, this study is one of a handful of case-control studies focusing on Naswar and 
the associated risk for oral cancer. Until larger cohort studies are carried out to further 
assess this risk, the evidence from this study may be used to inform SLT control policies in 
countries where Naswar is used. The use of Naswar pack-years could also be incorporated 
into research and clinical practice to assess future risks for oral cancer with the use of 
Naswar. 
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A gaping gap (smokeless tobacco control
in Pakistan)
Zohaib Khan1,2
Abstract
Oral cancer is second most common cancer in Pakistan and one of the major contributing factors to its high incidence
is smokeless tobacco (SLT) use. 5.3% of Pakistan’s youth are current SLT users. The World Health Organization requires
the signatories of its “Framework Convention on Tobacco Control” to officially ban the sale of tobacco products to
minors. We reviewed the Government of Pakistan’s tobacco control, and related supporting policies, to assess how
these address the issue of sale of SLT products to minors and found evident gaps in this regard. Legislations need to
be in place to ban the sale of SLT products to minors and avoid an SLT epidemic in the future.
Keywords: Smokeless tobacco, Youth, Oral cancer, Tobacco control, FCTC, Sales ban
Background
Smokeless tobacco is associated with a variety of oral
and systemic disease [1, 2], in particular with oral and
pharyngeal cancers [3]. Pakistan has one of the highest
incidence rates of oral cancer in the world [4]. It is the
most common cancer among men and the second most
common cancer among women in the country [5]. To-
bacco use and alcohol consumption are considered as
the leading modifiable risk factors for oral cancer and
account for over 70% of the population attributable frac-
tion for oral cancer [6]. A World Health Organization
(WHO) report from 2001 suggests that Pakistan has one
of the lowest per capita consumption of alcohol in the
world [7], which might be due to a public ban on
consumption and sale of alcohol. Tobacco, therefore,
seems to be a major reason for the high incidence of oral
cancer in Pakistan, this is substantiated by recent evi-
dence from systematic reviews of literature pertaining to
South Asia which implies that SLT is one of the main
factors responsible for a high incidence of oral cancer in
the region [8, 9]. Results from the Global Youth Tobacco
Survey (GYTS), carried out recently in Pakistan, show
that 5.3% (approx. 4.2 million) of the country’s youth
currently use smokeless tobacco (SLT) products and
another 4.7% were past users [10]. The results from
GYTS are particularly alarming because the survey sam-
ple consisted of school going children aged 13–15 years.
Evidence shows that a social disparity exist with regards
to both oral cancer incidence and SLT use i.e., People
from low socioeconomic status, and lower or no education
level, are at a higher of oral cancer and having an
SLT habit [11]. This could imply, that potentially the
actual prevalence of SLT use might even be higher
among the youth of Pakistan, given that the national
literacy rate is just 46% [12].
Pakistan is a signatory of the WHO’s Framework
Convention for Tobacco Control (FCTC) since 2005,
and has taken significant steps to curb smoking in the
country [13]. Article 16 of the FCTC states, “Each Party
shall adopt and implement effective legislative, executive,
administrative or other measures at the appropriate
government level to prohibit the sales of tobacco prod-
ucts to persons under the age set by domestic law,
national law or eighteen”, an intervention aimed at curb-
ing the use of tobacco among minors. However, the
results of the GYTS and evidence from more recent
studies [14, 15], suggest that tobacco control in Pakistan
may be lagging in its effectiveness to reduce the preva-
lence of tobacco products use among minors.
A 2014 research article explored public policy gaps
with regards to SLT control in four Asian countries
including Pakistan, by conducting a review of policy
documents and interviews with key informants [16], one
of the findings of this study was that, “the sale of
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smokeless tobacco to and by minors is prohibited in
Pakistan”. The dichotomy between the alarming preva-
lence of SLT use among minors in Pakistan and the re-
ported findings of the aforementioned policy review
study [16], warranted a review of the Government of
Pakistan policies to identify, how the issue of sale to and
by, and consumption of SLT by minors has been ad-
dressed in these policy documents.
Methods
We downloaded the official documents related to to-
bacco control from the official website of the Govern-
ment of Pakistan’s Tobacco Control Cell, a body
responsible for research, advocacy and legislation per-
taining to tobacco control in Pakistan. Documents per-
taining to child labor in Pakistan were downloaded from
the United Nations’ International labor Organization’s
“database of national labor, social security and related
human rights legislation (NATLEX)” database. Provincial
policy documents, if applicable, were downloaded from
the official websites of the respective provinces of
Pakistan. In order to supplement the information from
the official documents, we performed an electronic
search in Medline via PubMed using various combina-
tions of MeSH terms and keywords, to identify tobacco
control policy related literature from Pakistan. The final
search query used in PubMed was ((“pakistan”[MeSH
Terms] OR “pakistan”[All Fields]) AND (“tobacco”[-
MeSH Terms] OR “tobacco”[All Fields] OR “tobacco
products”[MeSH Terms] OR (“tobacco”[All Fields] AND
“products”[All Fields]) OR “tobacco products”[All
Fields])) AND (“policy”[MeSH Terms] OR “policy”[All
Fields]). From the retrieved articles those which
reviewed, or were specifically aimed at informing public
tobacco control policy in Pakistan, were included in this
review. Additionally, an email request was sent to the
authors of the 2014, SLT control policy review article, to
explain the basis of their findings regarding the prohib-
ition of sale of SLT to and by minors in Pakistan.
Results
Table 1 refers to key findings from the relative official doc-
uments of the Government of Pakistan. The PubMed
search returned 27 articles out of which two were eligible
to be included in this review. The first article was the
afore-cited review of the SLT control policies in South
Asia which had concluded that SLT sale to and by minors
is prohibited in Pakistan [16]. The second article was
based on a core Non-communicable disease prevention
policy document from Pakistan and only addressed the
prohibition of sale and consumption of cigarettes to mi-
nors, without any mention of SLT use among minors [17].
In response to the authors’ query, the authors of the art-
icle on SLT control policies in South Asia [16] cited
“section 9” of the “Prohibition of Smoking and Protection
of Non-Smokers Health Ordinance 2002”, and informa-
tion from a key personnel that the child labor act prohibits
children from working (Including selling tobacco
products), as the basis of their finding, that sale of SLT
products to and by minors in Pakistan is prohibited.
Discussion
The findings from table 1 clearly suggest gaps in public
policy with regards to SLT sale, to and by minors. The
“section 8” of the 2002 Ordinance only focuses on
“smoking tobacco” products sales to and by minors
without mentioning smokeless tobacco. On the contrary,
the monitoring tool designed to assess the implementa-
tion of the same ordinance assesses the sale of both
smoking and other forms of tobacco, to and by minors,
which implies a disconnect between the two documents.
The 2002 ordinance also puts a selective ban on the sale
of any tobacco products to any age group i.e., only inside
and in the near vicinity (50 m) of educational and public
sector institutions, and renders these public and educa-
tional buildings “smoke free”. This would technically imply
that a person, irrespective of age, can consume smokeless
tobacco within these institutions. Additionally, given that
54% of Pakistan’s population is not literate [12], the poten-
tial applicability of the section 9 of the ordinance may only
be limited to half of the country’s population. In Sindh
province there is a selective ban on manufacture and sale of
Gutka but other forms of SLT are still manufactured and
sold. In Khyber Pakhtunkhwa both children and adoles-
cents are not allowed to work in the manufacture or pro-
cessing of Naswar but there are no provisions for
prohibition of sale of Naswar to and by minors.
With regards to the difference between our finding and
those reported by Khan et al. [16]. We believe that the
basis on which they concluded that “In Pakistan, the sale
of SLT to and by minors is prohibited”, are too vague and
open to interpretation, to draw a solid conclusion from.
Firstly, “section 9” of the 2002 ordinance puts only a
“geographically limited” ban/prohibition on the sale of
tobacco products in, or in the near vicinity of selected
public/private buildings. Given that section 8 of the ordin-
ance only prohibits sale of cigarettes and other smoking
substances (not SLT) to and by minors, thus, technically a
minor could sell or buy an SLT product at a 51 m distance
from the institutions/buildings mentioned in the ordin-
ance. Secondly, the national act related to child labor in
Pakistan explicitly bans children from selected “occupa-
tions and processes”, none of which are related to SLT
sale. It is also pertinent to note that apart from the Khyber
Pakhtunkhwa province, where adolescents are also cov-
ered by its own child labor law, the national act is applic-
able only to children under the age of 14, while “minor”
has been defined as a person under the age of 18 in the
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Table 1 Smokeless tobacco control and minors in Pakistan
No Document name Available at Relevant sections/articles/paragraphs “SLT and minors” related findings
Prohibition of Smoking and
Protection of Non-Smokers
Health Ordinance 2002.
http://www.tcc.gov.pk/downloads.php • Section 8, titled Prohibition of sale of cigarettes, etc. to minors- “No
person shall sell cigarettes or any other smoking substance to any
person who is below the age of eighteen years”.
• Section 9, “Prohibition of storage, sale and distribution of cigarettes,
etc.,in the immediate vicinity of educational institutions” – No person
shall himself or by any person on his behalf, store, sell or distribute
cigarettes or any other smoking substance or any other tobacco
product within (fifty) meters from any college, school or educational
institution.
• Explanation of Educational institutions: “All schools in the
country, Primary, Secondary, Higher Secondary, all Colleges,
Intermediate degree, Medical Colleges, Engineering Colleges,
Agriculture and all other institutions and all the Universities, private
or Government have declared 100% smoke free. No student, teacher,
persons who are working in the above mentioned institutions and
all heads of institutions cannot smoke in the premises”.
“No tobacco products can be sold within the 50 meters area of the
premises of all above mentioned”
• Sale of cigarettes and other smoking substances
to minors is banned, no mention of SLT.
• Selective prohibition i.e., Ban on sale of all
kinds of tobacco in and in the immediate
vicinity of various institutions.
• All institutions mentioned are declared “smoke
free” and not “tobacco free”.
SRO on “The Prohibition of Sale
of Cigarettes to Minors
Rules, 2010
http://www.tcc.gov.pk/downloads.php • No mention of smokeless tobacco. • None
Monitoring Checklist for
Implementation
Committee, 2002
http://www.tcc.gov.pk/downloads.php • Section 8, Sale of cigarettes and other tobacco products to
minors Yes/No
• Section 9, Presence or absence of cigarette sales outlet/s within
50 m of the institution, and the presence or absence of cigarette
sale in the institutions cantine.
• Monitoring of tobacco products sale to minors.
• Monitoring of sale of tobacco products in, or
in the vicinity, of institutions mentioned in
section 9 of the 2002 ordinance.
Media Resource Kit on
Tobacco Control
http://www.tcc.gov.pk/downloads.php The media tool kit has a section on SLT, however, there are no
particular references to minors.
• None.
Employment of children
act, 1991a
http://www.na.gov.pk/uploads/documents/
1335242011_887.pdf
• Section 3. Prohibition of Employment. “No child shall be employed
or permitted to work in any of the occupations set forth in Part I of
the Schedule or in any workshop wherein any of the processes set
forth in Part II of that Schedule is carried on:
Tobacco processing and manufacturing including niswarc and
bidib making.” Is mentioned as one of the processes (part II)
where child employment is illegal.
• None
• Children under 14 years of age are not
allowed to be involved in processing or
manufacturing of tobacco.
The Khyber Pakhtunkhwa
Prohibition of Employment
of Children Act, 2015 (Act
No. XIX of 2015).
http://www.pakp.gov.pk/2013/acts/
the-khyber-pakhtunkhwa-prohibition-of-
employment-of-children-act-2015/
• Section 3. Prohibition of employment.
“(1) No child shall be employed or permitted to work in any
establishment:
Provided that a child not below the age of 12 years may be
engaged in the light work, alongside his family member, for a
maximum of two hours per day mainly for the purpose of
acquiring skills, in a private undertaking, or in any school established,
assisted or recognized by Government for such purpose.
(2) No adolescent shall be employed or permitted to work in any
hazardous work included in the Schedule”.
The above mentioned “Schedule” includes “Tobacco processing
and manufacturing including Niswar and bidi making”.
• No children or adolescent is allowed to work
in tobacco processing and manufacturing.
Khan
Tobacco
Induced
D
iseases
 (2016) 14:36 
Page
3
of
5
Table 1 Smokeless tobacco control and minors in Pakistan (Continued)
Shops and Establishments
Ordinance 1969
http://www.ilo.org/dyn/travail/docs/
1008/West%20Pakistan%20Shops%20
and%20Establishments%20
Ordinance%201969.pdf
Section 20. Prohibition of employment of children. “No child shall be
required or allowed to work in any establishment”
Section 7. Opening and closing hours of establishments
“Except with the permission of Government, no woman or young
person shall be employed in any establishment otherwise than
between the hour of 9–00 a.m. to 7:00 p.m”.
Children under 14 years are not allowed to
work in any establishment, which may also
include tobacco sale shops.
Government of Sindh
Resolution, PAS/Legis-R-202/
2016/734-A
http://www.pas.gov.pk/index.php/
mediacenter/ntf/en/31/1404
Resolution- “This Assembly resolves that Provincial Government
impose ban on import, sale and purchase of beetal nut & Gutka in
the entire Province of Sindh. According to medical statistics
chewing Gutka is injurious to health and is pre-cancerous”.
• Selective ban on SLT i.e., Gutkac only.
aAmended version (via SRO 387)
bHand rolled cigarettes comprising of tobacco wrapped in a plant leaf
cDifferent forms of SLT
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official documents of the Tobacco Control Cell of
Pakistan. The “shops and establishments act” is also aimed
at children under the age of 14, prohibiting them to work
in any establishment. Again the word “establishment” is
not clearly defined in the ordinance and may or may not
be applicable to shops where tobacco is sold.
From these findings it is evident that there are gaps re-
garding children and particularly “adolescents”, in the
SLT control policies of Pakistan. Adolescence is consid-
ered one of the most vulnerable age groups for tobacco
uptake and therefore shall be one of the primary targets
of a tobacco control policies and interventions [18].
From the review of the official documents of the
Government of Pakistan, we can also infer that most of
the focus is on the supply side i.e., manufacture and sale
of tobacco products, with no legislations regarding the
demand side i.e., Possession, use, and purchase (PUP) of
tobacco products by minors. Sufficient evidence exists
that PUP laws aimed at reducing access to tobacco prod-
ucts are an effective adjuvant to any tobacco control
measures [19].
Conclusions and policy implications
From the results and discussion we can conclude that a
differential focus with regards to smoking and smokeless
tobacco products exists in the current tobacco control
policies in Pakistan. There is also some evidence that the
tobacco industry as well as some part of the scientific
community suggest SLT use as means of harm reduction
[20], which might lead to an increase in the uptake of
SLT products in Pakistan. As such, this warrants a non-
differential focus on both smoking as well as SLT prod-
ucts from the Government of Pakistan and calls for fash-
ioning of legislative measures, aimed to curb both the
sale and consumption of SLT products among minors.
Some of the gaps identified above are technical and
others need more explicit explanation or clarification.
The sale and consumption of SLT by minors has not
been adequately and explicitly addressed in the relevant
legislation. The supporting laws in tobacco control e.g.,
“Employment of children act”, may need revisions and
must also address adolescents.
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had a high concentration of biochemical 
agents that are labelled as carcinogenic 
to humans by the International Agency 
for Research on Cancer.
 In the light of these findings, we 
reviewed the various tobacco control 
policy documents in Pakistan to identify 
areas which could be strengthened to 
curb SLT use in the country. The analysis 
of the three tobacco control ordinances 
i.e. “Cigarettes (Printing of Warning) Or-
dinance”-1979 ,”Prohibition of Smoking 
and Protection of Non- smokers Health 
Ordinance No. LXXIV” -2002, “The 
Cigarette (Printing of Warning) (Amend-
ment) Ordinance No. LXXV”-2002, and 
the related statutory regulation led us to 
the following conclusions:
• Smoking tobacco is the main emphasis 
of tobacco control in Pakistan.
• Any references to SLT are at best, 
vague.
• There are no provisions to regulate 
the manufacture of SLT products.
• Health warnings on the packaging do 
not apply to SLT products.
• Only cigarettes and smoking tobacco 
products, are prohibited to be sold to 
and by minors.
 The biggest point of concern among 
these conclusions is the sale of SLT, to and 
by minors. Although it can be argued that 
the article 5 of the 2002 ordinance on 
prohibition of smoking which prohibits 
tobacco use inside and in the vicinity of 
Public buildings as well as educational 
institutions, includes minors, a counter 
argument can be made that “use” does 
not entail “sale”. The only official doc-
ument from the current day Pakistan 
which forbids the consumption of SLT by 
a minor can be dated back to 1959, when 
the Princely State of Swat (Not a part of 
Pakistan at the time), by the decree of 
1? PhD Scholar, Leibniz  Institute for 
Prevention Research and Epidemiol-
ogy-BIPS GmBH, Achters 30,28359, 
Bremen, Germany
 Ph: 004917661881594
 E-mail: khan@bips.uni-bremen.de
The oxford medical companion is a very useful resource to have in 
the arsenal of any health professional 
dealing with illness and disease. But 
perhaps one of its greatest contribution 
to public health has been its description 
of tobacco. A medicinal herb to some 
and a recreational drug for others, the 
Oxford Medical Companion describes 
tobacco as“...tobacco is the only legally 
available consumer product which kills 
people when it is used entirely as intend-
ed”.1 Tobacco kills one person every six 
seconds.2 Tobacco killed more people in 
the 20th century than the two world wars 
combined and if the current trends of 
tobacco consumption continue, it will be 
responsible for more than a billion deaths 
by the end of the 21st century.3
 Recent estimates suggest that more 
than 250 million people in South Asia 
use smokeless tobacco (SLT) products4 
and Pakistan is no stranger to these 
products with 13.3% of the population 
using either Naswar, Paan, Gutkha and 
other SLT products.3 Naswar use is a 
major public health challenge in Khyber 
Pakhtunkhwa, where an estimated 15% 
of the province’s population is addicted 
to this mixture of tobacco, ash and lime.5 
Naswar use is associated with a variety 
of conditions including upper aerodiges-
tive tract cancers, cardiovascular and 
gastrointestinal disease.6 Oral cancer 
has become the most common cancer 
among men and the second most com-
mon cancer among women in Pakistan. 
An estimated 6000 Pakistanis lose their 
lives to oral cancer every year.7 Studies 
from Karachi show that Naswar is a ma-
jor player in the etiology of oral cancer 
in Pakistan.8,9
 As part of a doctoral research, the au-
thor has recently concluded a multi-cen-
ter case control investigation into the risk 
of oral cancer associated with Naswar 
use in Khyber Pakhtunkhwa. It was the 
first adequately powered epidemiological 
study to assess this causal association in 
the context of the province. The results 
of our study, which have been submit-
ted for publication elsewhere, suggest 
a strong causal association between 
Naswar use and oral cancer in Khyber 
Pakhtunkhwa. Users of Naswar were 
20 times more likely to develop oral 
cancer compared to non-users. We also 
observed a dose-response relationship 
between Naswar and oral cancer i.e. 
the risk of oral cancer increased with 
increasing frequency, duration of each 
use and the total duration of the habit. 
One of the most striking findings of our 
study was that if Naswar use was stopped 
in the Khyber Pakhtunkhwa, there will be 
a 70% decline in oral cancer incidence 
in the province. The results of our study 
are supported by the findings of a bio-
chemical analysis of 30 brands of Naswar 
use in Khyber Pakhtunkhwa reported 
by Zakiuallh et al.6 They concluded that 
Naswar available in the Pakistani market 
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the Wali-e-Swat, levied a punishment 
and a monetary fine on the use and sale 
of Naswar, to and by minors. This de-
cree was absolved when Swat acceded 
to Pakistan in 1969. There are other 
federal legislations e.g. “Employment of 
children act, 1991” and the “Shops and 
Establishments Ordinance, 1969”, which 
prohibit children under 14 years of age, 
from working in certain occupations, 
which could potentially include manu-
facture and/or sale of smokeless tobacco 
products, but the only tobacco product 
mentioned explicitly in these documents 
is “Bidi” , a form of local cigarette. 
Another argument can be put forward 
that “Minors” are defined as “a person 
who is below the age of 14” in Pakistani 
law and hence adolescents between the 
age of 14 and 18 are exempted from all 
the articles pertaining to minors. To its 
credit though, the 2015 provincial act 
of Khyber Pakhtunkhwa, “The Khyber 
Pakhtunkhwa Prohibition of Employment 
of Children Act, 2015 (Act No. XIX of 
2015)”, does explicitly prohibits children 
to work in tobacco manufacturing. 
 The Khyber Pakhtunkhwa Govern-
ment is currently in the process of devis-
ing a new tobacco control legislation for 
the province. Based on our study findings 
and the review of policy documents, fol-
lowing recommendations are proposed 
to be addressed in the new legislation.
i. First and foremost, “Smokeless 
Tobacco” is a recognized term by 
the World Health Organization and 
hence should be used as such, rather 
than vague terminologies like “other 
tobacco”, which can be misleading 
and may be misinterpreted.
ii. The use of smokeless tobacco, 
explicitly citing “Naswar”, shall be 
prohibited in public places, offices 
and educational institutions, akin to 
the prohibition of tobacco smoking.
iii. Sale of all forms of tobacco (smoking 
and smokeless), to and by a person 
who is younger than 18 years of age 
shall be prohibited.
iv. Health warnings should be made 
mandatory on Naswar packaging.
v. As opposed to an absolute ban on 
Naswar, the Government should try 
to introduce regulatory legislation 
regarding the composition of Naswar. 
The content of carcinogenic agents in 
Naswar could be reduced using the 
“Swedish Snus” model.
vi. These policy provisions should be 
supplemented with media and school 
campaigns on the deleterious effects 
of Naswar.
 These changes in policy are necessary, 
particularly in the wake of soaring ciga-
rette prices and the absence of evidence 
based advocacy regarding SLT use. The 
easy availability and considerably lower 
prices of SLT like Naswar may lead to 
more people taking up these products as 
alternatives to smoking. A differential fo-
cus on smoking and SLT could potentially 
prove counterproductive in the long run, 
a drop in smoking may be accompanied 
by an increase in SLT products use, as 
has been seen in Sweden.10 A compre-
hensive approach, including targeting 
both smoking and smokeless tobacco 
use, is therefore needed to avoid this 
scenario. At the same time legislation 
regarding the contents of Naswar and 
the regulation of its production need to 
be fashioned. In the authors view, the 
policy considerations that have been 
recommended, would ensure a gradual 
decline in the prevalence of SLT habits in 
Khyber Pakhtunkhwa, as well as reducing 
its potential toxicity. This could ultimately 
lead to a lower tobacco related morbidity 
and mortality, which should be the prima-
ry goal of any tobacco control program 
and policy.
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Lifestyle questionnaire “Cases” 
 
 
1. Identification number |__|      |__|__|__| 
                                       Centre   Person number 
 The identification number is composed of the values for centre and person number. 
 Person numbers are consecutive numbers within each centre and should not include the 
identifier of case or control status. 
 
2.  General guidelines 
 
 
? The columns should be filled in justified to the right e.g., valid |    |  1|  2| , not valid |  1|  2|  
? Leave blank if question is not asked or not applicable. 
? Avoid missing or unknown codes; insist to get an answer even if it is only estimation.  
? If you do not succeed in getting an answer or estimation, the columns should be filled in 
with 9.  
? When “specify” is written, note your answer on the uninterrupted line.  
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Good morning. 
 
My name is ....................... and first of all I would like to thank you for agreeing to 
participate in this study. We are conducting a study in order to clarify if certain 
characteristics and habits of men and women are related to certain diseases. For 
this purpose, we will interview many patients attending this and other hospitals. 
 
If you agree, I will ask you several questions and the answers will be recorded on 
this form. I would like to reassure you that all that is said during the interview will be 
strictly confidential and that the information collected from several hundreds of 
people will only be used in scientific reports without any personal name or 
identifiers being mentioned.  
 
Any likely benefits of the study for the well-being of the population rely on the 
accuracy of your answers. Therefore, if you do not understand the meaning of any 
of the questions, please don’t be afraid to ask. At any time you may refuse to 
continue or to answer specific questions.  
  
Before starting, I invite you to carefully read the enclosed acceptance form and to 
sign it. I will be happy to explain to you any detail regarding the study before you 
decide to sign the form. By signing the form, you accept to participate in this 
research: the acceptance as well as the refusal to participate, however, will have 
no consequence on the medical acts related to your current disease. 
 
Can we start now? 
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Name__________________________________________________________ 
 
Date of Interview      d_d_/ m m / y_ e_ a_ r_ 
 
Interview start time ________________________________________________ 
 
Interview end time_________________________________________________ 
 
Informed consent attached     □??
 
Clinical records checked                □ 
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A.  Personal Data 
 
A.1. Age_____________ (In Years) ,                        D.O.B d_d_/ m m / y_ e_ a  r_(Optional) 
 
A.2. Sex            |__| 
 
(1) Male     
(2) Female     
(3) Other    
 
A.3. Address 
House # ______________________________________________________ 
Street / Mohalla / Village__________________________________________ 
District________________________________________________________ 
 
A.4. For how long have you been living at this address?      |__|  
(1) ≥ 1 year  
(2) < 1 year  
 
A.5. Which country were you born in?        |__| 
(1) Pakistan  
(2) Afghanistan   
(3) If other specify _______________________________________________ 
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A.6. What is your ethnic origin?        |__| 
      
(1) Pashtun   
(2) Hindkowi    
(3) Persian      
(4) Muhajir      
(5) Chitrali       
(6) Other  (Specify)____________________________________________________     
 
A.7. What is your religion?         |__|  
(1) Muslim    
(2) Christian   
(3) Hindu    
(4) Sikh    
(5) Parsi    
(6) Other (Specify) 
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B. Oral cancer history (To be crosschecked / filled with the help of clinical report, The 
questions requiring checking of clinical records should be dealt with at the 
beginning or the end of the interview).  
 
B.1. Date of definitive diagnosis (Or date of return of biopsy) d_d_/ m m / y_ e_ a_ r_ 
 
B.2. Site of tumor according to definitive diagnosis     |__| 
1. Upper Lip 
2. Lower Lip 
3. Gums 
4. Tongue 
5. Floor of the mouth 
6. Soft Plate 
7. Hard Palate 
8. Oro pharynx 
9. Buccal mucosa 
10. Others (Specify) 
B.3. Tumor Stage at time of diagnosis (If available in records)    |__| 
(1) Stage 0   
(2) Stage I   
(3) Stage II   
(4) Stage III   
(5) Stage IVA   
(6) Stage IVB   
(7) Stage IVC  
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B.4. Can you recall when did you became aware of your condition              d_d_/ m m / y e a r 
1. Can you recall when did you first consult a health provider for this condition (date)            
d_d_/ m m / y_ e_ a_ r_ 
B.5. Which healthcare provider did you consult first for this condition?    |__| 
(1) Dentist 
(2) Medical Practitioner 
(3) Others (Specify)________________________________ 
B.6. What course of action did the health provider take?             |__| 
(1) Referral  
(2) Biosy         
(3) Treatment and follow up  
(4) Other (Specify) _____________________________________________________ 
1. When did you first report to a Maxillofacial/ENT deptt  (Date, verbal and from record)          
d_d_/ m m / y_ e_ a_ r_ 
B.7. When was the Biopsy taken (Date, verbal and from record)         d_d_/ m m / y_ e_ a_ r_ 
 
B.8. What treatment is planned (Ascertain from clinical records and mark as many as apply) 
|__| 
(1) Surgery              
(2) Chemo therapy            
(3) Radio Therapy             
(4) Other (Specify)_______________________________________________________ 
B.9. When will this Treatment start (Date, verbal and from record) d_d_/ m m / y_ e_ a_ r 
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C. Socioeconomic status  
C.1. How many household members are 13 years old or younger?    |__| 
(1) Five or more   
(2) Four   
(3) Three   
(4) Two   
(5) One   
(6) None 
  
C.2.  How many children ages 5 to 13 attend school?      |__| 
(1) Not all   
(2) All, or no children ages 5 to 13   
 
C.3. How many household members work in elementary occupations (not senior officials, 
managers, professionals, technicians or associated professionals, clerks, salespeople, 
service or shop workers, skilled workers in agriculture or fishery, craft or trade workers,  or 
plant/machinery operators)?        |__| 
(1) Two or more   
(2) One   
(3) None   
  
C.4. What is the highest educational level  completed by the female head/spouse? |__| 
(1) Less than Class 1 or no data 
(2) No female head/spouse   
(3) Class 1 or higher   
Study I.D    __ / _ _ _  
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C.5.  What is the main source of drinking water for the household?    |__| 
(1) Others  
(2) Hand pump, covered/closed well, motorized pump/tube well, or piped water   
 
C.6.  What type of toilet is used by your household?     |__| 
(1) None or other  
(2) Flush connected to pit/septic tank or open drain   
(3) Flush connected to public sewerage  
  
C.7.  Does the household own a refrigerator or freezer?      |__| 
(1) No  
(2) Yes   
 
C.8. Does the household own a television?       |__| 
(1) No   
(2) Yes   
 
C.9.  Does the household own a motorcycle, scooter, car, or other vehicle?   |__| 
(1) No  
(2) Yes  
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D. Oral Hygiene and Oral Health 
 
D.1. How often do you clean your teeth (Think about one year ago)?    |__| 
 (0) Never  
 (1) Less than once a week (5) 2 times a day 
 (2) 1 to 2 times a week (6) 3 times a day 
 (3) Every other day (7) more 3 times a day 
 (4) Once a day 
 
D.2. Which of the following do you use to clean your teeth? (These may not be mutually  
exclusive)                                                                           |__| 
 
(1) Tooth brush   
(2) Dental floss   
(3) Toothpaste   
(4) Other (specify)_________________________________________________________   
 
D.3. Do you wear a denture?   |__| 
 
(1) Yes ► D.4. 
(2) No ► D.7. 
 
 
 
 
Study I.D    __ / _ _ _  
11 
. 
Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH, Achter St. 30, 28359 
Bremen, Germany 
D.4. If yes, in the upper jaw do you wear?   |__| 
(1) Full denture 
(2) Partial denture 
(3) No denture 
 
D.5. In the lower jaw do you wear?   |__| 
(1) Full denture,  
(2) Partial denture,  
(3) No denture 
 
D.6.  At which age did you start wearing dentures?  |__|__|. 
 
D.7.  Did your gums bleed when you clean your teeth? |__| 
(1) No 
(2) Sometimes;  
(3) Always or almost always 
 
D.8. Have you ever felt that your teeth are shaky?  |__| 
(1) Yes         
(2) No 
D.7. How often do you visit a dentist?                        |__|          
(1) Once an year 
(2) Twice an year 
(3) Only when there is a need 
(4) Never 
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D.8. Have you ever been diagnosed with an oral disease?  |__| 
(1) Yes 
(2) No  
 
D.9. If yes, can you specify what it was?__________________________________________ 
 
D.10. Have you ever experienced trauma inside your mouth?      |__| 
(1) Yes  
(2) No   
D.11. If yes, do you remember when (year)? |__|__||__|__| 
 
 
D.12. Did the condition resolved by itself or did you seek any medical help for it?  |__| 
(1) Resolve  
(2) Help  
 
D.13. Did the condition resolve after you sought medical help?   |__| 
(1) Yes  
(2) No  
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E. Diet and lifestyle 
 
1. How often did you consume the following foods and beverages one year ago?  
 
 Unit Food item      How many times per day, week, month, 
year? (mark one column only) 
   day week month year Never 
E1 1 portion Beef |__|__| |__|__| |__|__| |__|__| |__| 
E2 1 portion  Mutton |__|__| |__|__| |__|__| |__|__| |__| 
E3 1 portion  Poultry |__|__| |__|__| |__|__| |__|__| |__| 
E4 1 portion  Other meat  |__|__| |__|__| |__|__| |__|__| |__| 
E5 1 portion Fish |__|__| |__|__| |__|__| |__|__| |__| 
E6 1 portion Liver, Kidney, Paaye |__|__| |__|__| |__|__| |__|__| |__| 
E7 1 portion  Raw green vegetables and 
salads 
|__|__| |__|__| |__|__| |__|__| |__| 
E8 1 portion Cooked green vegetables |__|__| |__|__| |__|__| |__|__| |__| 
E9 1 portion Carrots |__|__| |__|__| |__|__| |__|__| |__| 
E10 1 portion Fresh tomatoes |__|__| |__|__| |__|__| |__|__| |__| 
E11 1 portion Pulses (peas, beans, etc.) |__|__| |__|__| |__|__| |__|__| |__| 
E12  As a summary, how often would 
you say that you ate any kind of 
vegetables (potatoes excluded)? 
|__|__| |__|__| |__|__| |__|__| |__| 
E13 1 portion Fresh fruit juices |__|__| |__|__| |__|__| |__|__| |__| 
E14 1 portion Apples or pears |__|__| |__|__| |__|__| |__|__| |__| 
E15 1 portion Citrus fruit (oranges, Kino, 
lemons) 
|__|__| |__|__| |__|__| |__|__| |__| 
E16 1 portion Bananas |__|__| |__|__| |__|__| |__|__| |__| 
E17 1 portion Melons (Water Mellon, Mellon 
etc) 
|__|__| |__|__| |__|__| |__|__| |__| 
E18 1 portion Plums, peaches, apricots (in 
season) 
|__|__| |__|__| |__|__| |__|__| |__| 
E19 1 portion Grapes |__|__| |__|__| |__|__| |__|__| |__| 
 
E20 1 portion As a summary, how often would 
you say that you ate any kind of 
fresh fruit (including fruit salads)? 
|__|__| |__|__| |__|__| |__|__| |__| 
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E21 1 cup Green Tea |__|__| |__|__| |__|__| |__|__| |__| 
E22 1 cup Black Tea |__|__| |__|__| |__|__| |__|__| |__| 
 
E23                     At what temperature did you usually drink your tea? 
                                    |__| 1 very hot     |__| 2 hot        |__| 3 warm 
 
E24 I portion How often do you use olive oil:      
  For salads? |__|__| |__|__| |__|__| |__|__| |__| 
  For cooking |__|__| |__|__| |__|__| |__|__| |__| 
 
E25  Do you use vegetable oil or ghee for cooking?      |__| 
(1) Ghee 
(2) Vegetable oil 
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F. Substance Usage 
 
F.1. Do you or did you ever smoke cigarettes, at least once a week for a year?     |__| 
(1) Yes, still  
(2) Only in the past (stopped at least 12 months ago) 
(3) Never ►F2 
 
First period:  
a) At what age or in 
what year did you 
first start 
smoking 
cigarettes? 
c) Which type of 
cigarettes did you 
mostly smoke?   
d) How many 
cigarettes did 
you smoke? 
(per day or per 
week)  
e) Did you continue 
to smoke in this way 
or did you stop or 
change your 
smoking habits 
substantially 
anytime? 
f) When was that? 
(Probing: At which 
age or in which year 
did you stop smoking 
or change your 
smoking habits?) 
 
g) (If stopped) 
Did you ever start 
smoking 
cigarettes again 
subsequently? 
     (age)  or (year) (1)Manufactured with 
filter  
(2)Manufactured 
without filter  
(3)Hand-rolled 
 
 |__| 
per 
day    or  
week 
(1) no change► F2 
(2) stopped ►f 
(3) changed►f 
 
 
  
|__| 
(age) or (year) yes► a next period 
no►F2 
 
 
|__|__|  or  |__|__|__|__| 
 
 
|__|__|  or 
|__|__|  
 
 
|__|__| or 
|__|__|__|__| 
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Subsequent periods: 
a) When did you begin 
smoking again or 
change to smoking a 
different amount or 
different product? 
(Probing: ...at which age 
or in which year was 
that?) 
c) Which type of 
cigarettes did you 
mostly smoke? 
d) How many 
cigarettes did 
you smoke? 
(per day or per 
week)  
e) Did you continue 
to smoke in this way 
or did you stop or 
change your 
smoking habits 
substantially 
anytime? 
f) When was that? 
(Probing: At which 
age or in which year 
did you stop smoking 
or change your 
smoking habits?) 
 
g) (If stopped) 
Did you ever start 
smoking 
cigarettes again 
subsequently ? 
 
 
 
|__|__|  or |__|__|__|__| 
(1)filter                
(2)non-filter (3)hand-
rolled 
  
|__| 
 
 
 
|__|__|  or 
|__|__|  
(1) no change ►F.2. 
(2) stopped ►f 
(3)changed►f   
 |__| 
 
 
 
|__|__| or 
|__|__|__|__| 
 
yes► a next period 
no►F.2. 
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F.2. Do you or did you ever smoke Cheelum/Hukkah at least once a week for a year?     |__| 
                  (1) still  
(2) Only in the past (stopped at least 12 months ago) 
(3) Never ►F.3. 
 
 
First period:  
(a) At what age 
or in what year did you first 
start smoking Cheelum? 
d) How many 
cheelums did you 
smoke? 
(per day or per week)  
e) Did you continue 
to smoke in this way 
or did you change 
your smoking habits 
substantially at 
anytime? 
f) When was that? 
(Probing: At which age or 
in which year did you stop 
smoking or change your 
smoking habits ?) 
 
g) (If stopped) 
Did you ever start 
smoking Cheelum 
again subsequently ? 
     (age)  or (year) per 
day    or    week 
(1) no change ►F.3. 
(2) stopped ►f 
(3)changed►f          
|__| 
(age) or (year) yes► a next period 
no►F.3. 
|__|__|  or  |__|__|__|__| |__|__|  or |__|__|  |__|__| or |__|__|__|__| 
Subsequent periods: 
a) When did you begin 
smoking again or change to 
smoking a different amount 
or different product? (Probing: 
...at which age or in which year 
was that?) 
d) How many 
Cheelum did you 
smoke? 
(per day or per week)  
e) Did you continue 
to smoke in this way 
or did you change 
your smoking habits 
substantially 
anytime ? 
f) When was that? 
(Probing: At which age or 
in which year did you stop 
smoking or change your 
smoking habits ?) 
 
g) (If stopped) 
Did you ever start 
smoking Cheelum 
again subsequently ? 
|__|__|  or |__|__|__|__| |__|__|  or |__|__|  (1) no change ►F.3. 
(2) stopped ►f 
(3)changed►f          
|__| 
 |__|__| or |__|__|__|__| 
 
yes► a next period 
no►F.3. 
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F.3. Do you or did you ever used Paan at least once a week for a year? |__| 
(1) Yes, still 
(2) Only in the past (stopped at least 12 months ago) 
(3) Never ►F.4. 
First period:  
a) At what age or in 
what year did 
first start paan? 
b) Which type of paan 
did you mainly take? 
 
d) How many 
paans? 
(per day or per 
week)  
e) Did you continue to 
use in this way or did 
you stop or change 
your eating habits 
substantially anytime? 
f) When was that? 
(Probing: At which 
age or in which year 
did you stop using 
paan or change 
your paan habits?) 
 
g) (If stopped) 
Did you ever start 
paan again 
subsequently? 
     (age)  or (year) (1) With tobacco 
(2) Without tobacco 
per 
day    or  
week 
(1) no change ►F.4. 
(2) stopped ►f 
(3) changed► f    
                               |__| 
(age) or (year) yes► a next period 
no►F.4. 
|__|__|  or  |__|__|__|__|  
|__| 
|__|__|  or 
|__|__|  
|__|__| or 
|__|__|__|__| 
Subsequent periods: 
a) When did you begin 
paan again or change 
to different amount or 
different product? 
(Probing at which age 
or in which year was 
that?) 
b) Which type of paan 
did you mainly use? 
 
(1) With tobacco 
(2) Without tobacco 
d) How many 
paans did 
you take? 
(per day or per 
week)  
e) Did you continue to 
take paan in this way 
or did you stop or 
change your paan 
eating habbit 
substantially anytime? 
f) When was that? 
(Probing: At which 
age or in which year 
did you stop paan?) 
 
g) (If stopped) 
Did you ever start 
paan again 
subsequently? 
 
 
|__|__|  or |__|__|__|__| 
 
 
 
|__| 
 
 
|__|__|  or 
|__|__|  
(1) no change ►F.4. 
(2) stopped ►f 
(3)changed►f       |__| 
 
 
|__|__| or 
|__|__|__|__| 
 
 
yes► a next period 
no►F.4. 
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F.4. Do / did you you ever take Naswar at least once a week for a year? |__| 
(1) Yes, still  
(2) Only in the past (stopped at least 12 months ago) 
(3) Never ►G 
First period:  
a) At what 
age or 
in what 
year did 
first 
start 
using 
Naswar
? 
b) Which site of 
the Mouth you 
generally used to 
put Naswar in? 
Which Quadrant 
 
c) What 
is/was 
the 
average 
duration 
of each 
dip? 
d) Which 
type of 
Naswar 
did you 
mostly 
use? 
e) How 
many 
units 
did you 
dip? 
(per 
day or 
per 
week)  
f) What did/ 
do you do 
with saliva 
coming into 
mouth? 
g) Did you 
continue to 
use in this way 
or did you 
stop or 
change your 
use habits 
substantially 
anytime? 
h) When was 
that? 
(Probing: At 
which age or 
in which year 
did you stop 
using or 
change your 
usage habits?) 
 
i) (If stopped) 
Did you ever 
start naswar 
use again 
subsequently? 
(age)  or (year) (1) Upper Right 
(2) Upper Left 
(3) Lower Right 
(4) Lower Left 
Time in 
mins 
(1)Black 
Moist (2) 
Black Dry 
(3) Green 
Moist 
(4) Green 
Dry 
(5) Other 
 
|__| 
per 
day    
or    
week 
(1)Spit 
(2)Swallow 
(3)Both 
(1) no change 
►G 
(2) stopped ►h 
(3) changed►h   
                           
 
 
 
|__| 
(age) or 
(year) 
yes► a next 
period 
no►G 
 
 
 
|__|__|  or  
|__|__|__|__| 
 
 
 
|__| 
if more than one 
|__||__||__||__| 
 
 
 
 
 
|__|__| 
 
 
|__|__|  
or 
|__|__|  
 
 
 
 
|__| 
 
 
 
|__|__| or 
|__|__|__|__| 
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Subsequent 
period:  
a) At what 
age or 
in what 
year did 
first 
start 
using 
Naswar
? 
b) Which site of 
the Mouth you 
generally used to 
put Naswar in? 
Which Quadrant 
 
c) What 
is/was 
the 
average 
duration 
of each 
dip ? 
d) Which 
type of 
Naswar 
did you 
mostly 
use? 
e) How 
many 
units 
did you 
dip? 
(per 
day or 
per 
week)  
f) What did/ 
do you do 
with saliva 
coming into 
mouth? 
g) Did you 
continue to 
use in this way 
or did you 
stop or 
change your 
use habits 
substantially 
anytime? 
h) When was 
that? 
(Probing: At 
which age or 
in which year 
did you stop 
using or 
change your 
usage habits?) 
 
i) (If stopped) 
Did you ever 
start naswar 
use again 
subsequently? 
(age)  or (year) (1) Upper Right 
(2) Upper Left 
(3) Lower Right 
(4) Lower Left 
Time in 
mins 
(1)Black 
Moist (2) 
Black Dry 
(3) Green 
Moist 
(4) Green 
Dry 
(5) Other 
 
 |__| 
per 
day    
or    
week 
(1)Spit 
(2)Swallow 
(3)Both 
(1) no change 
►G 
(2) stopped ►h 
(3) changed►h   
                           
 
 
 
|__| 
(age) or 
(year) 
yes► a next 
period 
no►G 
 
 
 
|__|__|  or  
|__|__|__|__| 
 
 
 
|__| 
if more than one 
|__||__||__| 
 
 
 
 
 
|__|__| 
 
 
|__|__|  
or 
|__|__|  
 
 
 
|__| 
 
 
 
|__|__| or 
|__|__|__|__| 
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G. DRINKING HABITS 
 
 
G.1. Have you ever drunk alcoholic beverages?  |__|   
(1) Yes ► G.2. 
(2) No  ► H 
 
G.2.  If yes how frequently did you drink alcoholic beverages one year ago?  |__|   
 (1) Every day 
 (2) Most days but not every day 
(3) 1 to 3 times per week 
 (4) More than once per month & less than once per week 
(5) Less than once per month 
 
G.3. Regarding your normal drinking habits one year ago, when did you normally drink?       |__|
  
(1) With meals 
(2) Between meals 
(3) Both  
 
G.4. Have you ever in your lifetime drank large amounts of alcohol in a short period of time, (eg 
more than 10 drinks in a couple of hours)?  |__|   
(1) Yes 
(2) No 
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G.5. If yes how often did you do this?  |__|   
(1) Every day 
(2) 4 to 6 times per week 
(3) 1 to 3 times per week 
(4) More than once per month & less than once per week 
(5) Less than once per month 
 
G.6. From what age did you do this?  |__|__|   to what age ? |__|__| 
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H. Systemic Health 
H.1. Throughout your life, have you ever had skin warts/ veruccae (Picture) ?  |__|   
(1) Yes ►Next part of the question 
(2) No;  
(3) Don’t know [if ‘No’ or “don’t know” go to H.2.] 
 
If ‘Yes’, where?  |__|   
(1) Hands   
(2) Feet  
(3) Head & Neck   
(4) Other (specify) ___________________________________________________________  
 
H.2. Throughout your adult life, have you ever had Candida Albicans/ thrush? (Explanation with 
pictures)  |__|   
(1) Yes ►Next part of the question 
(2) No 
(3) Don’t know [if ‘No’ or “don’t know” go to H.3.] 
 If ‘Yes’, where?  |__|   
(1) Genitals   
(2) Mouth   
(3) Other (specify) __________________________________________________  
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H.3.  Have you ever had herpetic lesions (cold sore)? (Picture explanation)  |__|   
(1) Yes ►Next part of the question 
(2) No 
(3) Don’t know [if ‘No’ or “don’t know” go to H.4.] 
If ‘Yes’, where?  |__|   
(1) Lip  
(2) Genitals  
(3) Other (specify) ____________________________________________________  
 
H.4.    Have you ever had heartburn?  |__|   
(1) Yes ►Next part of the question 
(2) No 
 [If ‘No’ go to H7]  
If yes, how frequently?  |__|   
(1) At least once a day 
(2) 2 to 6 times per week 
(3) Once per week 
(4) Less than once per week 
 
H.5. At what age did you first begin suffering from heartburn?  |__||__|   
 
H.6. Do you take or have you taken medication for heartburn?  |__|            
(1) Yes;  
(2) No 
If yes which (name of medicine)__________________________________________________ 
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H.7.  Do you ever suffer from regurgitation? |__| 
(1) Yes ► H.8. 
 (2) No ► H.10. 
If yes, how frequently? |__| 
(1) At least once a day 
(2) 2 to 6 times per week 
(3) Once per week 
(4) Less than once per week 
 
H.8. At what age did you first begin suffering from regurgitation?  |__||__|   
 
H.9. Do you take or have you taken medication for regurgitation?  |__|   
(1) Yes 
(2) No 
If yes which _________________________________________________________ 
 
H.10. Have you ever taken aspirin regularly (at least once a week for a year)?     
(1) Yes 
(2)   No 
  If yes,  from age |__|__| to age|__|__| 
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I. Sun Exposure 
Think of your exposure to direct sunlight during the past 1 year, and respond regarding a typical 
week 
 
I.1. Usually, how many days in a week did you go out in the sunlight during the daytime? |__| 
 
(1) One 
 
(2) Two 
 
(3) Three 
 
(4) Four 
 
(5) Five 
 
(6) Six 
 
(7) seven 
 
 
 
I.2. Usually, between 9 am-4 pm, what was the average amount of time (hours) spent outdoor in 
the sunlight in a typical day?         |__| 
 
(1) One 
 
(2) Two 
 
(3) Three 
 
(4) Four 
 
(5) Five 
 
(6) Six 
 
(7) seven 
 
 
I.3. How much of your head and neck was generally covered during outdoor hours (between 9 
am - 4 pm)?           |__| 
 
(1) Head  
 
(2) Face 
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(3) Neck 
 
I.4. Were any of these a part of your attire during outdoor hours (between 9 am- 4 pm)?         |__| 
 
(1) Jelbaab/abaya/Burka____________________________ 
 
(2) Niqab________________________________________ 
 
(3) Pagree_______________________________________ 
 
(4) Other (specify)_________________________________ 
 
 
 
 
 
 
 
Dear Mr / Ms _________________________________, Thankyou very much for your 
cooperation, we are done now with the interview. We hope the valuable information that we got 
from your interview will be very useful for us in identifying potential causes for oral cancer in this 
population and help in its prevention. 
 
 
 
 
 
 
 
 
 
 
Signature Interviewer _____________________________ 
 
Date and place__________________________________ 
 
 
Signature Field Coordinator (After checking for completeness)_______________________ 
 
Date and place__________________________________ 
 
 
Signature Data entry Operator______________________ 
 
Date and place__________________________________ 

                                                                                                                             Study I.D _ _ / _ _ / _ _ _ 
“Epidemiology of Oral Cancer in the Khyber Pakhtunkhwa Province” 
 Consent Form 
Zohaib Khan (Investigator), 
Prof. Dr. Hajo Zeeb (Study Supervisor), 
Prof. Dr. Wolfgang Ahrens (Co- Supervisor), 
Leibniz Institute for Prevention Research and Epidemiology (BIPS) 
Achterstrasse 30, 28359 
Bremen, Germany. 
 
Dear Sir/Madam, 
 
Thank you for taking your time to read this.  BIPS is a public sector research oriented institute 
affiliated with the University of Bremen, Germany. The principal investigator is a PhD student 
from Pakistan working at BIPS. We want to assess the role of different risk factors in the 
development of oral cancer in the Khyber Pakhtunkhwa province. For this purpose we are 
conducting a case control research study in different hospitals of the province to get information 
from people who have been diagnosed with oral cancer and also people who are not suffering 
from oral cancer, we tend to compare different habits among these two groups to come up with 
evidence regarding risk factors for oral cancer in the Pakistan in general and Khyber 
Pakhtunkhwa in specific. We hope that our study will provide evidence to inform policy for 
prevention against oral cancer. We hereby request you to spare some time for a verbal 
interview and access to your clinical record, the interview will last from 30-60 mins. Your 
consent is also needed for access to your biopsy sample, collection of 3cc of your blood and a 
sample of your oral mucosal cells through exfoliation by a tooth brush. 
 
? If you have any questions regarding the study please do not hesitate to ask the 
interviewer or contact the Principal Investigator at the given address. 
? You may refuse to answer any question  
? You may choose to stop the interview at any time 
? Your name will not be disclosed at any time during or after the study. 
? The information gained by this study will be kept confidential and used entirely for the 
purpose of improving the prevention strategies against oral cancer. 
 
Do I have your consent to proceed            Yes      No  
 
Name of Respondent: ___________________Thumb Impression  
 
 
Name of Witness: ______________________         CNIC #:    ______________________ 
 
Name of Person obtaining consent: ______________________ 
Signature:         ______________________ 
Date:          ______________________ 
Versicherung der eigenständigen 
Verfassung 
 
 
Hiermit versichere ich, dass ich die vorliegende Dissertation selbständig verfasst und 
keine weiteren als die angegebenen Quellen und Hilfsmittel verwendet habe. Alle Stellen, 
die ich wörtlich oder sinngemäß aus anderen Werken entnommen habe, sind unter 
Angabe der Quellen als solche kenntlich gemacht. 
Diese Arbeit hat in gleicher oder ähnlicher Form noch keiner anderen Prüfungsbehörde 
vorgelegen.  
 
 
________________________________   _____________________________ 
Ort und Datum      Unterschrift 
 
